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Man's liver is a brownish blob  
That does a most prodigious job. 
It manufactures gall, or bile  
And normally keeps some on file  
Stored neatly in a pear-shaped sac.  
From there the liver's yields attack  
The food man eats, to change its state  
By methods man can't duplicate,  
Or even halfway understand.  
He ought to treat this outsize gland,  
With due respect and loving care  
To keep it in top-notch repair,  
Because to get along at all 
Man needs an awful lot of gall. 
Irene Warsaw, JAMA, 1975, v. 231, p. 1260 
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The known is finite, the unknown infinite; 
intellectually we stand on an islet in the midst of an 
illimitable ocean of inexplicability.  Our business in 
every generation is to reclaim a little more land.  
- T.H. Huxley, 1887  
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 ABSTRACT 
 
ENZYMOLOGY AND MOLECULAR BIOLOGY OF BILE ACID 7α- AND 7β- 
DEHYDROXYLATION BY THE INTESTINAL BACTERIA CLOSTRIDIUM 
SCINDENS AND CLOSTRIDIUM HYLEMONAE 
 
Jason Michael Ridlon 
 
A dissertation submitted in partial fulfillment of the 
requirements for the degree of Doctor of Philosophy at the 
Virginia Commonwealth University 
 
Virginia Commonwealth University, 2008. 
 
      Director: Dr. Phillip B. Hylemon 
    Professor of Microbiology and Immunology 
    and Medicine. 
 
 The collective microbial genomes within our gut 
(microbiome) represent a powerful metabolic force, leading 
many authors to call our GI flora an “organ within an 
organ”, and the metagenomic sequencing of our microbiome, 
“the second human genome project”.  Bile acids, 
endogenously produced by the host liver, represent both a 
strong selective pressure for potential colonizers, as 
well as substrates for microbial metabolism.  Indeed, 
microbes have evolved enzymes to deconjugate bile salts, 
epimerize bile acid hydroxyl groups, and 7α-dehydroxylate 
primary bile acids.  The products of microbial 7α-
xvii
 dehydroxylation, secondary bile acids, are suggested by 
numerous lines of evidence to be involved in promoting 
colon carcinogenesis. 7α-dehydroxylating activity is a 
multi-step pathway, genes of which have only been 
identified in a small number of organisms within the genus 
Clostridium. The biochemistry of this pathway has been 
largely worked out.  The third step in the pathway is 
introduction of a Δ4-double bond; however, the gene 
product(s) responsible have not been identified.  The 
baiCD and baiH genes were cloned, expressed and shown to 
have NAD+-dependent 3-oxo-Δ4-steroid oxidoreductase 
activity showing stereospecificity for 7α-hydroxy and 7β-
hydroxy bile acid, respectively.   
 In addition, bai genes were isolated from C. 
hylemonae TN271 by bidirectional genome-walking by PCR.  
This represents the first report of bai genes from a “low 
activity” 7α-dehydroxylating bacterium.  The gene 
organization and sequence of the baiBCDEFGHI operon was 
highly conserved between C. hylemonae TN271 and the “high 
activity” 7α-dehydroxylating bacterium C. scindens VPI 
12708.  The baiA gene was located by PCR using degenerate 
oligonucleotides. Bi-directional genome-walking revealed 
what appears to be several novel genes involved in bile 
acid metabolism which were also located in C. scindens VPI 
12708.  Expression of a 62 kDa flavoprotein and reaction 
with [24-14C] 3-oxo-DCA and NADP resulted in a product of 
greater hydrophilicity than deoxycholic acid.  The 
identity of this product was not determined.  A second 
gene appears to share a common evolutionary origin with 
xviii
 the baiF gene.  A hypothesis is offered regarding the 
function of these homologues as Type III CoA transferases 
recognizing 5β-bile acids, or 5α-bile acids (allo-bile 
acids). A third gene encodes a putative short chain 
reductase, similar in size and predicted function to the 
baiA gene, which may be involved in the final reductive 
step in the pathway. These novel genes also contained a 
conserved upstream regulatory region with the bai 
oxidative genes. Finally, two genes were identified which 
may serve as potential drug targets to inhibit bile acid 
7α-dehydroxylation.  The first is an ABC transporter which 
may be co-transcribed with the other novel bile acid 
metabolizing genes, and what appears to be a bile acid 
sensor/regulator similar to the Tryptophan-rich sensory 
protein (TspO)/mitochondrial peripheral benzodiazepine 
receptor (MBR) family of proteins.   
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 INTRODUCTION 
 
 Bile salt metabolism by intestinal bacteria 
   The human large intestine harbors a complex 
microbial flora (1).  Bacterial density in the human colon 
is among the highest found in nature, approaching 1012 
bacteria/ gram wet weight feces (2, 3).  In contrast, the 
host suppresses significant bacterial colonization of the 
small intestine by a variety of mechanisms including rapid 
transit times, antimicrobial peptides, proteolytic 
enzymes, and bile (4).  Failure of these mechanisms leads 
to bacterial overgrowth of the small intestine, resulting 
in malabsorption as bacteria compete with the host for 
nutrients.  Under normal conditions, bacterial 
fermentation in the colon represents an important salvage 
mechanism.   Complex carbohydrates, which are 
intrinsically indigestible, or which escape digestion and 
absorption in the proximal gut, are fermented by colonic 
bacteria to yield short chain fatty acids.  It has been 
estimated that these short-chain fatty acids constitute 3-
9% of our daily caloric intake (4).   Colonic bacteria 
also contribute to salvage of bile salts that escape 
1
 active transport in the distal ileum.   The major bile 
salt modifications in the human large intestine include 
deconjugation, oxidation of hydroxy groups at C-3, C-7 and 
C-12, and 7α/β-dehydroxylation (Figure 1).  Deconjugation 
and 7α/β-dehydroxylation of bile salts increases their 
hydrophobicity and raises their pKa, thereby permitting 
their recovery via passive absorption across the colonic 
epithelium.   However, the increased hydrophobicity of the 
transformed bile salts also is associated with increased 
toxic and metabolic effects.  Elevated concentrations of 
secondary bile acids in feces, blood and bile have been 
linked to the pathogenesis of cholesterol gallstone 
disease and colon cancer (5).   The following is a current 
review of the microbiology of bile acid metabolism in the 
human gastrointestinal tract focusing on understanding the 
biochemical mechanisms and physiological consequences of 
such metabolism on both the bacterium and the human host.  
 
The enterohepatic circulation of bile acids 
Bile acids are saturated, hydroxylated C-24 
cyclopentanephenanthrene sterols synthesized from 
cholesterol in hepatocytes.  The two primary bile acids 
2
 
 
 
 
 
 
 
Figure 1.  Bacterial bile salt-biotransforming 
reactions in the human intestinal tract. 
Hydroxy group carbons of cholate are 
numbered and the AB rings are identified. 
The 3, 7, and 12 carbons of cholic acid (CA) 
are numbered. Nomenclature is that of 
Hofmann et al. (160). BSH, bilesalt 
hydrolase; HSDH, hydroxysteroid 
dehydrogenase. 
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 synthesized in the human liver are cholic acid (CA) (3α, 
7α, 12α-trihydroxy-5β-cholan-24-oic acid) and 
chenodeoxycholic acid (CDCA) (3α, 7α-dihydroxy-5β-cholan-
24-oic acid).  Bile acids are further metabolized by the 
liver via conjugation (N-acyl amidation) to glycine or 
taurine, a modification that lowers the pKa to around 5. 
Thus, at physiological pH, conjugated bile acids are 
almost fully ionized, and may be termed bile salts (6). 
Bile salts are secreted actively across the canalicular 
membrane and are carried in bile to the gallbladder where 
they are concentrated during the inter-digestive period. 
Following a meal, release of cholecystokinin from the 
duodenum stimulates the gallbladder to contract, causing 
bile to flow into the duodenum (7).  Bile salts are highly 
effective detergents that promote solubilization, 
digestion and absorption of dietary lipids, and lipid 
soluble vitamins throughout the small intestine.  High 
concentrations of bile salts are maintained in the 
duodenum, jejunum and proximal ileum, where fat digestion 
and absorption take place.  Bile salts are then absorbed 
through high-affinity active transport in the distal ileum 
(6).  Upon entering the bloodstream, bile salts are 
5
 complexed to plasma proteins and returned to the liver.  
Upon reaching the liver they are cleared efficiently from 
the circulation by active transporters on the sinusoidal 
membrane of hepatocytes and rapidly secreted into bile. 
This process is known as the enterohepatic circulation.  
Figure 2 depicts the enterohepatic circulation in the 
context of the gastrointestinal anatomy and also indicates 
the relative numbers and genera of the predominant 
bacteria inhabiting each section of the GI tract.   
During the enterohepatic circulation, bile salts 
encounter populations of facultative and anaerobic 
bacteria of relatively low numbers and diversity in the 
small bowel.  Bile salt metabolism by small bowel microbes 
consists mainly of deconjugation and hydroxy group 
oxidation.  Ileal bile salt transport is highly efficient 
(~95%), but approximately 400-800 mg of bile salts escape 
the enterohepatic circulation daily and become substrate 
for significant microbial biotransforming reactions in the 
large bowel (6). Comparison of bile acid composition in 
the gallbladder and feces illustrates the extent of 
microbial bile acid metabolism in the large intestine 
(Figure 3).  Secondary bile acids deoxycholic acid (DCA) 
6
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Anatomy, physiology, and microbiology of the 
gastrointestinal tract. Large arrows denote 
the enterohepatic circulation of bile acids, 
which begins with contraction of the 
gallbladder, releasing bile into the 
duodenum. Small arrows denote the passive 
absorption of bile acids that escape active 
transport. * Secondary bile acids produced 
by 7α-dehydroxylation are passively absorbed 
in the large intestine and returned to the 
liver (see Fig 3). The genera of predominant 
bacteria isolated from each region of the 
lower gastrointestinal tract are listed. 
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Figure 3.  Composition of bile acids in the gallbladder 
and feces of healthy individuals. ‘‘Other’’ 
bile acids refer to oxo- and 3β-hydroxy 
derivatives of secondary bile acids. Values 
were derived from published sources (6, 93, 
161, 162). CDCA, chenodeoxycholic acid; DCA, 
deoxycholic acid; LCA, lithocholic acid; 
UDCA, ursodeoxycholic acid. 
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 (3α, 12α-dihydroxy-5β-cholan-24-oic acid) and lithocholic 
acid (LCA) (3α-hydroxy-5β-cholan-24-oic acid) are produced 
solely by microbial biotransforming reactions in the human 
large intestine. DCA accumulates in the bile acid pool 
(LCA to a much lesser extent) due to passive absorption 
through the colonic mucosa and the inability of the human 
liver to 7α-hydroxylate DCA and LCA to their respective 
primary bile acids.  LCA is sulfated in the human liver at 
the 3-hydroxy position, conjugated at C-24 and excreted 
back into bile (6).  The resultant bile acid sulfate is 
poorly reabsorbed from the gut.  Even though 3-sulfo-LCA 
glycine and taurine conjugates are deconjugated and to 
some extent desulfated by intestinal bacteria, 3-sulfo-
LCA/LCA is lost in feces and does not normally accumulate 
in the enterohepatic circulation (8).   
 
Deconjugation of Bile Salts 
Characteristics of bile salt hydrolase(s) (BSH) 
Deconjugation refers to the enzymatic hydrolysis of 
the C-24 N-acyl amide bond linking bile acids to their 
amino acid conjugates.  This reaction is substrate 
limiting and goes to completion in the large bowel.  BSH 
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 are in the choloylglycine hydrolase family (EC 3.5.1.24) 
and have been isolated and/or characterized from several 
species of intestinal bacteria (Table 1).  The importance 
of the position, charge, shape, and chirality of various 
analogues of taurine/glycine conjugates on the rate of 
hydrolysis by BSH has also been investigated (9). BSH 
differ in subunit size and composition, pH optimum, 
kinetic properties, substrate specificity, gene 
organization and regulation. BSH do, however, share in 
common several conserved active site amino acids (Cys2, 
Arg18, Asp21, Asn175, and Arg228) and share a high degree 
of amino acid sequence similarity with the penicillin V 
amidase (PVA) of Bacillus sphaericus (Figure 4).  The 
conservation of Tyr82 in PVA and Asn82 in BSH are likely a 
result of differing steric requirements for their 
respective substrates (10).  Recently, a bsh from 
Clostridium perfringens has been crystallized both in the 
apo-enzyme form and in complex with TDCA (hydrolyzed 
product) at resolutions of 2.1 and 1.7 Å, respectively 
(11).  The structure revealed the Cys2 residue is in 
position for nucleophilic attack of the N-acyl amide bond. 
Site directed mutagenesis of the Cys2 residue from the BSH 
12
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Figure 4.  Multiple sequence alignment of cholylglycine 
hydrolases. Protein sequences were obtained 
from the National Center for Biotechnology 
Information (http://www.ncbi.nlm.nih.gov/). 
Alignments were made with the ClustalW 
program (http://www.ebi.ac.uk/clustalw/) 
using the GONNET 250 matrix. Residues 
highlighted in yellow are predicted active 
site amino acids based on the crystal 
structure of the BSH from C. perfringens 
(11) as well as on site-directed mutagenesis 
and biochemical data (10, 12–14). Residues 
highlighted in gray correspond to residues 
involved in substrate binding in the BSH 
from C. perfringens (11). The secondary 
structural elements, which are based on the 
conjugated bile acid hydrolase from C. 
perfringens (CBAH-1) crystal structure, are 
shown above the alignment. The a and b 
designations of Lactobacillus johnsonii 
refer to the two isoforms of the genes found 
in this bacterium. 
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Cl.perfringens M--CTGLALETKDGLHLFGRNMDIEYSFNQSIIFIPRNFKCVNKSN-KKELTTKYAVLGM 57
Li.monocytogenes M--CTSITYTTK--DHYFGRNFDYELSYKEVVVVTPKNYPFHFRK--VEDIEKHYALIGI 54
En.faecalis M--CTAITYVSK--DHYFGRNFDYEISYNEVVTITPRNYKFSFRE--VGNLDHHFAIIGI 54
La.plantarum M--CTAITYQSY--NNYFGRNFDYEISYNEMVTITPRKYPLVFRK--VENLDHHYAIIGI 54
La.gasseri M--CTSILYSPK--DHYFGRNLDYEIAYGQKVVITPKNYEFEFTD--LPAEKSHYAMIGV 54
La.johnsonii(α)  M--CTSIVYSSNN-HHYFGRNLDLEISFGEHPVITPRNYEFQYRK--LPNKKAKYAMVGM 55
Bi.longum M--CTGVRFSDDEGNTYFGRNLDWSFSYGETILVTPRGYHYDTVFG-AGGKAKPNAVIGV 57
Bi.adolescentis M--CTGVRFSDEEGNMYFGRNLDWSFSYGESILATPRGYHYDNVFG-AERKATPNAVIGV 57
Bi.bifidum M--CTGVRFSDDEGNMYFGRNLDWSFSYGETILVTPRGYQYDYEYG-AEGKSEPNAVIGV 57
La.johnsonii(β) M--CTGLRFTDDQGNLYFGRNLDVGQDYGEGVIITPRNYPLPYKF--LDNTTTKKAVIGM 56
La.acidophilus M--CTGLRFTDDQGNLYFGRNLDVGQDYGEGVIITPRNYPLPYKF--LDNTTTKKAVIGM 56
Ba.sphaericus MLGCSSLSIRTTDDKSLFARTMDFTMEPDSKVIIVPRNYGIRLLEKENVVINNSYAFVGM 60
Cl.perfringens GTIFDDYPTFADGMNEKGLGCAGLNFPVYVSYSKEDIEGKTNIPVYNFLLWVLANFSSVE 117
Li.monocytogenes AAVMENYPLYYDATNEKGLSMAGLNFSGNADYKDFAEG-KDNVTPFEFIPWILGQCATVK 113
En.faecalis AAGIADYPLYYDAINEKGLGMAGLNFSGYADYKKIEEG-KENVSPFEFIPWVLGQCSTVD 113
La.plantarum TADVESYPLYYDAMNEKGLCIAGLNFAGYADYKKYDAD-KVNITPFELIPWLLGQFSSVR 113
La.gasseri AAVADNTPLYCDAINEKGLGVAGLSFAGQGKYFPNAAD-KKNIASFEFISYLLATYETVD 113
La.johnsonii (α) AIVEDNYPLYFDASNEEGLGIAGLNFDGPCHYFPENAE-KNNVTPFELIPYLLSQCTTVA 114
Bi.longum GVVMADRPMYFDCANEHGLAIAGLNFPGYASFVHEPVEGTENVATFEFPLWVARNFDSVD 117
Bi.adolescentis GVVMADRPMYFDCANEHGLAIAGLNFPGYAEFVHEPVEGTDNVATFEFPLWVARNFDSVD 117
Bi.bifidum GVVMTDRPMYFDCANEHGLAIAGLNFPGYASFAHEPVEGTENVATFEFPLWVARNFDSVD 117
La.johnsonii (β) GIVVDGYPSYFDCYNEDGLGIAGLNFPHFAKFSDGPIDGKINLASYEIMLWVTQNFTHVS 116
La.acidophilus GIVVDGYPSYFDCFNEDGLGIAGLNFPHFAKFSDGPIDGKINLASYEIMLWVTQNFTKVS 116
Ba.sphaericus GSTDITSPVLYDGVNEKGLMGAMLYYATFATYADEPKKGTTGINPVYVISQVLGNCVTVD 120
Cl.perfringens EVKEALKNANIVDIPISENIPNTTLHWMISDITGKSIVVEQTKE-KLNVFDNNIGVLTNS 176
Li.monocytogenes EARRLLQRINLVNISFSENLPLSPLHWLMADQN-ESIVVECVKD-GLHIYDNPVGVLTNN 171
En.faecalis EAKKLLKNLNLVNINFSDELPLSPLHWLLADKE-QSIVVESTKE-GLRVFDNPVGVLTNN 171
La.plantarum EVKKNIQKLNLVNINFSEQLPLSPLHWLVADKQ-ESIVIESVKE-GLKIYDNPVGVLTNN 171
La.gasseri QVKESLTNANISNVSFAKNTPASELHWLVGDKTGKSIVVESDEK-GLHVYNNPVNALTNA 172
La.johnsonii (α)      EVKDALKDVSLVNINFSEKLPLSPLHWLMADKTGESIVVESTLS-GLHVYDNPVHVLTNN 173
Bi.longum EVEEALRNVTLVSQIVP-GQQESLLHWFIGDGK-RSIVVEQMAD-GMHVHHDDVDVLTNQ 174
Bi.adolescentis EVEEALKNVTLVSQIVP-GQQESLLHWIIGDSE-RSIVVEQMAD-GMHVHHDDVDVLTNQ 174
Bi.bifidum EVEEALKNVTLVSQVVP-GQQESLLHWFIGDGT-RSIVVEQMAD-GMHVHHDDVDVLTNQ 174
La.johnsonii (β) EVKEALKNVNLVNEAINTSFAVAPLHWIISDSD-EAIIVEVSKQYGMKVFDDKVGVLTNS 175
La.acidophilus DVKEALKNVNLVNEAINSSFAVAPLHWIISDKD-EAIIVEISKQYGMKVFDDRLGVLTNS 175
Ba.sphaericus DVIEKLTSYTLLNEANIILGFAPPLHYTFTDASGESIVIEPDKT-GITIHRKTIGVMTNS 179
Cl.perfringens PTFDWHVANLNQYVGLRYNQVPEFKLGDQSLTALGQGTGLVGLPGDFTPASRFIRVAFLR 236
Li.monocytogenes PTFDYQLFNLNNYRVLSSETPENNFSNEIDLDAYSRGMGGIGLPGDLSSMSRFVKATFTK 231
En.faecalis PTFDYQLFNLNNYRVLSTRTPKNNFSDQIELDIYSRGMGGIGLPGDLSSVSRFVKATFTK 231
La.plantarum PNFDYQLFNLNNYRALSNSTPQNSFSEKVDLDSYSRGMGGLGLPGDLSSMSRFVRAAFTK 231
La.gasseri PLFPEQLTNLANYASVVPGEPDNNFLPGVNLKLYSRSLGTHHLPGGMDSESRFVKVCFAL 232
La.johnsonii (α) PEFPGQLRNLANYSNIAPAQPKNTLVPGVDLNLYSRGLGTHFLPGGMDSASRFVKIAFVR 233
Bi.longum PTFDFHMENLRNYMCVSNEMAEPTSWGKASLTAWGAGVGMHGIPGDVSSPSRFVRVAYTN 234
Bi.adolescentis PTFGFHMENLRNYMCVGNEMAEPATWGKASLSAWGAGVSMHGIPGDVSSPSRFVRVAYAN 234
Bi.bifidum PTFDFHMENLRNYMCVSNEMAEPTTWGKAELSAWGAGVSMHGIPGDVSSPSRFVRVAYTN 234
La.johnsonii (β) PDFNWHLTNLGNYTGLNPHDATAQSWNGQKVAPWGVGTGSLGLPGDSIPADRFVKAAYLN 235
La.acidophilus PDFNWHLTNLGNYTGLDPHDATAQSWNGQKVAPWGVGTGSLGLPGDSIPADRFVKAAYLN 235
Ba.sphaericus PGYEWHQTNLRAYIGVTPNPPQDIMMGDLDLTPFGQGAGGLGLPGDFTPSARFLRVAYWK 239
β1 β2 β3 β4 β5 β6
β6 β7 β8 β9 α1
α2 β10 β11 β12 β13
α3 β14 β15 α4 α5
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Cl.perfringens DAMIKNDKDSIDLIEFFHILNNVAMVRGSTRTVEEKSDLTQYTSCMCLEKGIYYYNTYEN 296
Li.monocytogenes LNSVSGDSESESIGQFFHILGSVEQQKGLCDVGGEKYEHTIYSSCCNIDKGIYYYRTYGN 291
En.faecalis LNSVSRSSEYESISQFFHILSSVEQQKGLCDVGDEKYEYTIYSSCCNLEKGIYYYRTYDN 291
La.plantarum LNSLSMQTESGSVSQFFHILGSVEQQKGLCEVTDGKYEYTIYSSCCDMDKGVYYYRTYDN 291
La.gasseri NHAPKDSDEVENVTNFFHILESVEQAKGMDQIGPNSFEYTMYTSCMNLEKGILYFNCYDD 292
La.johnsonii (α)       AHSPQGNNELSSVTNYFHILHSVEQPKGTDEVGPNSYEYTIYSDGTNLETGTFYYTNYEN 293
Bi.longum AHYPQQNDEAANVSRLFHTLGSVQMVDGMAKMGDGQFERTLFTSGYSSKTNTYYMNTYDD 294
Bi.adolescentis THYPQQEGEAANVSRLFHTLGSVQMVDGMAKMSNGQFERTLFTSGYSSKTNTYYMNTYDD 294
Bi.bifidum THYPQQNNEAANVSRLFHTLVSVQMVDGMSKMGNGQFERTLFTSGYSGKTNTYYMNTYED 294
La.johnsonii (β)       ANYPTVKGEKANVAKFFNILKSVAMIKGSVVNDQGSDEYTVYTACYSSGSKTYYCNFEDD 295
La.acidophilus VNYPTVKGKKANVAKFFNILKSVAMIKGSVVNKQGSNEYTVYTACYSAATKTYYCNFEND 295
Ba.sphaericus KYTEKAKNETEGVTNLFHILSSVNIPKGVVLTNEGKTDYTIYTSAMCAQSKNYYFKLYDN 299
Cl.perfringens NQINAIDMNKENLDGNEIKTYKYNKTLSINHVN------ 329
Li.monocytogenes SQITGVDMHQEDLESKELAIYPLVNEQQLNIVNK----- 325
En.faecalis SQITAVDMNKENLEKDSLIVYPMVETQQINYAN------ 324
La.plantarum SQINSVSLNHEHLDTTELISYPLRSEAQYYAVN------ 324
La.gasseri SRISAVDMNKEDLDSSDLVVYDLFKKQDISFIN------ 325
La.johnsonii (α)       NQINAIELNKENLNGDELTDYKLIEKQTINYQN------ 326
Bi.longum PAIRSYAMADYDMDSSELISVAR---------------- 317
Bi.adolescentis PAIRSYAMADFDMDSSELITAA----------------- 316
Bi.bifidum PAIRSFAMSDFDMDSSELITAD----------------- 316
La.johnsonii (β)       FELKTYKLDDHTMNSTSLVTY------------------ 316
La.acidophilus FELKTYKLDDETMNADKLITY------------------ 316
Ba.sphaericus SRISAVSLMAENLNSQDLITFEWDRKQDIKQLNQVNVMS 338 
α6 α7 β16 β17
β18 α8 β19
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 of Bifidobacterium longum and Bi. bifidum (9, 17) as well 
as sulfhydryl inhibition of several BSH have shown the 
importance of this residue in catalysis (10, 12, 13).  
Alignment of amino acid sequences from BSH shows the Cys2 
residue is conserved in all BSH characterized to date 
(Figure 4).  The broad substrate specificities reported 
(Table 1) are potentially a function of a lack of 
conservation observed in residues making up the substrate 
binding pocket of the conjugated bile acid hydrolase gene 
product (CBAH-1) of C. perfringens and the corresponding 
residues predicted in amino acid multiple sequence 
alignment with other BSH (Figure 4).  The sterol moiety is 
bound primarily through hydrophobic interactions in the 
CBAH-1 of C. perfringens (residues highlighted in grey in 
Figure 4) as well as hydrogen bonds to the carboxylate 
group. While the crystal structure of CBAH-1 did not 
reveal specific recognition of the taurine/glycine moiety, 
kinetic data from several BSH suggest the conjugates are 
important in substrate specificity (Table 1).  Therefore, 
additional crystallization and site-directed mutagenesis 
(preferably with mutagenesis of Cys2) of BSH from 
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 different species will be helpful in explaining kinetic 
observations of substrate specificity.   
 
Distribution, genetic organization, and regulation of BSH 
Genes encoding BSH have been cloned from C. 
perfringens (14), Lactobacillus plantarum (15), La. 
johnsonii (16, 17), Bi. longum (10), Bi. bifidum (18), Bi. 
adolescentis (19), and Listeria monocytogenes (20, 21).  
Homologues and putative bsh genes have also been 
identified recently through microbial genome analysis. The 
organization and regulation of genes encoding BSH differs 
between species and genera.  Monocistronic BSH genes have 
been reported in La. plantarum (15), La. johnsonii (17), 
Li. monocytogenes (21), and Bi. bifidum (18).  A gene 
encoding BSH (CBAH-1) cloned from C. perfringens (14) 
differed significantly in size and amino acid sequence 
from a BSH purified from a different strain of C. 
perfringens (12).  The inactivation of the gene encoding 
CBAH-1 resulted in only partial reduction in BSH activity 
(BSH activity 86% of WT) suggesting multiple BSH genes in 
C. perfringens.  Furthermore, the crystal structure showed 
that the enzyme encoded by the CBAH-1 gene forms an active 
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 homotetramer (11).  These observations, coupled with 
detection of both intracellular and extracellular BSH 
provides further evidence for multiple isoforms though 
organization and regulation of the bsh gene(s) from C. 
perfringens are not presently known (22).  Polycistronic 
operons encoding three genes involved in bile salt 
deconjugation (cbsT1, cbsT2, cbsHβ) have been 
characterized in La. johnsonii and La. acidophilus (17).  
Genes cbsT1 and cbsT2 appear to be gene duplications each 
of which encode TCA/CA antiport proteins of the major 
facilitator superfamily while cbsHβ encodes the BSH β-
isoform (23).  In addition, an uncharacterized 
extracellular factor has been detected in La. johnsonii 
100-100 which stimulates BSH activity and uptake of 
conjugated bile salts during stationary growth phase (17, 
24).  BSH expression is also growth phase dependent.  
Stationary phase expression has been reported in 
Bacteroides fragilis (25) while exponential phase 
expression was reported for Bi. longum (10).   
 
Benefits of BSH to the bacterium 
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 BSH appear to enhance the bacterial colonization of 
the lower GI tract of higher mammals.  The physiological 
advantages of BSH are not fully understood and may vary 
between bacterial species and genera.  It has been 
hypothesized that deconjugation may be a mechanism of 
detoxification of bile salts.  De Smet et al (1995) 
observed significantly higher rates of deconjugation of 
GDCA over TDCA in La. plantarum (26).  Mutants lacking 
functional BSH (bsh−) exhibited pH and concentration 
dependent toxicity of GDCA as compared to wild type cells; 
whereas, this effect was not demonstrated with TDCA.  De 
Smet et al. (1995) hypothesized that the difference in 
dissociation constants between GDCA and TDCA resulted in 
the collapse of cellular proton motive force by 
intracellular deprotonation with the glycine-conjugate 
(26).  The presence of a functional BSH results in the 
intracellular accumulation of free bile acids which become 
protonated in a stoichiometric fashion decreasing energy 
dependent H+ ATPase driven proton efflux.  BSH from human 
intestinal lactobacilli generally have higher affinity for 
glycine conjugates (26-29). This observation may lend 
weight to the hypothesis of De Smet et al. (1995) or the 
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 higher affinity of BSH for glycine conjugates may have 
evolved because glycine conjugates are generally higher in 
proportion (3:1) than taurine conjugates in human bile 
(6). Tannock et al. (1989) argued against the hypothesis 
of deconjugation as a means of detoxification in 
lactobacilli, pointing to the fact that free bile acids 
are more cytotoxic than their conjugates (30).  However, 
when the free bile acids become 7-dehydroxylated by other 
intestinal bacteria in vivo, the resultant secondary bile 
acids tend to precipitate (extent depending on luminal pH) 
and bind to insoluble fiber or may be absorbed through the 
colonic membrane, and may exist in low concentrations in 
the bacterium’s microenvironment.  Therefore, additional 
studies comparing various characteristics of bsh knockouts 
with their isogenic parent strain will be needed to 
determine the function of deconjugation in Lactobacillus 
spp.   
Strategies to resist bile salt toxicity have been 
observed in pathogens that colonize the intestinal tract 
(31-33).  Recently, a BSH from Li. monocytogenes was shown 
to be a novel virulence factor (21).  Comparative genome 
analysis revealed the absence of a bsh gene in the closely 
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 related non-virulent Li. innocua (20).  The bsh gene is 
positively regulated by PrfA, which is a transcriptional 
activator of numerous virulence genes in Li. 
monocytogenes.  Deletion of the bsh gene results in 
decreased resistance to bile salts, and significantly 
reduced infectivity in vivo.  These results demonstrate 
the importance of BSH activity for survival in vivo and 
infection in the intestinal and hepatic phases of 
listeriosis.  The mechanism by which BSH activity in L. 
monocytogenes enhances survival and virulence is currently 
unknown.   
Deconjugation may provide a means of obtaining 
cellular carbon, nitrogen, and sulfur for some bacterial 
species.  This has been demonstrated in bacteroides (34) 
and is suggested in Bi. longum (10).  In fact, the bsh 
gene from Bi. longum is co-transcribed with the gene 
encoding glutamine synthetase adenylyltransferase (glnE); 
a component of the nitrogen regulation cascade (10).  In 
this regard, hydrolysis of the conjugated bile acid may 
provide amino nitrogen; providing a possible explanation 
for coordinate regulation of these seemingly 
physiologically unrelated genes (10).  Taurine utilization 
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 is also widespread and can serve as an energy source under 
both aerobic and anaerobic conditions (35).  Glycine can 
be utilized as an energy source by certain clostridia by 
the Stickland reaction (36). The Stickland reaction is a 
form of amino acid fermentation where one amino acid 
donates electrons which are accepted by another amino acid 
distinct from the electron donor. Another hypothesis 
suggests BSH are detergent shock proteins enabling 
survival during stress (37).  De Smet et al. (1995) found 
no evidence for this in lactobacilli after growth with 
various detergents (26).   
 The widespread distribution of BSH across gram 
negative and gram positive intestinal bacteria coupled 
with a wide range of substrate specificities, genetic 
regulation and the occurrence of multiple isoforms in 
certain strains have created conflicting reports regarding 
the physiological benefit to the bacterium in hydrolyzing 
bile acid conjugates. Determining the mechanism(s) by 
which BSH aid bacteria in colonization of the mammalian 
intestine will be of great interest, especially in regards 
to bacterial pathogenesis.    
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 Taurine, hydrogen sulfide production and colon cancer 
 The bile acid conjugates glycine and taurine serve as 
substrate in microbial metabolism.  Unlike glycine, 
taurine contains a sulfonic acid moiety which is reduced 
and dissimilated to hydrogen sulfide following 
deconjugation (38, 39).  Hydrogen sulfide is highly toxic, 
and has been shown to increase colonocyte turnover (40).  
Activation and upregulation of the ERK 1/2 signaling 
pathway has been suggested as a possible mechanism for 
sulfide induced colonocyte proliferation (41). Hydrogen 
sulfide also inhibits butyrate metabolism in colonocytes, 
a key nutrient and regulator of cell turnover in the gut 
(40).  Levitt et al (1999) demonstrated that colonocytes 
have evolved a highly efficient mechanism to detoxify 
volatile reduced sulfides through oxidation to thiosulfate 
(42).  Defects in this detoxification system are suggested 
to play a role in the etiology of ulcerative colitis, a 
known risk factor for colon cancer (42, 43). Recently, 
sulfide has been implicated in preventing apoptosis in the 
adenocarcinoma cell line HCT116 after exposure of cells to 
β-phenylethyl isothiocyanate (PEITC), a phytochemical 
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 found in cruciferous vegetables, which has been shown to 
prevent colon carcinogenesis (44, 45).   
A diet high in meat has been shown to significantly 
increase the levels of both taurine conjugation to bile 
acids (46, 47), and the production of hydrogen sulfide in 
the colon (48).  A relationship exists between generation 
of hydrogen sulfide in the colon and chronic 
gastrointestinal illness such as inflammatory bowel 
disease and colon cancer (5, 49).  Populations such as 
native black Africans with low incidence of colon cancer 
consume low meat diets (50). Native black Africans also 
have low ratios of taurine to glycine conjugation (1:9) 
and low hydrogen sulfide production when compared to 
populations consuming a “Western diet” (46, 47).  In human 
fecal slurries obtained from individuals consuming a 
“Western diet”, taurine addition generated some of the 
highest sulfide levels of any organic or inorganic sulfur 
source added (43).  Taurine addition to a co-culture of a 
species of bacteroides and an unidentified 7α-
dehydroxylating bacterium resulted in significant sulfide 
production, which stimulated increased rates of DCA 
production (34).   
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 While the extent to which taurine metabolism 
contributes to total colonic sulfide production has yet to 
be established, several key points have been made: 1) the 
extent of taurine conjugation in the bile acid pool is 
largely affected by diet;  2) the same dietary factors 
which increase taurine conjugation are hypothesized to 
increase colon cancer risk; 3) taurine metabolism by 
intestinal bacteria results in hydrogen sulfide 
generation; 4) sulfide generation is linked to the 
carcinogenesis process through enhanced cell 
proliferation, inhibition of butyrate metabolism and 
activation of cell signaling pathways; 5) sulfide 
generation may enhance DCA formation in the gut through 
stimulation of the microbial bile acid 7α-dehydroxylation 
pathway.  
 
Microbial bile acid hydroxysteroid dehydrogenase(s) (HSDH) 
 
Oxidation and epimerization  
 
Oxidation and epimerization of the 3-, 7-, and 12-
hydroxy groups of bile acids in the gastrointestinal tract 
are carried out by HSDH expressed by intestinal bacteria 
(Figure 1).  Epimerization of bile acid hydroxy groups is 
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 the reversible change in stereochemistry from α to β 
configuration (or vise versa) with the generation of a 
stable oxo-bile acid intermediate.  Epimerization requires 
the concerted effort of two position-specific, 
stereochemically distinct HSDH of intraspecies or 
interspecies origin.  For example, the presence of both 
7α- and 7β-HSDH in C. absonum allow epimerization by a 
single bacterium (51); whereas epimerization also can be 
achieved in co-cultures of intestinal bacteria, one 
possessing 7α-HSDH and the other 7β-HSDH (52, 53). 
The extent of the reversible oxidation and reduction 
of bile acid hydroxy groups by HSDH depends in part on the 
redox potential of the environment.  Addition of oxygen to 
the culture medium increases the accumulation of oxo-bile 
acids (51).  Generation of oxo-bile acids may be more 
favorable under the higher redox potentials found on the 
mucosal surface (4); while reduction of oxo-bile acids may 
be more favorable under the low redox potential (-200 to -
300mV) in the large intestinal lumen.  Thus, while the 
redox potential of the colon is net reductive, 
microenvironments at the mucosa may provide oxidizing 
conditions favorable for certain microbial reactions.  
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 HSDH differ in their reductive and oxidative pH optima, 
NAD(H) or NADP(H) requirements, Mr, and gene regulation 
(Table 2).   
 
3α- and 3β-HSDH 
3α/β-HSDH specifically catalyze the reversible, 
stereospecific oxidation/reduction between 3-oxo-bile 
acids and 3α- or 3β-hydroxy bile acids.  3α-HSDH have been 
detected in some of the most prevalent intestinal bacteria 
including C. perfringens (54), Peptostreptococcus 
productus (55) and Eggerthella lenta (formerly Eubacterium 
lentum) (56, 57) as well as intestinal bacteria present in 
lower numbers (≤ 105/g wet weight feces) including C. 
scindens (58), and C. hiranonis (59), and in non-
intestinal bacteria including Pseudomonas testosteroni 
(60, 61).  3β-HSDH activity has been described in species 
of Clostridium and Rumminococcus (62-64).  It appears that 
intraspecies 3-epimerization favors the 3α-position.  In 
fact, growing cultures of C. perfringens in the presence 
of 3-oxo-CDCA formed CDCA (84%) preferentially over iso-
CDCA (16%) under anaerobic conditions (65). 
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 Pyridine nucleotide cofactor requirements differ 
between 3α/β-HSDH.  3α-HSDH require NAD(H), with the 
exception of the enzyme purified from C. perfringens, 
which uses NADP(H) and that purified from C. scindens 
which can use either NAD(H) or NADP(H) (54, 56-58, 61).  
3β-HSDH have been shown to preferentially require NADP(H), 
with the exception of C. innocuum which uses NAD(H) (62-
64).  Dihydroxy bile acids (DCA, CDCA and UDCA) are 
generally better substrates than trihydroxy bile acids 
(CA) (62, 65).   
3α/β-HSDH characterized to date are constitutively 
expressed with the exception of C. scindens and C. 
hiranonis which are induced by primary bile acids CA and 
CDCA.  In fact, three copies of 3α-HSDH genes (baiA1, 
baiA2 and baiA3) have been identified from C. scindens 
(66-67) and the baiA1 gene has been expressed in E. coli 
and characterized (58). The baiA gene products are unique 
among 3α/β-HSDH due to their high specificity toward CA-
CoA and CDCA-CoA conjugates and relatively low activity 
toward free bile acids (58).   
 
7α- and 7β-HSDH 
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  7α/β-HSDH catalyze the reversible, stereospecific 
oxidation/reduction of the 7α- and 7β-hydroxyl groups of 
bile acids.  While 7α/β-HSDH are common among intestinal 
bacteria,  the extent of 7α/β-dehydrogenation in the 
intestine, or in mixed fecal suspensions is difficult to 
interpret due to the competing, and irreversible 7α/β-
dehydroxylation of bile acids (see section 6) (68).  
 7α/β-HSDH are widespread among the bacteroides and 
clostridia as well as Escherichia coli, and Ruminococcus 
sp. (Table 2) (54, 64, 69-74).  In addition, several 
intestinal clostridia express both 7α- and 7β-HSDH and 
have been shown to epimerize the 7α/β-hydroxy group (75, 
76-78).  7α/β-HSDH have been partially purified from 
intestinal bacteria including Ba.  fragilis (71, 79), Ba. 
thetaiotaomicron (74), C. scindens (80), C. sordellii 
(70), E. coli (73), as well as the soil isolates 
Xanthomonas maltophilia (81), C.  absonum (82),  and C. 
bifermentans (83).  Interestingly, several intestinal 
bacteria with 7α/β-HSDH activity also possess BSH 
including: Ba. fragilis (25), C. sordellii (70), C. 
perfringens (84), C. innocuum (63), and the soil isolate 
C. bifermentans (83).    
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 7α-HSDH generally utilize NADP(H) as a cofactor, with 
the exception of E. coli (85), and Ba. thetaiotaomicron 
(74).  C. bifermentans, C. absonum, and Ba. fragilis 7α-
HSDH can utilize either NAD(H) or NADP(H) as a cofactor 
(76, 79, 83).  7β-HSDH enzymes characterized to date 
utilize NADP(H) as a cofactor (53, 62, 75, 76).  7α/β-HSDH 
enzymes have higher affinity for dihydroxy bile acids 
(CDCA, 7-oxo-LCA) than trihydroxy (CA, 7-oxo-DCA).  C. 
limosum cell extracts utilized both free and conjugated 
bile acids, while whole cells only oxidized free bile 
acids (75, 85).  This is due to intracellular location of 
the 7α-HSDH, and the inability of the organism to take up 
a conjugated bile salt.  The genes encoding 7α-HSDH have 
been cloned from E. coli (73), C. scindens (69), and C. 
sordellii (70).  Sequence similarity suggests these 
enzymes belong to the short-chain polyol dehydrogenase 
family.  Regulation of 7α/β-HSDH expression is generally 
growth phase dependent and inducible by bile acid 
substrates (Table 2).  C. scindens and E. coli 
constitutively express 7α-HSDH and are non-inducible (69, 
85).  Unexpectedly, the non-substrate DCA can induce 7α-
HSDH expression in C. absonum and C. sordellii though the 
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 reason for this induction remains unclear (70, 76).   
Macdonald et al. (1983) observed the expression of five 
soluble and two membrane polypeptides upon exposure of C. 
absonum to DCA and CDCA in the culture medium although the 
functions of these additional polypeptides have not been 
determined (82).   
 Crystal structures of the E. coli 7α-HSDH binary and 
ternary complexes have been solved and a mechanism for 7α-
dehydrogenation proposed (Figure 5) (87).  Binding of 7α-
hydroxy bile acids elicits major conformational changes at 
the substrate binding loop and C-terminal domain.  A two 
step mechanism is proposed in which Tyr159 acts as a 
catalytic base removing the C-7 hydroxy hydrogen.  
Hydrogen bonding by Ser146 is hypothesized to stabilize 
the intermediate. Regeneration of the catalyst occurs 
through transfer of the acquired hydride from the phenolic 
group on Tyr159 to Lys163 to position 4 of NAD+.  Lys163 
serves two important roles: anchoring NAD+ through 
bifurcated hydrogen bonding, and indirect hydride transfer 
from Tyr159 to position 4 of NAD+ (87). Site directed 
mutagenesis confirmed the role of these amino acids in 7α-
HSDH catalysis (88).  Analysis of the 7-oxo-GLCA bile acid 
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Figure 5.  Proposed catalytic mechanism of bile acid 
7α-dehydrogenation based on the crystal 
structure and site-directed mutagenesis of 
active site amino acids of the 7α-
dehydrogenation from E. coli. See text for a 
description of catalysis. Reprinted with 
permission from Tanaka et al. (87). 
Copyright @ 1996 American Chemical Society. 
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 substrate/enzyme complex revealed tight binding of the 
sterol with loose association for the glycine conjugate.  
Binding of glycine and taurine conjugates of CDCA were not 
significantly different from the free bile acid (87). 
   
12α- and 12β-HSDH 
12α/β-HSDH have been detected mainly among members of 
the genus Clostridium.  NADP-dependent 12α-HSDH have been 
detected in C. leptum (89), Clostridium group P (89), 
while NAD-dependent 12α-HSDH activity was reported in Eg. 
lenta (56), and C. perfringens (54).  12β-HSDH have been 
detected in C. tertium, C. difficile and C. paraputrificum 
(91, 92). 12α/β-HSDH characterized to date are 
constitutively expressed, and non-inducible, with the 
exception of the 12β-HSDH from C. paraputrificum which is 
induced by 12-oxo-bile acid substrates (92). 12α/β-HSDH 
generally have higher affinity for dihydroxy (DCA) than 
trihydroxy bile acids (CA, iso-CA) and free vs. conjugated 
bile acids.  The 12α-HSDH from C. leptum is an exception; 
demonstrating higher affinity for CA conjugates than free 
CA (89). 12α-HSDH appear to be repressed by the addition 
of bile acid substrates (DCA>CDCA>CA) to the growth medium 
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 at 1 mM concentrations.  It has been suggested that these 
enzyme activities should be repressed in bacteria 
colonizing the large intestine (56, 92); although 12-oxo-
bile acids have been detected at low levels in the feces 
of healthy individuals (Figure 3) (93-94).   
  
Benefits of bile acid hydroxysteroid oxidoreductases to 
the bacterium 
The oxidation of bile acid hydroxyl groups generates 
reducing equivalents for cellular biosynthetic reactions 
and possibly electron transport phosphorylation.  Bile 
acid dehydrogenation is hypothesized to generate energy in 
Ba. thetaiotaomicron (74).  Sherod and Hylemon (1977) 
suggested that reduced pyridine nucleotides generated from 
7α-hydroxy oxidation serve to generate ATP via a 
cytochrome-linked electron transport chain in the presence 
of electron acceptors (i.e., fumarate) (74). 
Bile acids are potent antimicrobial agents provided 
the proper concentration and proportion of hydrophobic 
bile acids (CDCA, LCA, DCA) are present (95).  Alteration 
of hydroxy group stereochemistry has marked influence on 
the physiochemical properties of bile acids (96, 97).  The 
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 epimerization of the 7α-hydoxy group of CDCA lowers the 
hydrophobicity and toxicity of the bile acid (97).   
Macdonald, White and Hylemon (1983) observed that C. 
absonum grew on plates containing 1 mM UDCA, though was 
unable to grow on plates containing 1 mM CDCA (82).  
Furthermore, when cultured in the presence of 7-oxo-bile 
acids only low concentrations of CA and CDCA were formed 
while the majority of 7-oxo-bile acids were reduced to 7-
epi-CA and UDCA, respectively, by log phase C. absonum 
(51).  UDCA has also been shown to act as a repressor of 
7α/β-HSDH production in C. absonum suggesting UDCA is an 
end-product (76).  The enzyme also displays markedly 
higher affinity for CDCA than CA, the former being more 
toxic.  In summary, dehydrogenation may serve functions 
related to energy generation as well as attempts to 
maintain low concentrations of more hydrophobic bile acids 
in the bacterium’s microenvironment.   
 
Interplay between HSDH enzymes in human liver and 
intestinal bacteria 
The co-evolution between host and gut flora is 
evident when observing the interplay between liver and 
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 bacterial biotransforming reactions.  The liver 
synthesizes bile acids in which the hydroxy groups are in 
the α orientation.  In the α-hydroxy orientation, one face 
of the molecule is hydrophobic while the other side is 
hydrophilic.  This translates to efficient solubilization 
of lipid molecules through formation of mixed micelles 
capable of efficient emulsification while remaining 
soluble in aqueous environments.  Generation of β-hydroxy-
bile acids by microbial enzymes alters the efficiency of 
micelle formation due to hydrophilic groups on both faces 
of the sterol molecule.  The differences observed between 
the composition of bile acids in serum and bile are a 
result of the continual interplay between liver and 
bacterial enzymes. Exposure of bile salts to intestinal 
bacteria results in roughly 50% of bile acids requiring 
reconjugation and low levels of bile acids returned to the 
liver in the 3β-hydroxy orientation (98). Without a means 
of epimerizing bile acid hydroxy groups in the human 
liver, β-hydroxy bile acids would accumulate in the bile 
acid pool.  Interestingly, the liver seems to “allow” the 
accumulation of UDCA (7β-hydroxy) in the biliary pool as 
in the case of therapeutic administration of CDCA (99).  
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 The protective effects of UDCA observed in clinical 
studies (100), as well as cell culture studies (97, 101) 
may provide an evolutionary explanation for this 
phenomenon.   
 
The biochemistry and molecular biology of bile acid 7α/β-
Dehydroxylation 
 
Introduction 
Secondary bile acids (DCA, LCA) predominate in human 
feces (Figure 3).  Therefore, 7α-dehydroxylation is the 
most quantitatively important bacterial bile salt 
biotransformation in the human colon.  The rapid rate of 
conversion of primary to secondary bile acids is 
surprising given that current estimates suggest this 
metabolic pathway is found in roughly 0.0001% of the total 
colonic flora (102-104).  Human intestinal bacteria 
capable of bile acid 7α-dehydroxylation have been isolated 
(104, 105) and 16s rDNA phylogenetic analysis has led to 
their classification to the genus Clostridium (106-108). 
Unlike bile acid oxidation and epimerization, 7α/β-
dehydroxylation appears restricted to free bile acids.  
Removal of glycine/taurine bile acid conjugates via BSH 
enzymes is thus a prerequisite for 7α/β-dehydroxylation by 
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 intestinal bacteria (109-112).  Some intestinal bacteria 
are capable of both 7α/β-dehydroxylating activities (113), 
while 7β-dehydroxylation activity is absent in other 
intestinal 7α-dehydroxylating bacteria (113).  
Epimerization of UDCA (7β-hydroxy) to CDCA (7α-hydroxy) 
via 7β-HSDH produced by members of the gut flora result in 
subsequent 7α-dehydroxylation.  In this regard, it would 
appear the presence of 7β-dehydroxylation activity is more 
of a luxury than a necessity.     
 
Elucidating the bile acid 7α/β-dehydroxylation pathway 
 
Samuelsson (1960) administered [6α-3H, 6β-3H, 8β-3H]-
[24 14C] CA to bile duct cannulated rabbits and rats (114). 
Analysis of the products recovered following exposure to 
intestinal bacteria revealed a differential loss of the 
[6β-3H] during 7α-dehydroxylation of CA.  Previous work 
showed complete retention of the 7β-3H in [7β-3H]-[24-14C]-
CA during 7α-dehydroxylation in the rat intestine (115, 
116).  These data led Samuelsson (1960) to propose a 
mechanism for CA 7α-dehydroxylation involving two steps: 
diaxial trans-elimination of the 7α-hydroxy group and 6β-
hydrogen atom followed by reduction through trans-
hydrogenation of the 6β and 7α positions of the cholen-6-
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 oic acid intermediate forming DCA (114). Björkhem et al. 
(1989) showed the formation of a 3-dehydro-4-cholenoic 
acid intermediate following the differential loss of the 
5βH in vitro and in vivo using a [3β-3H]-[24-14C] and [5β-
3H]-[24-14C]-labeled CA (117).  Hylemon et al. (1991) 
subsequently observed accumulation of multiple bile acid 
intermediates in cell extracts of Clostridium scindens 
induced by CA (Figure 6) (118).  These radiolabeled CA 
intermediates were identified by mass spectrometry, then 
chemically synthesized and added to cell extracts of CA 
induced C. scindens.  Each [24-14C] CA intermediate was 
converted into [24-14C] DCA in cell extracts prepared from 
CA induced cultures of C. scindens.  These observations 
suggested that the 7α-dehydroxylation mechanism was more 
complex than the two-step mechanism proposed by Samuelsson 
et al (1960).  Furthermore, these data demonstrated that 
bile acid 7α-dehydroxylation was a multi-step pathway in 
C. scindens and suggested the presence of multiple bile 
acid inducible genes (bai).   
The induction of 7α-dehydroxylation activity in C. 
scindens by unconjugated C24 primary bile acids resulted in 
the appearance of several new polypeptides as observed on 
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Figure 6.  Accumulation of [24- C]CA intermediates 
during 7α-dehydroxylationin cell extracts of 
C. scindens VPI 12708. Cell extracts were 
prepared from either CA-induced (I) or 
control (C)cells. This figure was modified 
from Hylemon et al. (118). Copyright@ 1992 
American Society for Biochemistry and 
Molecular Biology, Inc. 
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 one and two-dimensional SDS-PAGE (119, 120).  Purification 
and N-terminal sequencing of these bai polypeptides 
facilitated cloning of bai genes through design of 
degenerate probes (121-123).  Northern blot analysis 
indicated the presence of a large CA inducible (≥ 10 kb) 
mRNA transcript and a smaller transcript (< 1.5 kb) in C. 
scindens (121, 124).  These studies led to the discovery 
of a bai regulon encoding at least 10 open reading frames 
(Figure 7).  Individual bai genes have been subcloned into 
E. coli and the functions of many determined (58, 67, 123, 
125-130, Hylemon P.B., unpublished data).  The proposed 
bile acid 7α/β-dehydroxylation pathway in C. scindens is 
shown in Figure 8. A bai operon has also been 
characterized from C. hiranonis (59), though the following 
discussion of the 7α/β-dehydroxylation pathway will center 
on C. scindens from which the functions of the gene 
products have been determined. 
 
bai genes: a regulon for 7α/7β-dehydroxylation 
The transport of unconjugated primary bile acids into 
C. scindens is facilitated by the baiG gene product which 
belongs to a major pump/facilitator superfamily of protein 
45
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.  Gene organization of the bile acid-inducible 
(bai) 7α/β-dehydroxylation operons 
characterized in C. scindens VPI 12708. P 
indicates the promoter region. 
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 transporters (126).  The baiG gene has been cloned into E. 
coli and shown to encode a 50 kDa H+-dependent bile acid 
transporter (126).  The BaiG facilitates transport of 
unconjugated CA and CDCA but not the secondary bile acids 
DCA or LCA (126). Computer-aided modeling suggests the 
baiG polypeptide contains 14 membrane spanning domains 
(126).      
Following transport, ligation to coenzyme A (CoA) is 
the first step in activating CA and CDCA for 7α-
dehydroxylation as several subsequent enzymatic steps are 
specific for CoA conjugates.  The baiB gene was shown to 
encode a 58 kDa bile acid CoA ligase (125).  CoA ligation 
is ATP, CoA, Mg2+ dependent and also requires a free 
carboxyl group on C24 bile acids (125).  CoA ligation may 
function both to sterically hinder the constitutive 7α-
HSDH committing the bile acid to 7α-dehydroxylation and 
trapping the bile acid inside the cell. 
The 3α-hydroxy group is oxidized following CoA 
ligation.  Oxidation of the 3-hydroxy group inhibits 7α-
hydroxy group dehydrogenation; favoring 7-dehydroxylation 
over constitutively expressed 7α-HSDH in C. scindens (58, 
80).  The baiA gene products encode 27 kDa polypeptides 
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 that have significant similarity with the short-chain 
alcohol/polyol dehydrogenase gene family (58, 124).  Amino 
acid multiple sequence alignment and comparison between 
baiA gene products and other members of the short-chain 
alcohol dehydrogenase family revealed a possible NAD(P) 
binding site and catalytic active site (58).  Three baiA 
genes have been cloned from C. scindens; the baiA1 and 
baiA3 genes are monocistronic while the baiA2 gene is part 
of the polycistronic bai operon (66, 67, 124). The baiA 
genes from C. scindens were cloned in E. coli and shown to 
encode 3α-HSDH (58).  The enzymes only recognize bile acid 
CoA conjugates and can utilize either NAD+ or NADP+ as 
electron acceptors (58). Interestingly, the different 3α-
HSDH of C. scindens share 92% amino acid sequence identity 
with one another suggesting gene duplication.  The 
physiological importance of multiple baiA genes remains 
unclear.   
The baiH gene encodes a 72 kDa polypeptide containing 
661 amino acids (121).  The BaiH protein exists as a 
homotrimer with NADH: flavin oxidoreductase activity 
(121).  The baiH gene has been subcloned into E. coli, 
purified and shown to contain 1 mol FAD, 2 mol iron, and 1 
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 mol copper per mol polypeptide subunit (129). The BaiCD 
polypeptide shows considerable amino acid sequence 
identity with the ‘Old Yellow Enzyme’ family, a putative 
NADH oxidase from Li. monocytogenes, several 2,4-dienoyl 
CoA reductases, as well as the baiH from C. scindens (121, 
129).  The physiological function of the baiCD and baiH 
gene products is currently unknown. 
 The baiF gene encodes a 47.5 kDa polypeptide 
containing 426 amino acids which was shown to have bile 
acid CoA hydrolase activity (122, 130).  However, the baiF 
gene is hypothesized to encode a CoA transferase due to 
reasons for energy conservation (Fig. 8) and homology to 
the type III family of CoA transferases (131).  The first 
few cycles of 7α-dehydroxylation would require ATP 
hydrolysis (Figure 8); though ATP independent recycling of 
the thioesterase intermediates via transfer of CoA from an 
accumulated downstream intermediate, to incoming primary 
bile acids would significantly conserve energy.  However, 
this hypothesis remains to be tested. 
7α-Dehydration of 3-dehydro-4-cholenoic acid and 3-
dehydro-4-chenodeoxycholenoic acid results in the 
generation of a conjugated double bond in rings A and B 
50
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.  Proposed bile acid 7α-dehydroxylation 
pathway in C. scindens VPI 12708(see text). 
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 forming a stable 3-dehydro-4,6-deoxycholdienoic acid and 
3-dehydro-4,6-lithocholdienoic acid intermediates,  
respectively.  The 7α-dehydration step results in the 
largest calculated energy change (-9.4 kcals/mol) of any 
reaction in this pathway, and the reverse reaction was not 
detected in vitro (128).  The 19.5 kDa bile acid 7α-
dehydratase is encoded by the baiE gene (128).  This 
enzyme showed no activity with 3-dehydro-4-
ursodeoxycholenoic acid (128).  The baiE gene product was 
modeled based on the crystal structure of protein 
homologues (secondary structure) ketosteroid isomerase 
(KSI) and scytalone dehydratase (STD) (Figure 9) (Woodford 
K et al. unpublished).  The putative active site/binding 
pocket is shown in Figure 10.  A catalytic mechanism has 
been proposed for the 7α-dehydration step based on the 
conservation in secondary structure and site directed 
mutagenesis of the key active site amino acids. Tyr30 acts 
as a general acid withdrawing electron density from the 3-
oxo-group. This shift in electron density is hypothesized 
to make the 6β-hydrogen labile for removal by the general 
base His83 (assisted by Asp35).  His83 is thought to 
donate its hydrogen to the 7α-hydroxy forming the water 
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Figure 9.  Model of the bile acid 7a-dehydratase (baiE) 
based on structural data from scytalone 
dehydratase, nuclear transport factor 2, and 
steroid D5-isomerase. The a-helices are 
denoted by white strands, β-sheets are 
denoted by the yellow backbone, and the blue 
structure represents a steroid molecule 
modeled into the binding/active site pocket. 
Model kindly provided by Dr. Alexey G. 
Murzin (Cambridge University). 
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Figure 10.  Putative binding/active site pocket of bile 
acid 7α-dehydratase. Putative active site 
amino acid residues are shown in relation to 
the bile acid substrate. See text for 
discussion of the proposed catalytic 
mechanism. 
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 leaving group which is stabilized by Asp106.  Site-
directed mutagenesis based on the proposed mechanism 
supports the important role of the putative active site 
amino acids in enzyme catalysis.  It is hypothesized that 
the baiI gene encodes a bile acid 7β-dehydratase due to 
amino acid sequence homologies between the baiE and baiI 
gene products. 
Genes involved in the reductive arm of the 7α/β-
dehydroxylation pathway have not been isolated.  These 
genes should encode oxidoreductases catalyzing the 
reduction of 3-dehydro-4,6-deoxycholdienoic acid → 3-
dehydro-4-deoxycholenoic acid → 3-dehydro-deoxycholic acid 
→ DCA as well as a bile acid exporter to remove secondary 
bile acid end-products from the bacterium (Figure 8).  
Genes encoding putative transcriptional regulators have 
been detected upstream of the bile acid inducible promoter 
region (Table 3) (Mallonee DH and Hylemon PB; unpublished 
data).  Additional studies will be required to determine 
the mechanism of induction/repression of this pathway and 
to identify additional bai genes.   
 
The benefits of 7α/β-dehydroxylation to the bacterium 
58
59
 The ability to utilize bile acids as electron 
acceptors is an important niche for 7α-dehydroxylating 
bacteria in the human colon.  The 7α/β-dehydroxylation 
pathway requires multiple oxidative and reductive steps 
with a net 2 electron reduction (Figure 8).  The 
hypothesized energy benefits of this pathway assume, 
however, that the baiF gene encodes a CoA-transferase and 
the toxic end-products, the secondary bile acid, are 
removed from the microenvironment in vivo (precipitation 
and binding to insoluble fiber).  The generation of 
secondary bile acids may also function to exclude bacteria 
sensitive to these hydrophobic molecules.   
 
Secondary bile acids and disease 
 In humans, DCA accumulates in the bile acid pool to 
high levels in some individuals.  An increase in DCA in 
the bile acid pool is associated with a decrease in CDCA 
(Figure 11).  Unlike rodents, the human liver can not 7α-
hydroxylate DCA forming CA.  Hence, under normal 
physiological conditions, there is no metabolic pathway 
for removing DCA from the bile acid pool in man.  The 
amount of DCA in the bile acid pool is a function of at 
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Figure 11.  Relationship between the percentage of CDCA 
and DCA in bile of patients at McGuire VA 
Hospital (Richmond, VA) (P. B. Hylemon et 
al., unpublished data). 
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 least three variables: 1) rate of formation and absorption 
of DCA through the colon (input) (132); 2) colonic transit 
time (133) and 3) colonic pH (134). 
 High levels of DCA in blood, bile and feces have been 
correlated with an increased risk of cholesterol gallstone 
disease and colon cancer, two major diseases of “Western 
Society” (5, 135).  High levels of CA 7α-dehydroxylating 
fecal bacteria have been correlated with increased amounts 
of DCA in bile of a subset of cholesterol gallstone 
patients (132).  Treatment of these cholesterol gallstone 
patients (high DCA group) with antibiotics significantly 
decreased the levels of fecal CA 7α-dehydroxylating 
bacteria, DCA in bile and the cholesterol saturation index 
in bile (132).  Early studies by Low-Beer and coworkers 
(1978) reported that treating control individuals with 
metronidazole, an antibiotic effective against anaerobic 
bacteria, significantly decreased the cholesterol 
saturation index of bile (135).  Moreover, excess DCA in 
bile has been reported to decrease the nucleation time for 
cholesterol crystallization (136, 137).  In total, these 
results suggest a possible link between intestinal 
63
 bacteria, DCA, and the risk of cholesterol gallstone 
disease in some patients.   
 DCA and LCA have been linked to colon carcinogenesis 
in a number of laboratory animal models and human 
epidemiological studies (For reviews see 5, 138).  Most 
animal studies conclude that DCA is a promoter of the 
carcinogenesis process (139-142).  However, some 
researchers argue that bile acids may cause DNA damage and 
act as carcinogens in humans (138).  Higher levels of DCA 
are found in the blood of colon cancer patients as 
compared to control patients (98, 143).  Moreover, DCA is 
a logical candidate for promoting colon carcinogenesis for 
the following reasons: 1) it is found in fecal water in 
high concentrations (> 100 μM) (138); 2) it can cross 
biological membranes via passive diffusion; 3) it can 
activate mammalian cell signaling pathways that are known 
to be involved in promoting the carcinogenesis process.  
In this regard, cell signaling pathways activated by DCA 
in mammalian epithelial cells include: protein kinase C 
(144); ERK 1/2 via the epidermal growth factor receptor 
(101, 145, 146); β-catenin (147) and JNK 1/2 (148).  
Secondary bile acids have been shown to cause apoptosis in 
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 colonic epithelial cells, and high concentrations of DCA 
and LCA in stool may promote carcinogenesis by exerting 
selective pressure for emergence of epithelial cell 
mutants which are resistant to apoptosis (for example, via 
loss of p53) (138). LCA has been found to be an excellent 
activator of the vitamin D receptor (149, 150).  
Activation of this receptor in intestinal epithelial cells 
activates genes that metabolize LCA (150).  This may be a 
protective mechanism that evolved to limit LCA toxicity to 
intestinal epithelial cells. 
 
Current trends and Future Issues 
Bile salt metabolism is a widespread and fundamental 
property of the gastrointestinal microflora encompassing 
the most commonly isolated species of intestinal bacteria 
including, but not limited to the genera Bacteroides, 
Clostridium, Lactobacillus, Bifidobacterium, Eubacterium, 
and Escherichia.  However, our current understanding of 
the intestinal microbiology of bile salt modifications is 
limited to cultivated species.  Discovering novel genes in 
the gut microbiome (collective genomes of the GI flora) 
encoding BSH, HSDH and enzymes involved in the 7α/β-
dehydroxylation pathway through molecular techniques will 
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 facilitate a much greater understanding of the diversity 
and complexity of these reactions in the human colon. 
Techniques such as PCR-denaturing gradient gel 
electrophoresis (PCR-DGGE) can be utilized to measure the 
diversity of organisms based on specific phylogenetic 
markers such as 16s rDNA as well as functional genes, 
potentially bile salt modifying enzymes (151, 152).  
Measuring the true diversity of bile salt modifying 
bacteria is crucial in studying the relationship between 
the levels and activity of these bacteria and disease 
risk. 
Determining the conditions in which secondary bile 
acids are formed in significant quantities and retained in 
the enterohepatic circulation of certain individuals is 
suggested to be important in the etiology of cholesterol 
gallstone disease and colon cancer.  Since secondary bile 
acids are formed exclusively through bacterial enzymatic 
reactions, the study of microbes capable of bile acid 
7α/β-dehydroxylation is important in understanding these 
chronic gastrointestinal illnesses.  The goal of such 
research is to find ways to block the source of secondary 
bile acid production.  Long-term use of antibiotics to 
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 prevent 7α-dehydroxylation of bile acids would be 
impractical.  The design of pharmaceuticals to block the 
7α-dehydroxylation pathway is a possibility.  However, 
this approach requires targeting microbial enzymes and 
runs the risk of eventual drug resistance as with 
antibiotics.  Alternatively, reducing secondary bile acid 
production may be achieved through administering 
specialized CA accumulating probiotic bacteria (153).  
Studies with bifidobacteria and lactobacilli isolated from 
human feces have shown their ability to assimilate CA 
spontaneously in vitro (153, 154).  The mechanism for CA 
uptake in lactic acid bacteria appears to be diffusion of 
a hydrophobic weak acid through the membrane via the 
transmembrane proton motive force (153, 154).  The higher 
intracellular pH causes the bile acids to become trapped 
due to ionization.  
The use of specific bacteria as “drugs” to treat 
chronic gastrointestinal illnesses caused in part by other 
intestinal bacteria certainly has potential, though 
rigorous studies are needed to demonstrate the 
effectiveness of such therapies.  Overall, clinical trials 
using probiotics to solve specific health disorders have 
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 been met with mixed results.  Discrepancies between 
studies are due in part to different methodologies, choice 
of probiotic strains, colony forming units (CFU) 
administered/day and patient characteristics.  One 
particular variable that would have to be addressed when 
determining bile acid assimilation by lactic acid bacteria 
in clinical trials is determining viability in vivo after 
passage through gastric juice and bile.  A bacterium must 
be alive in order to create a membrane potential capable 
of accumulating bile acids.  Targeted delivery of 
probiotic bacteria to the intestine in microencapsulated 
form has shown promise in improving viability in the 
presence of gastric conditions and bile (155, 156).  
Another issue is whether the introduction of billions of 
probiotic bacteria to the small bowel will have an effect 
on bile acid input into the colon.  Significant bile salt 
hydrolysis proximal to the terminal ileum reduces the 
efficiency of bile salt uptake through high affinity 
transport, allowing enhanced excretion of bile acids in 
feces.  This principle is behind attempts at lowering 
serum cholesterol using probiotics with bile salt 
hydrolytic activity (157-159).  Thus, the choice in 
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 probiotic delivery mechanisms is important in addressing 
both issues of bacterial viability as well as preventing 
increased bile salt hydrolysis proximal to the terminal 
ileum. The potential impact of probiotic bacteria in 
reducing secondary bile acid formation in the human colon 
through sequestering bile acids would be greatly reduced 
if these same bacteria cause an increase in bile acid 
input into the large intestine greater than their capacity 
for sequestering bile acids.   
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STATEMENT OF RESEARCH PROBLEMS AND OBJECTIVES 
 
Clostridium scindens is able to 7α- and 7β-dehydroxylate 
primary bile acids through an inducible multi-gene 
regulon.  Several of these gene products have been 
identified, cloned and characterized.  However, a number 
of remaining questions exist that will provide a more 
complete understanding of bile acid metabolism in the 
human colon.  First, while it has been observed that 
Clostridium scindens is able to 7β-dehydroxylation 
ursodeoxycholic acid to lithocholic acid, genes involved 
in this process have yet to be identified.  In addition, 
no physiological role has been given to the homologous 
baiCD and baiH gene products located together on the 
polycistronic oxidative operon of both Clostridium 
scindens and Clostridium hiranonis.  Second, while the 
gene organization for the oxidative operons in the “high 
activity” CA 7α-dehydroxylating activity strains 
Clostridium scindens and Clostridium hiranonis have been 
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 well characterized, the gene organization for the “low 
activity” CA 7α-dehydroxylating activity strain 
Clostridium hylemonae has yet to be determined.  Finally, 
genes in the “reductive arm” of the bile acid 7α-
dehydroxylating pathway have yet to be identified.  These 
genes are predicted to encode flavoproteins which reduce 
the 3-oxo-Δ4,6-DCA intermediate to 3-oxo-Δ4-DCA and finally 
to 3-oxo-DCA.  We predict the existence of a 
hydroxysteroid dehydrogenase which will reduce the 3-oxo-
DCA intermediate to the secondary bile acid DCA.  Finally, 
we predict an ABC permease which will act to remove DCA 
from the bacterial cell.   
 
 
The objectives of these studies include: 
 
Objective 1: Characterization of the baiCD and baiH gene 
products 
1) Perform bioinformatic and secondary structural 
predictions of baiCD and baiH gene products with 
other proteins in the databases to predict the 
functions of these gene products 
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 2) Subclone the baiCD and baiH genes from Clostridium 
scindens into E. coli for overexpression of 
recombinant protein. 
3) Synthesize appropriate substrates for enzyme assay 
and determine reaction product identity by thin layer 
chromatography and mass spectrometry 
 
Objective 2: Isolate and characterize bai genes from 
Clostridium hylemonae TN271 
1) Isolate a fragment of the bai oxidative operon from 
Clostridium hylemonae via polymerase chain reaction, 
clone and sequence this product. 
2) Perform bi-directional genome-walking by PCR to 
obtain the remainder of the genes and cis-elements in 
this operon. 
3) Characterize operon “in silico” 
4) Determine mRNA initiation site(s).   
 
Objective 3:  Identify novel bai genes in intestinal 
clostridia 
1) Locate reductive gene(s) in Clostridium scindens and 
Clostridium hylemonae 
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 2) Clone, overexpress and purify recombinant protein of 
one reductive gene in E. coli  
3) Synthesize bile acid substrate for characterization 
of reductive gene product 
4) Determine mRNA initiation site(s). 
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MATERIALS AND METHODS 
Bacterial strains, culture media, and conditions 
Clostridium scindens VPI 12708 (formerly Eubacterium 
sp. strain VPI 12708) was routinely cultivated under 
anaerobic conditions in Brain Heart Infusion (BHI) broth 
containing sodium cholate (100 μM) and maintained as 
previously described (111).  Clostridium hylemonae TN271 
was a generous gift of Dr. Fusae Takimine, University 
Riken, Japan.  C. hylemonae was cultivated under anaerobic 
conditions in BHI containing 0.02 % fructose.  Clostridium 
absonum (ATCC 27555) was purchased from ATCC. C. absonum 
was initially grown in cooked meat broth for 24 hrs at 
37˚C and subsequently stored at 4˚C and used for no more 
than 3 weeks as starter culture source. The cells were 
cultured in BHI supplemented with 0.2 % fructose (w/v). E. 
coli BL21-CodonPlus (DE3)-RIL and ArcticExpression 
Competent E. coli were purchased from Stratagene (La 
Jolla, CA) and used for expression of recombinant 
proteins. Recombinant E. coli cells were grown with 
shaking in modified TYGPN (tryptone 20 g, yeast extract 10 
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 g, 0.8 % glycerol, 5 g Na2HPO4, 10 g KNO3, and 3 μM hematin 
per liter; pH 7.0) containing 100 μg/ml ampicillin.   
 
General PCR and recombinant DNA methods 
 
Total genomic DNA from C. scindens VPI 12708 was purified 
as described previously (169) and used as a template for 
PCR amplification of the baiH gene using primers baiHF-
PstI (5’-TAGCACTGCAGGCCTATGTT-3’) containing PstI 
restriction site and baiHR-SacI (5’-ATCAGAGCTCATTGCCTTCAC-
3’) containing SacI restriction site (Figure 12). The 
expression vector for the baiCD gene from Clostridium 
scindens VPI 12708 was constructed in pSPORT1 (Invitrogen, 
Carlsbad, CA). The baiCD gene was cloned using primers 
baiCDF-Sal1 (5’-CCGTCGACGGAGGAGTAACAAAATGAGTTACG-3’) 
containing SalI restriction site and baiCDR-BglII (5’-
CGTAAGCTTCTAGATTGCCATTCCTGCGTC-3’) containing BglII  
restriction site.  The baiJ gene was PCR amplified using 
primers 12708baiJ-F (5’-
TGCATCTCCCTCGAGGGCACATTATGTTCCAGGC-3’) containing XhoI 
restriction site (bold) and 12708baiJ-R (5’-
TACAGGTACCAAGCATTGACTGTCCCGATGCT-3’) containing KpnI 
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Figure 12.   Schematic representation of cloning strategy 
for baiH gene from Clostridium scindens VPI 
12708.  Primers baiHF-PstI and baiHR-SacI 
(see text) with internally designed 
restriction sites were used to amplify a 2.2 
kb stretch encoding the baiH gene.  
Following restriction digestion of both the 
insert and vector, and GENECLEAN 
purification of electrophoresed restriction 
products, the 2.2 kb baiH insert was ligated 
with T4 DNA ligase to the 4.1 kb pSport1 
vector with PstI and SacI “sticky ends” 
generating the 6.3 kb vector pSport1-baiH.   
 
 
 
76
baiH
2.0 kb
PCR
Forward primer carrying 
PstI site
Reverse primer carrying 
SacI site
baiIbaiG
baiH
2.2 kb
5′
3′
PstI
SacI
baiH
2.2 kb SacI
PstI PstI / SacI digestion
Ligation
pSPORT1
(4.1 kb)
baiH gene (2.2 kb)
pSPORT1-
baiH
(6.3 kb)
Amp
Ori
LacI
Promoter
T7 
Promoter
LacILacI
LacII
promoter
T7 
Promoter
Ori
Amp
PstI SacI
77
 restriction site (bold). The baiL gene was PCR amplified 
using forward primer baiLpETF (5’-
GTCAGAATTCCAGTTTGCCATGGAGG-3’) containing EcoRI 
restriction site (bold) and reverse oligonucleotide 
baiLpETR (5’ ATTCTCGAGCATATTCAGGAAGCCGGCGTCG-3’)containing 
XhoI site (bold) for pET-21a(+) vector.   
The PCR reaction mixture contained 100 ng of C. 
scindens VPI 12708 genomic DNA, 100 pmol each primer, 0.3 
mM dNTPs, Pfu polymerase buffer, and 2.5 U Pfu DNA 
polymerase in a total volume of 50 μl.  Cycling parameters 
included an initial 3 min denaturation at 94˚C followed by 
30 cycles of amplification 94˚C for 35 s, 52˚C for 30 s 
and 68˚C for 2 min followed by one additional 7 min 
elongation at 68˚C. Amplification of the baiH PCR product 
was performed on a DNA Thermal cycler (MJ research, 
Watertown, MA).   
The baiJ gene and all subsequent PCRs were performed 
on an Eppendorf Mastercycler Gradient PCR thermocycler 
(Eppendorf, Westbury, NY, USA).  The baiH PCR product and 
pSport1 (Invitrogen, Carlsbad, CA) vector were double-
digested with PstI and SacI, gel purified (GENECLEAN spin 
kit) and ligated with T4 DNA ligase (New England Biolabs). 
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 The baiJ PCR product and pT7-SBP-2 Expression vector 
(Sigma, St. Louis, MO) were double-digested with XhoI and 
KpnI, gel purified (GENECLEAN spin kit) and ligated with 
T4 DNA ligase (New England Biolabs, Ipswich, MA, USA).   
Plasmids were transformed into E. coli DH5α (Bio-line, 
Randolph, MA) by electroporation using an Eppendorf 2510 
electroporator at 2500V. The recombinant plasmids 
(pSport1-baiH, pT7SBP2baiJ, p12708baiL) were purified from 
E. coli DH5α and transformed into E. coli BL21-CodonPlus 
(DE3)-RIL or ArcticExpress E. coli for overexpression.  
The sequence was verified at the Virginia Commonwealth 
University Nucleic Acid Core Facility using standard 
primers.    
 
Polyacrylamide gel electrophoresis and immunoblot analysis 
 
Protein samples were separated and analyzed on a 10% 
SDS-polyacrylamide gel electrophoresis (PAGE) (170). 
Protein samples were prepared for SDS-PAGE by heating for 
5 min at 100˚C in an equal volume of sample buffer (0.1 M 
Tris-HCl, 5 % SDS, 0.9 % 2-mercaptoethanol (2ME), 20 % 
glycerol, pH 6.8). Gels were stained with 0.2 % (w/v) 
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 Coomassie brilliant blue R-250 (Sigma, St. Louis, MO) in 
ethanol: acetic acid: water (30:10:60, v/v/v). A broad-
range protein weight marker (Bio-Rad, Hercules, CA) was 
used for protein size determinations. For western blot 
analysis, proteins were similarly separated by SDS-PAGE, 
and electrophoretically transferred to a nitrocellulose 
membrane by electroblotting using a Bio-Rad Immuno-Blot 
assay kit.  
Antiserum against purified baiH gene product was 
raised in rabbits as described previously (121).   
Detection of the baiH gene product on nitrocellulose 
membranes was performed using a goat anti-rabbit alkaline 
phosphatase conjugate.   Detection of the baiJ gene 
product was performed using anti-Strep-Tactin Horse radish 
peroxidase(HRP) conjugate (IBA, Gottingen, Germany). 
Detection of the baiL gene product was performed using 
Novagen HRP Anti-his tag monoclonal antibody (Novagen, 
Madison, WI, USA).   
Enzyme Assays  
 NADH:FOR activity was determined at 25˚C by 
monitoring the oxidation of NADH at 340 nm (ε340=6.22 mM-
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 1cm-1) using a Beckman DU-640 spectrophotometer (Fullerton, 
CA). The standard assay mixture (1 ml) contained 100 mM 
sodium phosphate buffer (pH 6.8), 150 μM NADH, 150 μM FAD 
and an appropriate amount of enzyme added to initiate the 
reaction. Assays were performed under aerobic conditions 
in a 1 ml quartz cuvette with a 1 cm pathlength. One unit 
of NADH:FOR activity is defined as the amount of enzyme 
catalyzing the oxidation of 1 μmol of NADH min-1mg-1 of 
protein. Protein concentrations were determined according 
to Bradford (171) using the Bio-Rad protein assay kit, 
with BSA as standard for routine assays. 
BaiH and BaiCD oxidoreductase activity assays were 
performed in reaction mixtures containing the following: 
50 mM sodium phosphate buffer (pH 6.8), 1.5 mM NAD+,  225 
μM [24-14C]-3-dehydro-UDCA (3-oxo-7β-hydroxy) or [24-14C]-3-
dehydro-CDCA  (3-oxo-7α-hydroxy)  (specific activity of 
0.01 μCi μmole-1 substrate) and purified recombinant BaiH 
protein (100 μg) or 1 mg cell extract containing 
overexpressed BaiCD.  
BaiJ oxidoreductase activity assay was performed in 
the following mixture:  100 mM sodium phosphate buffer (pH 
6.8), 1.5 mM NAD+ (or NADP+), 90 μM [24-14C] 3-dehydro-
81
 DCA(~SCoA) (specific activity 550 DPM/nmole).  The 
reaction mixture (500 μl) was incubated 37 oC for 30 min.  
BaiJ reaction was initially brought to pH 10 with 5N NaOH 
and boiled 30 min to hydrolyze CoA ester (125).  The pH 
was then lowered to ~3 with 5 N HCl and bile acid 
metabolites were extracted three times with 1 vol ethyl 
acetate, dried under a stream of nitrogen gas, dissolved 
in 15 μl MeOH, spotted, separated by thin layer 
chromatography on Baker flex silica gel IB-2 plates (J.T 
Baker Chemical Co, Philipsburg, NJ) using a solvent system 
S1 (benzene:dioxane:glacial acetic acid 75:20:2 (v/v/v)) 
and radiolabeled bile acid metabolites were visualized by 
autoradiography (Kodak MS film, Rochester, N.Y) (172). 
Extracts prepared from E. coli containing pSport plasmids 
without baiH or baiCD gene inserts served as negative 
controls. Sections of TLC silica gel containing bile acid 
reaction products were scraped and radioactivity 
quantified by liquid scintillation spectrometry (Packard, 
Meriden, CT). 
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 Expression and purification of recombinant baiH gene 
product 
 
E. coli BL21-CodonPlus(DE3)-RIL harboring pSport1-
baiH were grown in 5 ml of modified TYGPN medium 
containing 100 μg of ampicillin per ml at 37˚C for 8 hrs. 
The culture was stored at 4˚C overnight. The next day, 
cells were collected by centrifugation (3,000 × g, 10 min) 
and suspended in 5 ml of TYGPN medium containing 100 μg/ml 
ampicillin. This cell suspension was used to inoculate 2 
liter flasks containing 600 ml TYGPN broth medium 
containing 100 μg/ml ampicillin. The cells were cultivated 
at 37˚C with shaking at 250 rpm for about 3 hr to reach an 
A600 of about 0.4 at which point the cultures were induced 
by addition of isopropyl-β-D-thiogalactopyranoside (IPTG) 
to 1 mM final concentration. Cultures were grown at 25˚C 
for an additional 4 hr at which time the cells were 
harvested by centrifugation at 5,500 × g, 15 min at 4˚C. 
The cells were suspended in 400 ml of buffer A (50 mM 
sodium phosphate buffer; pH 6.8, 2% (w/v) glycerol, 15 mM 
of 2-mercaptoethanol (2ME)) cells were lysed by sonicating 
twice for 10 min intervals and cell debris removed by 
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 centrifugation at 21,000 × g for 30 min. The supernatant 
fluid containing soluble recombinant BaiH was removed for 
further purification.  
All purification methods were followed essentially as 
described previously with some modifications (129). Frozen 
cells were suspended in buffer A, disrupted by sonication 
on ice, and centrifuged at 21,000 × g for 30 min. Protein 
was concentrated and protein under 50 kDa removed using 
Centriprep YM50 (50 kDa cut-off) concentrators (Millipore, 
Billerica, MA). The protein solution was then applied to a 
2 x 10 cm Protein–Pak DEAE 40HR column (Waters, Milford, 
MA) equilibrated with buffer A. After the column was 
washed with 60 ml of buffer A, NADH:FOR was eluted with a 
500 ml linear gradient of NaCl (0 to 1.0 M) in buffer A at 
a flow rate of 2 ml min-1. Fractions with a yellow color 
and NADH:FOR activity were pooled and dialyzed overnight 
against 2 L of the same buffer. The dialyzed solution was 
loaded onto a 1.0 × 5.5 cm Cibacron blue 3GA agarose 
column (Sigma, St. Louis, MO) equilibrated with buffer A. 
The column was then washed with 100 ml of buffer A, and 
protein partially eluted with 20 ml of buffer A containing 
1 mM NADH, 1 mM FAD, and 20 mM dithiothreitol (DTT). The 
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 remaining protein was eluted with buffer A containing 1M 
KCl. Active protein fractions eluted with NAD and FAD were 
pooled and loaded onto a 1.0 × 6.4 cm Bio-Scale CHT5-1 
hydroxyapatite column (Bio-Rad, Hercules, CA) equilibrated 
with buffer C (5 mM potassium phosphate buffer pH 7.0, 2% 
glycerol, 15 mM 2-ME). After the column was washed with 
buffer C at 1ml min-1, active fractions were eluted with a 
linear gradient of 0 to 0.5 M potassium phosphate (pH 
7.0). The purified protein from this step was dialyzed 
with buffer A, concentrated by a Centriprep YM50 
concentrator and stored in buffer A containing 50% 
glycerol (w/v) at -20 ˚C.  Protein remained active for 4 
weeks under these conditions. 
 
Expression and purification of the baiJ and baiL gene 
product 
 
E. coli Arctic ExpressBL21-CodonPlus(DE3)-RIL 
harboring pT7SBP-baiJ (Figure 13) was grown in 5 ml of LB 
medium (tryptone 10 g; yeast extract 5g; NaCl 10g) with 
100 μg of ampicillin per ml at 37˚C for 8 hrs. The culture 
was transferred to 2 Liter flasks containing 500 ml 
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Figure 13.  Cloning strategy for baiJ gene from C. 
scindens VPI 12708. The baiJ gene was PCR 
amplified using primers 12708baiJ-F (5’-
TGCATCTCCCTCGAGGGCACATTATGTTCCAGGC-3’) 
containing XhoI restriction site (bold) and 
12708baiJ-R (5’-
TACAGGTACCAAGCATTGACTGTCCCGATGCT-3’) 
containing KpnI restriction site (bold). 
Double digestion of PCR product and vector 
pT7SBP-2 with XhoI and KpnI, gel 
purification and ligation resulted in vector 
pT7SBP2baiJ. 
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 Modified TYGPN broth medium containing 100 μg/ml 
ampicillin. The cells were cultivated at 18˚C with shaking 
at 250 rpm for about 18 hr to reach an A600 of about 0.4 at 
which point the cultures were induced by addition of IPTG 
to 0.8 mM final concentration. Cultures were grown for an 
additional 12 hr at which time the cells were harvested by 
centrifugation at 5,500 × g, 15 min at 4˚C. The cells were 
suspended in 40 ml of Strep buffer (50 mM sodium phosphate 
buffer; pH 7.9, 15 mM of 2-mercaptoethanol (2ME) and 1M 
NaCl) and the cells were lysed by sonicating twice for 15 
min intervals. Cell debris was removed by centrifugation 
at 21,000 × g for 30 min. The supernatant fluid containing 
soluble recombinant BaiJ was removed for further 
purification.  
All purification methods using IBA Strep-tag 
purification were followed according to the manufacturer 
(IBA, Gottingen, Germany). Eluents were concentrated by 
Centriprep YM10 (10 kDa cut-off) concentrators (Millipore, 
Billerica, MA).  
The baiL gene was expressed in E. coli BL21 
CodonPlus(DE3)-RIL in a similar manor to the baiJ gene, 
except at 25˚C and 3 hour growth following induction with 
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 IPTG.  Protein concentration was determined by Bradford 
protein assay.  
 
Enzymatic and biological preparation of bile acid 
substrates 
 
[24-14C]-CDCA was purchased from American Radiolabeled 
Chemicals, Inc. (St. Louis, Mo), and determined to be 
99.9% pure by TLC.  C. absonum expresses both 7α-HSDH and 
7β-HSDH and can be used to efficiently epimerize CDCA to 
UDCA (76, 77).  [24-14C]-UDCA was biologically synthesized 
from [24-14C]-CDCA using Clostridium absonum ATCC 27555 
grown in BHI.  C. absonum was induced at O.D600nm 0.4 by 
addition of 200 μM sodium chenodeoxycholate (CDCA) plus 2 
μCi of [24-14C]-CDCA for production of [24-14C]-UDCA (0.01 
μCi μmole-1).   After 24 hr growth following induction, the 
pH of the culture medium was lowered to ~pH 3 and bile 
acid metabolites were extracted twice with ethyl acetate, 
dried under a stream of nitrogen gas and dissolved in 100 
μl of absolute methanol (MeOH). [24-14C] CDCA, [24-14C] 7-
oxo-LCA and [24-14C] UDCA were separated by TLC as 
described above.  Non-radiolabeled CDCA and UDCA standards 
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 (Sigma, St. Louis, Mo, USA) were also chromatographed 
along with the radiolabeled reaction products and this 
portion of the plate stained with phosphomolybdic acid for 
detection. Radiolabeled bands co-migrating with UDCA 
standard (Sigma) were scraped and extracted with ethyl 
acetate, dried, and suspended in MeOH.  
[24-14C] UDCA was converted to [24-14C] 3-dehydro-UDCA 
(3-oxo-7β-hydroxy) enzymatically using commercially 
available 3α-HSDH (Sigma) in the following reaction 
mixture: 0.5 ml total volume 50 mM sodium phosphate buffer 
(pH 6.8), 1 U 3α-hydroxysteroid dehydrogenase, 1.5 mM NAD+, 
100 μM unlabeled UDCA and 1 μCi  [24-14C]-UDCA. The 
reaction mixture was allowed to incubate for 4 h at 37 oC.  
Bile acids were separated by TLC as described above and 
radiolabeled bile acid reaction products were detected by 
autoradiography. 
[24-14C] 3-oxo-DCA was produced from commercially 
available [24-14C] CA and non-labeled CA (Sigma).  1 μCi 
[24-14C] CA and 5μl 100 mM CA (500 nmoles) was added to 5 
ml BHI and inoculated with C. scindens VPI 12708 and grown 
48 hrs at 37˚C.  The reaction products were extracted in 
the usual manner.  The concentrated reaction products were 
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 separated by TLC in solvent system S1 (172).  The band 
corresponding to DCA standard was scraped and [24-14C] DCA 
was extracted with ethyl acetate and concentrated under 
nitrogen gas.  The pellet was resuspended in 50 mM sodium 
phosphate buffer and reacted with commercially available 
3α-HSDH in the presence of 100 μM NAD+ as co-substrate.  
Substrate and product were separated by TLC and band 
corresponding to [24-14C] 3-oxo-DCA (Rf=1.74; Solvent SI) 
was extracted (118).   
 
 
 
Chemical synthesis of bile acid substrates 
 
3-oxo-DCA-CoA is hypothesized to be a common 
substrate for both the baiJ and baiL gene products.  Thus, 
3-oxo-DCA was synthesized from commercially available DCA 
essentially as described by Jones et al. (1949) and 
Danielsson et al. (1962) with some modifications (173, 
174).   Toluene was substituted for benzene in the reflux 
step as well as the chromatography.   Briefly, 5 grams of 
deoxycholic acid was methylated overnight in 250 ml 
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 absolute methanol and 3 ml concentrated sulfuric acid.    
The solvent was evaporated under nitrogen gas and the 
crude methyl ester was resuspended in chloroform and 
chromatographed over 100 g silicic acid with a step-wise 
gradient of acetone in chloroform up to 25%.  The DCA-
methyl ester was then oxidized in 140 ml toluene and 55 ml 
acetone with 5.3 g aluminum tert.-butoxide under reflux 
for 18 hours.  After cooling, the reaction mixture was 
poured into an equal volume 2N sulfuric acid and 
emulsified.  The toluene layer was separated and washed 
once again with 2N sulfuric acid followed by equal volumes 
of 7% sodium hydrogen carbonate (twice), and water (once).  
The toluene layer was then dried under CaCl2 and 
evaporated.  The methyl ester was hydrolyzed overnight in 
2 M methanolic potassium hydroxide.  The crude acid was 
added slowly to 0.5 N HCl and filtered under vacuum.  The 
crude acid was dissolved in ethyl acetate, dried with 
sodium sulfate, concentrated under nitrogen gas and 
chromatographed on 100 g silicic acid with an increasing 
gradient of acetone in toluene.  Fractions eluted with 15% 
acetone in toluene yielded semi-pure 3-oxo-DCA as observed 
on thin layer chromatography. Identity of 3-oxo-DCA was 
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 confirmed by comparison of Rf value after reaction with 3α-
HSDH in the presence of 150 μM NADH.  Commercially 
available deoxycholic acid (Sigma) was used as a standard. 
Material used in enzyme reactions was scraped from TLC 
plate and purified by ethyl acetate extraction.   
 The sodium hydrogen carbonate fraction was acidified 
with dilute (10% v/v) sulfuric acid and allowed to 
precipitate overnight.  The precipitate was vaccum 
filtered and worked up and purified as described above.   
Pure 3-oxo-DCA was esterified to coenzyme A by the 
method of Killenberg and Dukes (1976) which was a slight 
modification of Shah and Staple (1968) (175, 176).  
Tetrahydofuran and methylene chloride were distilled prior 
to use and γ-collidine was dried over sodium sulfate. 3.5 
mg [24-14C] 3-oxo-DCA (550 DPM/nmole) was added to 700 μl 
dry methylene chloride and incubated ten minutes at room 
temperature.  250 μl of methylene chloride containing 1.4 
μl ethyl chloroformate was added and the solution was 
magnetically stirred on low for one hour.  The solvent was 
then evaporated under nitrogen gas and the pellet was 
suspended in 600 μl tetrahydrofuran.  The tetrahydrofuran 
solution was slowly added to 600 μl solution of 62.5 M CoA 
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 in water (pH 8.0).  After fifteen minute incubation, the 
pH was lowered to 5 with 1% perchloric acid and the 
organic solvent evaporated under nitrogen gas.  The 
aqueous layer containing 3-oxo-deoxycholyl-CoA was washed 
three times with 2 vol diethyl ether.  The aqueous 
solution was acidified with 170 ml 10% perchloric acid and 
the 3-oxo-deoxycholyl-CoA was collected by centrifugation 
at 15,000 x g for 30 minutes.  The pellet was stored at -
80˚C overnight and used the next day.   
Purification and mass spectrometry of BaiCD and BaiH 
reaction products 
The analysis and identification of BaiH catalyzed 
bile acid reaction product was carried out on a Shimadzu 
HPLC (Kyoto, Japan) with a SIL-HTC Autosampler by reverse-
phase HPLC using a Brownlee RP-300 (Perkin Elmer, 
Wellesley, MA) C8 7m 2.1 i.d. × 100 mm column. The mobile 
phase consisted of 10 mM ammonium acetate (solvent A) and 
10 mM ammonium acetate in acetonitrile (solvent B). The 
column was equilibrated in solvent A. After injection of a 
5 ml sample of the bile acid, solvent B was increased from 
0-100% at 10% min-1. The column was regenerated by 
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 switching back to solvent A and re-equilibrating for 5 
min. The flow rate was 0.2 ml min-1 and the eluted material 
was passed into the electrospray ionization interface of a 
MDS Sciex/Applied Biosystems API 4000 Q Trap (Foster city, 
CA) operating in the negative ion mode. Mass spectra were 
recorded over a 350-700 m/z range.       
 
Genome-walking by polymerase chain reaction 
 
Genome-walking DNA libraries were prepared using the 
Clontech Universal Genome-Walker Kit according to the 
manufacturer.  DNA was prepared essentially as described 
previously (177) with a few alterations.  To produce high 
molecular weight DNA (~50 kb), pipetting steps during 
phenol/phenol:chloroform:iso-amyl alcohol were changed to 
pouring the aqueous phase, which prevents substantial DNA 
sheering.  An 18 gauge needle was used to pierce the very 
bottom of 50 ml falcon conical tubes following 
centrifugation and the organic phase was emptied.  DNA was 
then precipitated by addition of 10% 3N sodium acetate and 
3 volumes of absolute ethanol, washed and resuspended in 
TE buffer, ph 7.6, overnight with agitation at 45 ˚C.    
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 DNA quality was determined on a 0.5% agarose gel 
containing 75 μg/ml ethidium bromide.  Prior to 
electrophoresis, the DNA sample was heated to 65˚C.  The 
gel was run 18 hours at 25 V overnight along with a High 
Molecular Weight DNA Marker (Invitrogen).  DNA >48 kb was 
restriction digested and adapter ligated using 
GenomeWalker kit. Genomic DNA libraries were stored at -
20˚C.  Oligonucleotides were designed using Primer3 
software with Tm values between 60˚C and 70˚C with ≥ 45% 
G+C and ≥ 25 mer in length.  
 PCR reactions were prepared using Advantage cDNA 
Polymerase Kit or Advantage 2 Polymerase Kit (Clontech) as 
follows:  40 μl ddH2O, 5 μl 10x Advantage PCR buffer, 1 μl 
dNTP mix (10 mM each), 1 μl adaptor primer AP1 (10 μM), 1 
μl gene-specific primer (10 μM), 1 μl Advantage Polymerase 
mix (50X) and 1 μl adaptor-ligated DNA restriction library 
template.  Reaction mixtures were mixed briefly and tubes 
quick spun.  “Touchdown” PCR amplification was performed 
on Eppendorf Mastercylcer Gradient PCR machine using the 
following parameters:  95˚C for 25 s, 72˚C for 3 min (7 
cycles); 94˚C for 25 s, 67˚C for 3 min (32 cycles); 67˚C 
for 7 min, hold 4˚C.  Products (5 μl) were separated by 
96
 electrophoresis on a 1% agarose/EtBr gel and visualized on 
a Fotodyne analyzer.  PCR products of interest were 
GENECLEAN purified from the gel and ligated into a pCR8 GW 
TOPO TA Cloning vector (Invitrogen) and transformed into 
TOP 10 Chemically Competant E. coli according to the 
manufacturer (Invitrogen).  Colonies were cultivated in LB 
broth containing 100 μg/ml spectinomycin.  Plasmids were 
purified using Qiagen Miniprep Spin Kit according to the 
manufacturer.  Sequencing was performed at the Nucleic 
Acid Research Facility, School of Medicine, Virginia 
Commonwealth University on ABI 3700 Sequencer using 
oligonucleotides synthesized by Integrated DNA 
Technologies (Coralville, IA, USA).   
 
SMART-RACE Polymerase Chain Reaction  
C. scindens VPI 12708 as well as C. hylemonae were 
cultivated in 400 ml BHI containing 0.02% fructose to an 
O.D.600nm 0.3 (C. scindens) or 0.2 (C. hylemonae) at which 
point the cultures were induced 3 times at hourly 
intervals with 50 μM CA.  One hour after the third 
induction, 1 ml culture was transferred to a serum bottle 
containing [24-14C] CA (0.5 μCi/500 nmoles) and incubated 
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 37˚C 30 minutes.  A non-induced control was also tested 
for 7α-dehydroxylation activity.  Cells were centrifuged 
13,000 x g for 30 min at 4˚C.  The cell pellet was 
suspended in 1 ml TE buffer and cells transferred to 1.5 
ml microcentrifuge tube and spun 1 min at 13,600 x g.  The 
supernatant was decanted and bacterial cells were stored 
in RNAlater solution (Ambion, Austin, TX, USA) and stored 
at - 70˚C until further processing.  
 Once 7α-dehydroxylating activity, and thus induction, 
was confirmed by presence of [24-14C] DCA in [24-14C] 
activity assay, total RNA was extracted using the Ribopure 
Bacteria RNA extraction kit (Ambion) essentially according 
to the manufacturer with the exception that cells were 
broken on a Mini-bead beater (Biospec Products Inc, 
Bartlesville, OK, USA) at 3,000 rpm for two cycles of 1 
min.  Optional DNase treatment was performed for 1 hour at 
37˚C.  Some of the RNA was poly-A tailed prior to cDNA 
synthesis using the A-Plus Poly(A) Polymerase Tailing Kit 
(Epicentre Biotechnologies, Madison, WI) according to the 
manufacturer with a 15 minute extension time.  cDNA was 
generated using the SMART-RACE cDNA synthesis kit 
(Clontech) according to the manufacturer starting with 1 
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 μg total RNA. 5’CDS primer and 3’CDS primer (Clontech) 
were used to make 5’ RACE ready cDNA and 3’ RACE ready 
cDNA, respectively, when poly-A RNA was used as the 
template; whereas gene-specific primers replaced 5’CDS 
primer and 3’ CDS primer when total bacterial RNA was used 
as template. Reaction was carried out for 1.5 hrs at 42˚C 
and terminated by addition of 50 μl TE buffer pH 7.6 and 
heating at 70˚C for 7 minutes.  SMART RACE PCR of 5’ ends 
was performed using the Advantage-GC 2 PCR Kit (Clontech) 
according to the manufacturer’s instruction.  0.5 μl GC-
Melt was added to each 50 μl reaction volume along with 
2.5 μl cDNA sample.  A nested PCR was performed when 
product concentration was low or to reduce non-specific 
products.  PCR products were excised from agarose gel and 
purified using the GENECLEAN Spin Kit (MP Biomedicals, 
Solon, Ohio).  The purified PCR product was then cloned 
into a pCR8 GW TOPO TA cloning vector (Invitrogen), 
transformed into TOP 10 Chemically Competent E. coli 
(Invitrogen) and selected on LB agar containing 100 μg/ml 
spectinomycin.  Plasmids containing insert were sequenced.   
 
Sequence analysis and Assembly 
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Sequence ABI files were edited and assembled using 
Vector NTI software (Invitrogen, Carlsbad, CA, USA), as 
well as CAP3 Sequence Assembly Program     
http://pbil.univ-lyon.fr/cap3.php. Pairwise alignments 
were performed to determine percent identity/similarity 
using EMBOSS Needle program   
http://www.ebi.ac.uk/emboss/align/. Homology searches were 
made against the UniProt database.  Multiple sequence 
alignments were prepared using T-COFFEE 
http://tcoffee.vital-it.ch/cgi-bin/Tcoffeecgi/index.cgi 
(178) or CLUSTALW2   
http://www.edi.ac.uk/Tools/clustalw2/index.html with some 
manual editing based on structural data.  Sequence 
conservation within multiple alignments was emphasized 
using the BOXSHADE utility 
http://www.ch.embnet.org/software/BOX_form.html.Protein Mr 
calculations were performed using the Compute pI/MW tool 
on the Expasy Proteomics Server 
http://www.expasy.ch/tools/pitool.html. Open reading 
frames (ORF) were detected using the ORF Finder Program 
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 http://www.ncbi.nlm.nih.gov/gorf/gorf.html and searched 
against Genbank by BLAST analysis (179).   
Clostridium scindens VPI 12708 baiH (AAC45417) and 
Clostridium hiranonis baiCD (AAF22846) genes were 
sequenced previously (59).  Secondary structural 
predictions were carried out with the PSIPRED program 
(http://bioinf.cs.ucl.ac.uk/psipred/) (180, 181).  
Secondary structural predictions of the BaiH gene product 
were compared with the known secondary structure from the 
crystal structure of 2, 4-dienoyl CoA reductase (dcr) from 
Escherichia coli (182).    
 
Nucleotide sequence accession number 
 
The baiC and baiD genes from C. scindens were 
originally reported as separate genes, however, after 
discovery that the baiCD is a single gene product in C. 
hiranonis, the baiC and baiD gene region was resequenced 
from C. scindens and found to encode a single gene (D.H. 
Mallonee and P.B. Hylemon, unpublished data).  Also, a 
baiH gene has been located downstream of the bai operon in 
C. hiranonis and has not been reported previously (J.E. 
101
 Wells and P.B. Hylemon, unpublished data).  GenBank 
accession numbers for the baiCD gene from C. scindens VPI 
12708 is U57489 and the baiH gene from C. hiranonis TO931 
is AF210152.  Genbank accession numbers for the 
baiBCDEFGHI operon from C. hylemonae TN271 is (EU675332).  
The baiA gene from C. hylemonae TN271 can be found using 
accession number (EU675329).  Genbank accession numbers 
for the baiJKL genes from C. scindens VPI 12708 and C. 
hylemonae TN721 are (Eu675330) and (EU675331), 
respectively.  
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RESULTS 
Characterization of the BaiCD and BaiH 
Amino acid sequence alignment and secondary structural 
prediction of the BaiH.   
Protein-protein BLAST searches of the baiH gene 
product suggests homology with a family of pyridine-
nucleotide dependent flavoproteins (Table 4) including 
NADH oxidase from Thermoanaerobacter brockii (CAA47660) 
(183), 2-enoate reductase from Clostridium tyrobutyricum 
(CAA71086) (184) and Moorella thermoacetica (CAA76082) 
(184), 2, 4-dienoyl-CoA reductase from several bacterial 
species, and Old yellow enzyme (OYE) from 
Thermoanaerobacter tengcongensis (NP_623692) (185).  E. 
coli 2, 4-dienoyl CoA reductase (dcr) (AAC76116) is a 73 
kDa protein which uses NADPH as an electron donor and 
contains a 4Fe-4S cluster, 1 mol FMN, and 1 mol FAD per 
mole subunit (182). The dcr gene product from E. coli 
shares 32 % identity and 49 % similarity at the amino acid 
sequence level with the baiH gene product from C. scindens 
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 VPI 12708.  A 2.4 Å structure has been solved for the E. 
coli dcr gene product allowing a basis of comparison for 
secondary structure prediction of the baiH gene product 
(Figure 14).  The predicted secondary structure of the 
BaiH is very similar to that of the dcr gene product 
suggesting a similar TIM-barrel fold.  It is interesting 
to note the conserved cysteine consensus pattern of C-
(2X)-C-(2-3X)-C-(11-12X)-C between the BaiH, E. coli Dcr 
and other homologues suggesting that the BaiH and BaiCD 
contain 4Fe-4S centers. 
 Several baiCD and baiH homologues introduce carbon-
carbon double bonds.  This suggests that the baiCD and 
baiH gene products encode flavoproteins which may 
introduce carbon-carbon double bonds into the bile acid 
structure.  Previously, we identified a 3-oxo-Δ4-cholic 
acid intermediate in the bile acid 7α-dehydroxylation 
pathway (117).  Because there are two homologous genes and 
two stereochemistries differing about the 7-hydroxyl 
between CA, CDCA (7α-hydroxy) and UDCA (7β-hydroxy), we 
hypothesize that the baiCD and baiH introduce the Δ4-bond 
in bile acids, recognizing one stereochemistry about the 
7-hydroxyl or the other.   
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Figure 14.  Amino acid sequence alignment of the BaiH 
(AAC45417) from C. scindens VPI 12708 with 
protein homologues: 2,4-dienoyl-CoA 
reductase (dcr) (AAC76116) from E. coli, 2-
enoate reductase (CAA71086) from C. 
tyrobutyricum, the baiCD gene product from 
C. scindens (EF539210) and C. hiranonas 
(AAF22846) and the baiH gene product from C. 
hiranonis (EF539211)  Secondary structural 
elements based on the crystal structure of 
DCR (182) are shown (below alignment).  
Predicted secondary structural elements of 
the BaiH protein are also shown (above 
alignment).  Arrows correspond to β-sheets 
and loops to α helices.  Residues 
corresponding to FMN binding (■), FAD 
binding (*), and cysteine residues involved 
in a 4Fe-4S center (♦) from the crystal 
structure of DCR are also shown.  The 
alignment was generated with the T-COFFEE 
program (178) and sequence 
similarities/identities highlighted with 
Boxshade 3.1. 
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12708H    MDMKHSRLFSPLQIGSLTLSNRVGMAPMSMD-YEAADGTVPKRLADVFVRRAEGGTGYVMIDAVTIDSK----YPYMGNTTALDRDELVPQFKEFADRVKEAGSTLVPQIIH----PGPE 111 
TO931H    MDMKNSKLFSPLTIGSLTLNNRVGMAPMSMD-YEAADGTVPKRLADIFVRRAEGGTGYVTIDAVTIDSK----YKYMGNTTALDSDDLVTQFKEFATRVREAGSTLIPQVIH----PGPE 111  
12708CD   --MSYEALFSPFKVRGLELKNRIVLPGMNTK-MAKNKHDIGEDMIAYHVARAKAGCALNIFECVALCPAP-HAYMYMG----LYTDHHVEQLKKLTDAVHEAGGKMGIQLWH----GGFS 108
TO931CD   --MSYDALFSPFKIRGLELKNRIVLPGMNTK-MAKNKHDLSDDMIAYHVARAKAGCALNIFECVALCPAP-HAYMYMG----LYNDNHVAQLKKLTDAVHEVGGKMAVQLWH----GGFS 108
enr       --MKNKSLFEPIKIGKVEVKNKISMAPMGAFGLVDNEGCYNQRAVDYYVERAKGGTGLIITSITKVENEIDKVVPGVIPIISINPGRFIMTSSEMTERVHAYGSKIFLQLTMGFGRSGAP 118
dcr       --MSYPSLFAPLDLGFTTLKNRVLMGSMHTG--LEEYPDGAERLAAFYAERARHGVALIVSGGIAPDLTG----VGMEGGAMLNDASQIPHHRTITEAVHQEGGKIALQILH-------T 105
12708H    SVCGYRHIAPLGPSANTNANCHVSRSISIDEIHDIIKQFGQAARRAEEAGCGAISLHCAHAYMLPGSFLSPLRNKRMDEYGGSLDNRARFVIEMIEEARRNVSPDFPIFLRIS------- 224  
TO931H    SICGYRHIAPLGPSVNTNANCHVSRAISVDEIHEIIKQFGQAARRVEEAGCGGIGLHCAHAYMLPGSFLSPLRNKRMDEYGGCLDNRARFVIEMIEEVRRNVSPDFPIMLRIS------- 224   
12708CD   PQMFFDETN----------TLETPDTLTVERIHEIVEEFGRGARMAVQAGFDAVEFHAAHSYLP-HEFLSPGMNKRTDEYGGSFENRCRFCYEVVQAIRSNIPDDMPFFMRADC------ 211    
TO931CD   PQMFFDKTN----------TLETPDTITVERIHEIVKEFGEGARRAVEAGFDAVEFHAAHSYLP-HEFLSPGMNKRTDEYGGNFENRCRFCFEVVEAIRANIPEDMPFFMRVDC------ 211    
enr       GTLLTSQPVSASSVPNYWDPTVTCRELTTSEVEWIVAKFIQGAAIAQKAGFDGVEIHAVHEGYLLDQFTLSIFNRRTDKYGGDLRGRLQLPIEIVQGIKAQVGSDFPVGLRYSVKSCIKD 238   
dcr       GRYSYQPHLVAPSALQAPINRFVPHELSHEEILQLIDNFARCAQLAREAGYDGVEVMGS-EGYLINEFLTLRTNQRSDQWGGDYRNRMRFAVEVVRAVRERVGNDFIIIYRLS------- 217  
  
12708H     -------GDERMIGGNSLEDMLYLAPKFVEAGVNMFEVSGG-TQYEGLEHIIPCQNKSRGVNVYEASEIKKVVGIPVYAVGKINDIRYAAEIVERGLVDGVAMGRPLLADPDLCKKAVEG 336    
TO931H     -------GDERMVGGNSLEDMLYLAPKFEAAGVSMLEVSGG-TQYEGLEHIIPSQNKSIGVNVHEASEIKKVVDVPVYAVGKINDIRYAAEIVERGLVDGVSIGRPLLADPDLCNKAKEN 336    
12708CD    -------IDELMEQTMTEEEIVTFINKCAELGVDVADLSRGNATSFATVYEVPPFNLAHGFNIENIYNIKKQINIPVMGVGRINTGEMANKVIEEGKFDLVGIGRAQLADPNWITKVREG 324  
TO931CD    -------IDELMDEVMTEEEIVEFINRCADLGVDVADLSRGNAQSFATVYEVPPFNLQHGFNIENIYNIKKQIKIPVMGVGRINTGEMANQVIADGKFDLVGIGRAQLADQDWVAKVREG 324   
enr        WRQGGLPDEDYVEKGRDLEEGLESPQILEAAGYDELNTDVG--TYDAWYWSHPPLYQKDGLYLPYTQELEKVVKIPVIVAGKLGVPQEAEKALDEGGADMIGLARPLLSDAYWPKKVLSG 356    
dcr        -------MLDLVEDGGTFAETVELAQAIEAAGATIINTGIG---WHEARIPTIATPVPRGAFSWVTRKLKGHVSLPLVTTNRINDPQVADDILSRGDADMVSMARPFLADAELLSKAQSG 327   
12708H     QFDEITPCASCGGSCISRSEAAPECH--CHINPRLGREYEFPDVPAEKSKKVLVIGAGPGGMMAAVTAAERGHDVTVWEADDKIGGQLNLAVVAPGKQEMTQWMVHLNYRAKKAGVKFEF 454
TO931H     LFDEITPCASCGGSCISRTADRPQCR--CHINPRVGFEYDYPEVPAEKSKKVLVVGAGPGGMMAAVTAAERGHDVTLWEADTQIGGQINLAVVAPGKQEMTKWLSHLNYRAKKAGVKMVL 454     
12708CD    KEDLIRHCIGCDQGCYDAVINPKMKHITCTHNPGLCLEY-QGMPKTDAPKKVMIVGGGMAGMIAAEVLKTRGHNPVIFEASDKLAGQFRLAGVAPMKQDWADVAEWEAKEVERLGIEVRL 445   
TO931CD    KEDLIRHCIGCDQGCYDAVINPQMTHITCTRNPHLCLEY-KGMPKTDEPKKVMIIGGGMAGILAAEVLKKRGHEPVIFEASDHLAGQFVLAGKAPMKEDWAAAAKWEAEEVARLGIEVRY 443  
enr        HPERIRPCIGCHVACLGRGFEGKPLS--CAVNPAAGRERYYEIRPAAIPKKVLIAGGGVAGMEAARMAVLRGHKVTLYESTDQLGGEIVPGSVPDFKIDDRRLLDWYRNEMKELKINVIF 474       
dcr        RADEINTCIGCNQACLDQIFVGKVTS--CLVNPRACHETKMPILPAVQKKNLAVVGAGPAGLAFAINAAARGHQVTLFDAHSEIGGQFNIAKQIPGKEEFYETLRYYRRMIEVTGVTLKL 445     
12708H     NKEATAEDVKALAPEAVIVATGAKPLVPPIKGTQDYPVLTAHDFLRGKFVIPKGRVCVLGGGAVACETAETALENARPN--------------SYTRGYD----ASIGDIDVTLVEMLPQ 556      
TO931H     GKEATVENIKEFAPEAVIVATGARPLVPPIKGTQDYPVLTAHDFLRGKFVIPKGKVCVLGGGAVACETAETVLENARPN--------------AFTRGFD----ASIGDVDVTLVEMLPQ 556       
12708CD    NTEVTAETIKEFNPDNVIIAVGSTYALPEIPGIDSPSVYSQYQVLKG-EVNPTGRVAVIGCGLVGTEVAELLASRGAQV--------------IAIERKG----VGTGLSMLRRMFMNPE 544      
TO931CD    NTKVTPELIEEFAPDHVVIAIGSDYVAPAIPGIDSDKVYTQYQVLKG-EVEPKGHVAVVGCGLVGTEVAQYLAARGAQV--------------TAIERKG----VGTGLSMLRRMFMNPE 544     
enr        NTEVTDKLVGKEQPDVVIVATGANDVKIKLPGMEKDKVSTAVDILNG-TKKSGKNVLIVGGGLVGCETALYLAKAGKKV--------------AIVEAKDKILDAGKPIPHMNKIMLEDL 579      
dcr        NHTVTADQLQAF--DETILASGIVPRTPPIDGIDHPKVLSYLDVLRD-KAPVGNKVAIIGCGGIGFDTAMYLSQPGESTSQNIAGFCNEWGIDSSLQQAGGLSPQGMQIPRSPRQIVMLQ 564   
12708H     LLTGV----CAPNREPLIRKLK-SKGVHINVNTKIMEVTDHEVKVQRQDGTQEWLEGFDYVLFGLGSRNYDPLSETLKEFVPEVHVIG--DAVRARQASYAMWEGFEKAYSL 669   
TO931H     LLTGV----CAPNRTPLIRKLK-NKGVHINVNTKILEVTDHDVKVQRADGAEEWLKGFDYILFGLGSRNYDPISEQIKEFVPEVHVVG--DAKRARQASFAMWEAFEAAYSL 661  
12708CD    FKYYK----IAKMSGTNVTALEQGKVHYIMTDKKTKEVTQGVLECDAT-----------VICTGITARPSDGLKARCEELGIPVEVIG--DAAGARDCTIATREGYDAGMAI 639   
TO931CD    FKYYK----INKMSGTNIVGIEPGKLHYIMTNKKTQEVTEGVLECDAA-----------VICTGITARPSEDLQEKCKELGVPFNVIG--DAAGARDARIATQEGYEVGMSI 639   
enr        IKKYN----IKVITGNSLLEVTDAGAVLIDSKFKQQEVSADTVVISIG------------------FKSNRKLYNKLHGKVTDLYLIG--DAYQAANIMDAIWSGNEIGLNC 667   
dcr        RKASKPGQGLGKTTGWIHRTTLLSRGVKMIPGVSYQKIDDDGLHVVING--ETQVLAVDNVVICAGQEPNRALAQPLIDSGKTVHLIGGCDVAMELDARRAIAQGTRLALEI 672
   
12708baiH
■ ■ ■■
■
■ ■
♦ ♦ ♦ ♦ * *
*
* *
dcr
12708baiH
12708baiH
12708baiH
12708baiH
12708baiH
dcr
dcr
dcr
dcr
dcr
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Purification of recombinant BaiH 
Initially, the baiH gene was cloned into a pET24a (+) 
vector with C-terminal hexa-histidine tag to make a BaiH-
His recombinant.  The BaiH-His showed NADH:FOR activity in 
crude extract prior to nickel affinity chromatography.  
However, following nickel affinity chromatography, the 
purified enzyme lost detectable NADH:FOR activity.  
Problems with His-tag use has also been reported for the 
YqjM protein from Bacillus subtilis; a baiH homologue 
(186).  The quarternary structure of recombinant His-
tagged YqjM was reported to be altered by the His-tag 
resulting in expression of an inactive enzyme.  This is 
not the case with the baiH gene product as the enzyme 
showed NADH:FOR activity in crude extract similar to 
previously reported in recombinant BaiH lacking affinity 
tag (129) before His-binding chromatography (data not 
shown).  The BaiH is known to contain 1 mol copper per 
subunit (129).  While the mechanism for this loss of 
activity is not known, we speculate that the nitriloacetic 
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 acid, which chelates Ni2+, Cu2+, and Co2+, and in turn binds 
the hexa-histidine tail, may have chelated copper from the 
enzyme causing inactivation (187, 188).  Addition of 
various concentrations of Cu2+ to the pure enzyme did not 
restore activity. Therefore, we opted to clone the gene 
into the pSport1 vector without an affinity tag.   
SDS-PAGE analysis of the active fractions after CHT5-
1 hydroxyapatite chromatography revealed a highly enriched 
protein with a subunit molecular mass of 72 kDa that was 
reactive against anti-BaiH antiserum (Figure 15).  The 
specific activity and purification fold were dramatically 
increased by Cibacron Blue 3GA and hydroxyapatite 
chromatography (Table 5).  The baiH gene product was 
purified 23–fold over the crude extract.  The final enzyme 
preparation had a NADH:FOR specific activity of 16.4 U mg-
1. NADH:FOR enzyme activity existed in bright yellow 
fractions as observed previously (129).  
Stereospecific NAD(H)-dependent 3-oxo-Δ4-cholenoic acid 
oxidoreductase activity. 
 The hypothesis that the baiH gene product encodes an 
NAD(H)-dependent 3-oxo-Δ4-cholenoic acid oxidoreductase was 
109
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15.  SDS-PAGE and immunoblot analysis of baiH 
gene product (NADH:FOR) overexpression and 
purification   (a.) Proteins were separated 
on a 10 % SDS-polyacrylamide gel and stained 
with Coomassie Blue R-250.  Lane 1, cell 
free extract after IPTG induction (20 μg 
loaded); Lane 2, flow-through from DEAE 40HR 
(20 μg loaded); Lane 3, flow-through from 
Cibacron Blue 3GA agarose (20 μg loaded); 
lane 4, flow-through from Hydroxyapatite 
CHT5-1 column (5 μg of purified enzyme 
loaded). (b.) Immunoblot of SDS-PAGE using 
anti-BaiH antiserum.   
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1      2     3       4   1       2        3        4   
100 kDa
76 kDa
37 kDa
26 kDa
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 tested by addition of substrates [24-14C] 3-dehydro-UDCA or 
[24-14C] 3-dehydro-CDCA with NAD+ and purified BaiH.  A 
single reaction product of more hydrophilic character was 
detected by autoradiography following TLC when [24-14C] 3-
dehydro-UDCA and NAD+ were substrates (Figure 16).  
Previous studies have shown the specificity of this enzyme 
for NAD(H) (129) and the BaiH did not show 3-oxo-Δ4-
cholenoic acid oxidoreductase activity with NADP(H) (data 
not shown). The bile acid metabolite generated following 
BaiH catalyzed reaction with NAD+ was scraped from TLC 
plates, pooled, further purified by ion exchange 
chromatography and identified by electrospray mass 
spectrometry (Figure 17). The deprotonated molecular ion 
given by the product was 2 Da lighter than that given by 
the 3-dehydro-CDCA substrate, consistent with a loss of 2 
hydrogens from the substrate and potentially indicating a 
3-dehydro-Δ4-CDCA structure.  Previous observations showed 
loss of the 5β hydrogen during incubation of [5β-3H] [24-
14C] CA to CA induced whole cells and cell extracts of C. 
scindens VPI 12708 (118).  Taken together, these 
observations strongly suggest the formation of a 3-
dehydro-Δ4-UDCA structure. 
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Figure 16.  TLC autoradiograph of BaiCD and BaiH 
catalyzed NAD(H)-dependent 3-oxo-Δ4-cholenoic 
acid oxidoreductase activity assays.  The 
reactions were carried out in a 500 μl 
volume consisting of 50 mM sodium phosphate 
buffer (pH 6.8) containing 225 μM of each 
respective substrate with a specific 
activity of 0.01 μCi μmole-1.  A: [24-14C] 3-
dehydro-CDCA standard, B: [24-14C] 3-dehydro-
UDCA, C: [24-14C] 3-dehydro-CDCA + 100 μg 
cell-free extract of E. coli (plasmid, no 
insert) D: [24-14C] 3-dehydro-CDCA + 1.6 U 
purified BaiH, E: [24-14C] 3-dehydro-CDCA + 
100 μg E.coli BL21(DE3) expressing baiCD. F: 
[24-14C] 3-dehydro-UDCA + 100 μg E. coli 
BL21(DE3) (plasmid, no insert), G: [24-14C] 
3-dehydro-UDCA + 100 μg cell-free extract 
ofE.coli BL21(DE3) expressing baiCD,  H: 
[24-14C] 3-dehydro-UDCA + 1.6 U purified 
BaiH.  All reactions were performed with 1.5 
mM NAD+ as co-substrate.  
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Figure 17.  HPLC and mass spectrometry analysis of BaiH 
catalyzed bile acid reaction products.  The 
bile acid metabolites produced by purified 
baiH gene protein were separated by TLC, 
scraped and further purified by reverse-
phase HPLC-ESI-MS.  The initial mobile phase 
was 10 mM NH4OAc; after injection bound 
materials were eluted by a 0-100 % linear 
gradient of acetonitrile in 10 mM NH4AOc at 
10 % min-1.  The eluate was passed into the 
electrospray interface operating in the 
negative ion mode.  Ions eluting from m/z 
350-700 were recorded and analyzed.  The 
upper trace is a selected ion chromatogram 
for m/z 389.  The mass spectra for the peak 
at 11.52 min were summed and presented in 
the bottom trace.  The m/z 389.2 ion 
corresponds to the expected [24-14C] 3-
dehydro-4-UDCA product.   
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  In addition, the baiCD gene was overexpressed in E. 
coli BL21 (DE3) and tested for 3-oxo-Δ4-cholenoic acid 
oxidoreductase activity.  The baiCD gene product was 
detected by SDS-PAGE at the expected molecular mass of 70 
kDa (Figure 18).  Addition of baiCD overexpressed E. coli 
cell extract to reaction mixture containing 1.5 mM NAD+ 
resulted in a product of greater hydrophilicity than the 
starting substrate [24-14C] 3-dehydro-CDCA (Figure 16).  
This reaction product was not obtained using cell-extract 
of E. coli BL21(DE3) containing pSport1 vector without 
baiCD gene insert.  BaiCD did not recognize the substrate 
[24-14C] 3-dehydro-UDCA. The product derived from reaction 
with [24-14C] 3-dehydro-CDCA was scraped from TLC plates, 
pooled and subjected to mass-spectrometry (Figure 19).  
The major mass ion was 2 amu less than the 3-dehydro-CDCA 
substrate and thus consistent with the loss of 2 hydrogens 
from the substrate bile acid and potentially a 3-dehydro-
Δ4-CDCA structure.   Figure 20 illustrates the reactions 
catalyzed by the baiCD and baiH gene products.    
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Figure 18.   SDS-PAGE of cell-extract of recombinant E. 
coli BL21(DE3) overexpressing baiCD gene.  
(M) Marker (UI) uninduced, (I) induced 1 mM 
IPTG.  30 μg protein loaded and gel stained 
with Coomassie brilliant blue R-250.  A 
large band at ~ 70 kDa was detected in IPTG 
induced cell-extracts indicating 
overexpression of baiCD gene.   
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Figure 19.   HPLC and mass spectrometry analysis of BaiCD 
catalyzed bile acid reaction products.  The 
bile acid metabolites produced by cell-
extract of E. coli overexpressing baiCD gene 
were separated by TLC, scraped and further 
purified by reverse-phase HPLC-ESI-MS.  The 
initial mobile phase was 10 mM NH4OAc; after 
injection bound materials were eluted by a 
0-100 % linear gradient of acetonitrile in 
10 mM NH4AOc at 10 % min-1.  The eluate was 
passed into the electrospray interface 
operating in the negative ion mode.  Ions 
eluting from m/z 350-700 were recorded and 
analyzed.  The upper trace is a selected ion 
chromatogram for m/z 389.   The mass spectra 
for the peak at 11. 59 min were summed and 
presented in the bottom trace.  The m/z 
389.3 ion corresponds to the expected [24-
14C] 3-dehydro-4-CDCA product. 
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Figure 20.  Proposed reactions catalyzed by the baiCD   
and baiH gene product.  R group may be the 
carboxylic acid or the coenzyme A conjugate. 
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 Isolation of bai genes from Clostridium hylemonae 
TN271  
Identification and Characterization of the baiBCDEFHGI 
operon  
 
Apart from basic biochemical characteristics and 16s 
rDNA sequence, little is known about C. hylemonae.  
Previously, our laboratory performed activity assays on 
cultured 7α-dehydroxylating bacteria and found that these 
organisms clustered into two groups based on relative rate 
of conversion of [24-14C] CA to [24-14C] DCA (189).  Much 
effort has been focused on the “high activity strains” C. 
scindens and C. hiranonas, however, organisms such as C. 
hylemonae, described as a “low activity strain” has 
received little characterization (See Intro). Recent data 
indicates that C. hylemonae may play a significant role in 
bile acid metabolism in the human colon based on in vivo 
studies where this species was found to be a numerically 
predominant 7α-dehydroxylating bacterium (190).  
Therefore, characterization of the bile acid 7-
dehydroxylating pathway in this organism is important.  
Genes involved in the bile acid 7α-dehydroxylating pathway 
125
 have yet to be isolated and sequenced from any “low 
activity strain”.  We were thus interested in elucidating 
the gene organization, gene and promoter sequence, as well 
as upstream regulatory genes and comparing these elements 
to “high activity strains” to see whether there are 
obvious differences that might underly the ten fold 
differences in relative rate of bile acid 7α-
dehydroxylation (189).   
Wells and Hylemon (2000) designed redundant PCR 
primers targeting the baiCD gene which are aimed at 
detecting 7α-dehydroxylating bacteria in the human colon 
(59).  Wells and Hylemon (2000) reported detection of the 
baiCD gene of C. hylemonae TN271 using these 
oligonucleotides.  Therefore, these primers were used to 
amplify a 1.2 kB segment of the baiCD gene from C. 
hylemonae which was subsequently cloned into a pCR8 GW 
TOPO TA vector and sequenced (Figure 21).   BLAST analysis 
of the sequence data and CLUSTALW alignment of the 
nucleotide and translated amino acid sequence verified the 
identity of a baiCD gene in C. hylemonae.  We hypothesized 
that the bai genes involved in the oxidative arm of the 
bile acid 7α-dehydroxylation pathway (baiA – baiI) would 
126
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21.   Region of partial baiCD gene from C. 
hylemonae TN271 used to design upstream and 
downstream genome-walking PCR primers.  
Sequence represents sense-strand of baiCD 
gene, arrows denote direction of 
amplification and grey font represents 
regions of primer design.  
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GAAGGCCGGGAGGAACTTATACGCCACTGCATTGGCTGCGACCAGGGCTGTTATGACGCAGTCATCGATCCAAAGATGAAACACATCACATGTACCCGTAATCCG  105
ATGCTCTGTCTGGAGTATAAAGGACTTCCGAAGACTGCCGCGCCCGAGAAAGTTATGATCGCAGGCGGCGGGATGGCCGGGCTCTTTGCGGCGGAAGTGCTGAAG  210
AAAAGAGGACATGAGCCGGTCATCTTTGAAGCGTCCGACAGGCTTGCAGGCCAGTTTACGCTTGCCGGTGTGTCACCGATGAAGCAGGACTGGGCGGCGGCTGCA  315
AAGTGGGAGGCAGAAGAGATCGGACGGCTTGGGATCGAGTTTCATCTGAATACGCCCGTGACGCCAAAGCTGATCGAACAATTTGCCCCAGACCGTGTCATCATC  420
GCAACAGGATCCGAATATACAGCTCCCGCTATACCGGGGATAGACGGCCCGAATGTGTATACCCAGTATGAGGTGCTAAGAGGAGAAGCCTCCCCTGCCGGTCAT  525
GTGGCAGTTATCGGATGCGGGCTGGTAGGAGCGGAGGTTGCGGAGCTGCTTGCATCCAGGGGAGCGCAGGTCACTGCCCTGGAGAAAAAGGGGGTCGG         623
WalkUP1
WalkUP1Nest
WalkDS1 
WalkDS1Nest
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 be located on a polycistronic operon flanking the baiCD 
gene.  Therefore, a bidirectional genome-walking by PCR 
strategy was used to isolate the remaining bai genes.   
A slight modification of the method of Ridlon et al. 
(2005) was utilized to prepare genomic DNA (>50 kb) from 
both C. scindens VPI 12708 and C. hylemonae TN271 for 
genome-walking by PCR (see Materials and Methods) (Figure 
22) (177).   Restriction libraries derived from this DNA 
sample yielded PCR products averaging 2 kB with a range of 
0.7 kb to 4 kb.  The limit of this technique, according to 
the manufacturer (Clontech GenomeWalker Universal Kit) is 
around 6 kB. Upstream genome-walking PCR using primer 
WALKUP1 and subsequent nested amplification using primer 
WALKUP1Nest resulted in 2,139 bp of sequence data which 
overlapped the baiCD gene data by 673 bp resulting in a 
2,690 bp contig (Figure 23). Analysis of this data 
revealed the 5’ end of the baiCD gene.  A second open 
reading frame (ORF) was detected 19 bp upstream of the 
baiCD gene.  BLAST results suggest this ORF encodes an 
AMP-dependent coenzyme A ligase with highest identity to 
the baiB gene from C. hiranonis.  Continued upstream 
genome-walking resulted in a PCR product of 1,964 bp 
129
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22.  Preparation of genomic DNA for genome-
walking by PCR restriction libraries.  
Representative 0.4% agarose/EtBr gel 
showing 1, 2, and 3 μg genomic DNA from C. 
scindens VPI 12708.  Size comparisons made 
with Invitrogen’s High Molecular Weight DNA 
ladder.   Electrophoresis was performed at 
25 volts for 18 hours. 
130
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Figure 23.   Genome-walking by PCR Upstream of partial 
baiCD gene in Clostridium hylemonae TN271.  
PCR products amplified using WALKUP1 and 
WALKUP1NEST PCR primers (Table 6).  “M” is 
marker “D”, “E”, “P”, “S” and “EN” represent 
genome-walking restriction library templates 
digested with DraI, EcoRV, PvuII. and StuI, 
respectively.  “EN” represents nested PCR 
amplification of EcoRV primary PCR product 
diluted 1:50.  The PCR product generated 
from nested amplification was purified by 
GENECLEAN and ligated into a pCR8 GW TA TOPO 
cloning vector (2.8 kb) to yield vector 
p271CDUP1 (4.9 kb). 
 
132
M      D  E   P   S  M  EN
1.0 kb
2.0 kb
3.0 kb
p271ENCDUP1
4.9 kb
pUC ori
T2
T1
attL1
attL2
TA cloning site
Specr
A
AEN CDUP1
2.1 kb
1.0 kb
2.0 kb
3.0 kb
a. b.
133
 (Figure 24).  Assembly of this data resulted in a 4,586 bp 
contig containing the complete baiB gene.  The 1.5 kb baiB 
gene is predicted to encode a 57.7 kDa polypeptide similar 
in size to the reported 58 kDa subunit recombinant BaiB 
polypeptide from C. scindens VPI 12708 (125).  Two 
additional interesting features were identified within 
this sequence data.  First, a conserved bile acid 
inducible promoter was located on the sense strand 49 bp 
upstream of the baiB gene (Figure 25) (59, 191).  SMART-
RACE PCR analysis of the cDNA from a CA induced culture of 
C. hylemonae led to the identification of the mRNA start 
site which appears in a short purine rich stretch 
corresponding to the ribosome binding site (Figure 26).   
Interestingly, the distance between the mRNA start site in 
the baiB polycistronic operon in C. hylemonae is only 11 
bp from the initiation codon while in the “high activity 
strains” there is a distance of 108 bp in C. hiranonis 
(59) and 68 bp in C. scindens (191).  As proof of 
principle, SMART RACE PCR was also performed on the baiB 
gene of C. scindens VPI 12708, whose mRNA initiation site 
was previously determined by primer extension (191).  The 
results obtained in the present study agree with those of 
134
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24.  Second upstream genome-walking by PCR from 
partial baiCD gene in Clostridium hylemonae 
TN271.  a.) PCR products amplified using 
WALKUP2 and WALKUP2NEST PCR primers (Table 
6).  Nested PCR product (DN=DraI template, 
nested primer amplification product) 
purified from 1% agarose gel by GENECLEAN 
Spin Kit and ligated into pCR8 GW TOPO TA 
cloning vector to make vector p271CDUP2 
(b.).  
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Figure 25.   Boxshade of CLUSTALW alignment of bai 
promoters upstream of baiB gene between C. 
hylemonae TN271, C. scindens VPI 12708 and 
C. hiranonis sp. strain TO931.  Putative -
10 element is indicated below alignment.  
Transcription initiation sites (TIS) 
highlighted in yellow (See Fig 26 for TIS 
data for C. hylemonae).  
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Figure 26. SMART RACE PCR analysis to determine TIS for 
the baiB transcript in Clostridium hylemonae 
TN271. (a.) RT-PCR analysis of C. hylemonae 
TN271 cDNA generated from CA induced (I) and 
uninduced (UI) cultures.  Primers against 
baiB gene (above) and gyrA gene (below) were 
used to determine whether baiB transcript 
was expressed.  Below RT-PCR is the 
corresponding [24-14C] CA activity assay 
performed prior to RNA isolation of I and UI 
cultures of C. hylemonae.  [24-14C] DCA is 
detected only in CA induced (50 μM) culture.  
(b.)  5’ SMART RACE PCR of baiB transcript 
using RACEB325 oligonucleotide against cDNA 
from induced culture of C. hylemonae TN271.  
PCR product was purified by GENECLEAN Spin 
Kit and cloned into a pCR8 GW TOPO TA 
cloning vector and sequenced.  (c.)  TIS for 
baiB transcript (underlined; direction of 
transcription designated by arrow).  “*” 
designates conserved bai promoter elements 
(See Figure 25), putative ribosome binding 
site in bold, “†” designates mRNA start site 
determined for baiB in C. scindens, “‡” 
designates mRNA start site for baiB in C. 
hiranonis sp. strain TO931, italics 
indicates anticodons with corresponding 
amino acids (below).   
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 Mallonee et al. (1990) providing proof of principle and 
additional evidence for the TIS of the baiB operon in C. 
scindens VPI 12708 (Figure 27) (191).   
The second notable feature is a conserved 47 kDa 
AraC/XylS transcription factor located on the anti-sense 
strand upstream of the bai promoter. Figure 28 illustrates 
the conserved helix-turn-helix motifs identified in the 
amino acid sequence of the “bile acid regulatory A” gene 
(barA).   Additional genome-walking upstream of the barA 
did not result in ORFs predicted to be involved in bile 
acid metabolism. 
Downstream genome-walking from the baiCD fragment 
yielded a PCR product of 1,131 bp which increased contig 
length to 5,625 bp (Figure 29).  This stretch of sequence 
resulted in completion of the 1.9 kb baiCD gene predicted 
to encode a 70 kDa polypeptide.  In the first section, 
overexpression of the recombinant baiCD gene from C. 
scindens VPI 12708 in E. coli resulted in a 70 kDa 
polypeptide as estimated by SDS-PAGE (Figure 18). In 
addition, 46 bp downstream of the baiCD gene we located a 
510 bp ORF predicted to encode the 19.8 kDa bile acid 7α-
dehydratase (baiE gene).  Dawson et al (1996) reported 
141
  
 
 
 
 
 
 
Figure 27.  Determination of transcription initiation 
site for baiB gene from Clostridium scindens 
VPI 12708 based on SMART RACE PCR analysis.   
Alignment shows determination of 
transcription initiation site (TIS) (arrow, 
underline)  based on alignment of SMART RACE 
sequence data (SR7, SR8) with baiB gene and 
upstream region from Clostridium scindens 
VPI 12708 (12708baiB).  TIS is determined 
based on the first base following 3’ end of 
SMART II A oligo sequence (boxed region) 
(5’-AAGCAGTGGTATCAACGCAGAGTACGCGGG-3’).  
This nucleotide (underlined, arrow) must 
also correspond to the known sequence of the 
upstream region of the gene.  The TIS 
determined through SMART RACE analysis 
agreed with primer extension analysis 
performed by Mallonee et al (1990) (191).   
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Figure 28:   ClustalW alignment of bile acid regulatory A 
gene (barA) between C. hylemonae TN271, C. 
scindens VPI 12708 and C. hiranonis sp. 
strain TO931.  Regions highlighted in red 
are predicted helix-turn-helix motifs shared 
between members of the Arac/XylS family of 
transcription factors.   
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12708barA M-PNTIKSKPICGSPVHS------------------VFTGKDKYLRLQKHTISDITPPIC 41
TO931barA    M-KEIPKSKSICGRPVHS------------------VYVDKDKYLRMQTYHINDITPPTS 41
TN271barA    MISNNPTSVSKIDLKKEKTDERSYKIQIDLRQASPFFFSGRDKYLRLQKHCISDITPPIS 60
: :  .* .  .   ..                  .: .:*****:*.: *.***** .
12708barA    ENESLFILVNSGCGTITINGVEFPFEQSTFVWLQSYHTFTIKADSDDPLELSICVYDYPL 101
TO931barA    ENESLFVLVKQGYGSIIINGVEFKLKVGAFLWLQSYHTFTIKCESDEPLELKICVYDYPL 101
TN271barA    ENESIFVFVTGGSGAITINGVSFPLKRGSFIWLQSYHTFTIRAGSVQPLLMSVCVYDYPL 120
****:*::*. * *:* ****.* :: .:*:**********:. * :** :.:*******
12708barA    SSFLALREPSPDTVDAIMVALPVIRLEGVYQQKIRDLFDEFEKEDSCFDPGSSLIKVSIL 161
TO931barA    SSFLTFREPTPTTIDAIMDATPVVYLEGKFLERVYDLFDDFEEFDDFYDPGSSLIKVSIL 161
TN271barA    SSFLTFHEPEPGTVDAIIDAPPVISLDGARLDKIEALFHEFEEEDSCFDPGSALIKVAVL 180
****:::** * *:***: * **: *:*   :::  **.:**: *. :****:****::*
12708barA  GQFAYFFIKHGIHQSQKDQDKDWPLGWQATLYIGSHFAEDITAESVAERFSTNASTLNRE 221
TO931barA  GELSKIFIDHSMRVFAKEEPSPKPLGWNAILYISEYFGKDLTAEKVAKIFDSNATTLNRE 221
TN271barA GQFANFFIHHSIKQHRPETNCERPLGWKAVLYISAHFAEDLTSQSVAAHFGSAAAVLNRE 240
*::: :**.*.::    :     ****:* ***. :*.:*:*::.**  *.: *:.****
12708barA    LRNISGYNFAHTLNRVRVNIASGALLYEDMSLSYVAEHSGFSSEVAFYRIFKKYTGTTPL 281
TO931barA   LRNISGYNFIQTLNRVRVNIAASALLYEDMSLSYIATHSGFSSEVVFYRIFKQYVGVTPV 281
TN271barA   LRLISGYSFSQFLNRVRVNIASVALLYDGMSLSYVAAHSGFTSEVAFYRIFKKYMGTTPI 300
** ****.* : *********: ****:.*****:* ****:***.******:* *.**:
12708barA EYRKQMLESGE-KVYRGMIMSQMLMDVLNHSYASFSSPIDIKDTSKSLYLSESVIRELVQ 340
TO931barA EYRKQIINHNEDKVYRGMIMSTSLMQILNHAYDNFSSSVDLKDASKSLFLSESTIRNIIF 341
TN271barA EYRNQLLNDGS-GVYRGMIMSTTLMEVLNHTYSSFSEPVDIKEASKRLYISESVIRDLVY 359
***:*::: ..  ********  **::***:* .**..:*:*::** *::***.**::: 
12708barA   EKFGASYKDITVLTRLRHAAALLLTTNLPVLDVAVNVGFNCSRSFSRAFNKLYKMTPGEY 400
TO931barA  DRFGTNYKYIIFFNRIRHSEALLLTTDLPILDIAINVGFNCSRSFSRAFNKFHNMTPSEY 401
TN271barA ETFRSHYKDLAVLTRIRHAEALLLTTDLPIVDIAVNVGFNCSRSFTRTFT-----SPGRR 414
: * : ** : .:.*:**: ******:**::*:*:**********:*:*. :*.. 
12708barA RSLYRGGENQ- 410
TO931barA RNKYRGVNRDE 412
TN271barA PRVP------- 418
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Figure 29.  Downstream genome-walk (DS1) from baiCD gene 
from Clostridium hylemonae TN271.  a.)  
Agarose gel of DS1 products using Dra1 (D), 
EcoRV (E), PvuII (P), StuI (S) restriction 
libraries of C. hylemonae TN271 genomic DNA 
as template with adaptor primer AP1 and 
gene-specific primer WALKDS-1 (See Table 6).  
b.) “DN” and “EN” represent nested PCR 
amplification using nested adaptor primer 
AP2 and gene-specific primer WALKDSNEST1 
(See Table 6).   C.) Schematic 
representation of TA cloning of GENECLEAN 
purified “DN” product (arrow) into 
pCR8/GW/TOPO TA vector (2.8 kb) yielding 3.9 
kb vector p271DNCDDS1.   
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 overexpression of the 19 kDa baiE gene from C. scindens 
VPI 12708 (128).  Multiple sequence alignment of this ORF 
with the baiE genes from C. scindens VPI 12708 and C. 
hiranonis sp. strain TO931 revealed >80% amino acid 
sequence identity and conservation of active site amino 
acids predicted through computer modeling and site-
directed mutagenesis data (Figure 30) (Hylemon et al 
unpublished data).  Continued downstream GW-PCR resulted 
in a 3,856 bp PCR product which when added to the previous 
alignment results in a contig of 9,291 bp (Figure 31).  An 
ORF was located 25 bp downstream of the baiE gene 1,275 bp 
in length predicted to encode a 47 kDa polypeptide in the 
Type III CoA transferase family of proteins.  BLAST 
analysis suggests this gene encodes the baiF gene product.  
Ye et al (1999) previously determined the Mr of the 
recombinant baiF from C. scindens VPI 12708 to be 47.5 kDa 
(130). A second ORF, 1.4 kb in length, was located 53 bp 
downstream of the baiF gene whose deduced amino acid 
sequence suggests this gene encodes a 49.5 kDa AraJ-like 
efflux permease.  BLAST analysis suggests this ORF encodes 
the baiG gene product. Mallonee et al (1996) overexpressed 
the 50 kDa baiG gene product in E. coli and showed that it 
148
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30.  Boxshade of CLUSTALW alignment of 7α-
dehydratase gene (baiE) between C. hylemonae 
TN271, C. scindens VPI 12708, and C. 
hiranonis sp. strain TO931.  Asterisks 
denote conserved active site amino acids 
predicted by computer modeling and site-
directed mutagenesis (Hylemon et al. 
unpublished data). 
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Figure 31.  Second downstream genome-walk (DS2) from 
baiCD gene from Clostridium hylemonae TN271.  
a.)  Agarose gel of DS2 products using Dra1 
(D), EcoRV (E), PvuII (P), StuI (S) 
restriction libraries of C. hylemonae TN271 
genomic DNA as template with adaptor primer 
AP1 and gene-specific primer WALKDS-2 (See 
Table 6).  b.) “EN” and “PN” represent 
nested PCR amplification using nested 
adaptor primer AP2 and gene-specific primer 
WALKDSNEST2 (See Table 6).   C.) Schematic 
representation of TA cloning of GENECLEAN 
purified “PN” product (arrow) into 
pCR8/GW/TOPO TA vector (2.8 kb) yielding 6.6 
kb vector p271PNCDDS2.   
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 is involved in transporting primary bile acids across the 
bacterial membrane (126).  Further analysis revealed a 
partial ORF 19 bp downstream of the baiG gene encoding an 
“Old Yellow Enzyme” like FMN oxidoreductase with the baiH 
gene from C. hiranonis sharing the highest amino acid 
identity.  The third downstream GW-PCR resulted in 
completion of the bai oxidative operon (Figure 32).  The 
2,019 bp baiH gene was completed and the deduced amino 
acid sequence suggested this gene encodes a 71.7 kDa 
polypeptide. The baiH gene from C. scindens VPI 12708 has 
been shown to encode a 72 kDa polypeptide (Figure 5)(121, 
129).   Finally, the 549 bp baiI gene was located 38 bp 
downstream of the baiH gene and predicted to encode a 21.8 
kDa polypeptide.  The complete bai oxidative operon from 
C. hylemonae is represented schematically in Figure 33 and 
compared to the gene organization in C. scindens and C. 
hiranonis.  Table 6 lists oligonucleotides used in 
isolation and sequencing of the baiBCDEFGHI operon in C. 
hylemonae.  Table 7 compares amino acid sequence 
identity/similarity between C. hylemonae and C. scindens.  
Clearly, there is a high degree of conservation both 
between the genes and several of the intergenic regions; 
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Figure 32.   Third downstream genome-walk (DS3) from the 
baiCD gene of Clostridium hylemonae TN271.  
a.)  Agarose gel of DS3 products using Dra1 
(D), EcoRV (E), PvuII (P), StuI (S) 
restriction libraries of C. hylemonae TN271 
genomic DNA as template with adaptor primer 
AP1 and gene-specific primer WALKDS-2 (See 
Table 6).  b.) “DN” represents nested PCR 
amplification using nested adaptor primer 
AP2 and gene-specific primer WALKDSNEST2 
(See Table 6).   C.) Schematic 
representation of TA cloning of GENECLEAN 
purified “DN” product (arrow) into 
pCR8/GW/TOPO TA vector (2.8 kb) yielding 5.9 
kb vector p271DNCDDS3.   
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Figure 33.   Schematic representation and comparison 
of the bai oxidative operons of C. 
hylemonae TN721 and C. scindens VPI 
12708.  See Table 7 for comparison of 
amino acid sequence identity and other 
parameters.  Notice the high degree of 
conservation in gene organization, with 
the exception of the baiA gene, present 
in both C. scindens and C. hiranonis 
though conspicuously missing from the bai 
oxidative operon of C. hylemonae TN271. 
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 not surprising given the close phylogenetic relation 
between these species as determined by neighbor-joining of 
16s rDNA sequences of 7α-dehydroxylating bacteria and 
other gut microbes (106).   One of the most striking 
observations is the fact that the baiA gene is not found 
within this operon in C.hylemonae as it is in C. scindens 
and C. hiranonis. We predict that the baiA gene will be 
found as a single cistron with a bai promoter region as 
observed in C. scindens with the baiA1 and baiA3 genes 
(67).  Taken together, these data indicate that genes 
located on the 9.5 kb bai oxidative operon of the “low 
activity strain” C. hylemonae TN271 are highly conserved 
both in organization as well as amino acid sequence with 
the homologous bai polycistronic operons identified in the 
“high activity” species C. scindens and C. hiranonis with 
the exception of the baiA gene. 
The ability of C. hylemonae TN271 to 7β-dehydroxylate 
UDCA has not been reported in the literature.  Therefore, 
C. hylemonae and C. scindens were induced with 50 μM CA 
for 2 hrs and tested for the ability to 7α-dehydroxylate 
[24-14C] CA and [24-14C] CDCA as well as 7β-dehydroxylate 
[24-14C] UDCA for 30 minutes (Figure 34) at 37˚C as well as 
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Figure 34.   Autoradiographs of TLC of 7α-dehydroxylation 
and 7β-dehydroxylation activity assay 
reaction products.  (a.) C. scindens VPI 
12708 induced with 50 μM CA during mid-log 
phase in BHI. 1 ml culture inoculated in 1 
ml activity assay consisting of BHI 
containing 0.1 μCi/2 μmole bile acid 
incubated 37˚C for 30 min. Lane 1: [24-14C] 
CA activity assay of CA induced culture of 
C. scindens.  Lane 2: [24-14C] CA activity 
assay of uninduced culture of C. scindens.  
Lane 3:[24-14C] UDCA activity assay of CA 
induced culture of C. scindens.  Lane 4: 
[24-14C] UDCA activity assay of uninduced 
culture of C. scindens.  Lane 5:[24-14C] 
chenodeoxycholic activity assay of uninduced 
activity assay.  Lane 6 represents [24-14C] 
CDCA activity assay of cholic acid induced 
culture of C. scindens.  The same order 
applies in (b.) for cultures of C. 
hylemonae.  Arrows depict positions of non-
radiolabelled bile acid standards.  Induced 
cultures of C. scindens and C. hylemonae 
were able to 7α-dehydroxylate both CA and 
CDCA (lanes 1 and 6) while only C. scindens 
was able to 7β-dehydroxylate UDCA (lane 3).  
Uninduced cultures showed no activity 
against bile acid substrates.  Solvent 
system was S1 according to Eneroth (172). 
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 overnight incubation (Data not shown).  Both C. scindens 
and C. hylemonae were able to 7α-dehydroxylate both CA and 
CDCA resulting in [24-14C] DCA and [24-14C] LCA, 
respectively.  However, while C. scindens was able to 7β-
dehydroxylate UDCA, we were unable to detect 7β-
dehydroxylation activity by C. hylemonae despite sequence 
data that indicated the presence of genes encoding enzymes 
suggested to be involved in 7β-dehydroxylation.  It is 
currently unclear why this activity is not present.   
 
Isolation and characterization of a baiA gene in 
Clostridium hylemonae TN271 
 
The 27 kDa baiA gene product from C. scindens VPI 
12708 catalyzes the first oxidative step in the bile acid 
7α-dehydroxylating pathway following ATP-dependent CoA 
ligation (125).  As noted in the previous section, and 
illustrated in Figure 33, the baiA gene was not found in 
the oxidative polycistronic bai operon in C. hylemonae.  
Therefore, redundant primers were designed based on a 
multiple sequence alignment of baiA genes from C. scindens 
and C. hiranonis (Figure 35).  A PCR product of 722 bp was 
163
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35. Design of degenerate PCR oligonucleotides 
for isolation of the baiA gene in C. 
hylemonae TN271.  Clustal alignment of 
baiA1, baiA2 and baiA3 genes from C. 
scindens VPI 12708 and the baiA gene from 
C. hiranonis sp. strain TO931.  Arrows 
indicate direction of PCR primers, the 
sequence of sense and antisense primer is 
shown below alignment.   
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baiA1           ATGAAACTTGTACAGGACAAAATTACAATTATCACAGGCGGAACCCGTGGAATCGGATTC 60
baiA3           ATGAAACTTGTACAGGACAAAATTACAATTATCACAGGCGGAACCCGTGGAATCGGATTC 60
baiA2           ATGAATCTCGTACAAGACAAAGTTACGATCATCACAGGCGGCACAAGAGGTATTGGATTC 60
baiATO931       ATGAACTTAGTACAGGACAAAATAGTTATAATAACAGGTGGAACAAGTGGTATAGGTCTT 60
*****  * ***** ****** *    ** ** ***** ** **  * ** ** **  * 
baiA1           GCAGCAGCAAAACTCTTTATTGAGAATGGAGCAAAAGTCTCCATATTTGGCGAGACCCAG 120
baiA3           GCAGCAGCAAAACTCTTTATTGAGAATGGAGCAAAAGTCTCCATATTTGGCGAGACCCAG 120
baiA2           GCCGCTGCCAAAATATTTATCGACAATGGCGCAAAAGTATCCATCTTCGGAGAGACGCAG 120
baiATO931       TGCGCAGCAAAAATATTCATGGATAACGGTGCAACAGTTTCTATATTCGGAAAAACTCAG 120
** ** *** * ** ** ** ** ** **** *** ** ** ** **  * ** ***
baiA1           GATCGCGAATGTATATCTGTTCCTTGCATCCGACCTGGCTAGCGGCATCACGGCTACGAC 719
baiA3           GATCGCGAATGTATATCTGTTCCTTGCATCCGACCTGGCTAGCGGCATCACGGCTACGAC 719
baiA2           GATCGCTAATGTATACCTGTTCCTGGCATCTGACTTGGCAAGCGGCATTACGGCTACTAC 719
baiATO931       AATAGCTAACACTTACTTATTCTTAGCTTCTGACTTAGCTAGTGGTATAACAGCTACAAC 719
** ** **    **  * *** * ** ** *** * ** ** ** ** ** ***** **
baiA1           GATCAGCGTAGATGGGGCTTACAGGCCATAG--- 750
baiA3           GATCAGCGTAGATGGGGCTTACAGGCCATAG--- 750
baiA2           GGTCAGCGTAGACGGGGCTTACAGACCATAA--- 750
baiATO931       TGTAAGCGTTGACGGTGCTTATAGACCATCATAA 753
* ***** ** ** ***** ** **** 
baiA271F: 5’-CAG GYG GMA CMM GWG GWA THG G-3’
baiA271R: 5’-GGR CTR TAA GCM CCR TCW TCG C-3’
165
 obtained, sequenced and predicted to encode the baiA gene 
by BLAST search (Figure 36).  The complete 789 bp gene 
encoding a predicted 27.9 kDa protein was obtained 
following bidirectional genome-walking from the initial 
sequence data (Figure 37).   Sequence analysis upstream of 
the baiA gene revealed a conserved bai promoter and RBS 
(Figure 37).  Regions identified as highly conserved 
within bai promoters showed 100% identity between the 
upstream baiB promoter and that of the baiA promoter.  5’ 
SMART RACE analysis suggests the mRNA initiation site is 
56 bp upstream of the baiA gene (Figure 37).  Figure 38 
displays an alignment of the baiA gene from C. hylemonae 
with baiA genes from C. scindens and C. hiranonis.   
 
Identification and characterization of novel genes 
suggested to be involved in bile acid metabolism 
in Clostridium hylemonae and Clostridium scindens 
 
The 3.3 kb contig containing the baiA and upstream 
bai promoter was further analyzed for additional ORF 
potentially involved in the reductive arm of the bile acid 
7α/β-dehydroxylation pathway (Figure 39; Figure 40) (Table 
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Figure 36.   Isolation of partial baiA gene from C. 
hylemonae TN271 using degenerate PCR 
oligonucleotides designed from conserved 
regions of C. scindens and C. hiranonis baiA 
genes.  Arrow indicates PCR product 
corresponding to partial baiA gene as shown 
in nucleotide sequence alignment.  PCR 
product was cloned into a pCR8 GW TOPO TA 
cloning vector resulting in vector p271OXA.   
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Figure 37.  Isolation of baiA gene from C. hylemonae 
TN271 and characterization of upstream 
promoter elements.  (a.)  Schematic 
representation of sequence alignment and 
location of baiA gene relative to PCR 
product alignment.  (b.) CLUSTALW alignment 
of C. hylemonae TN271 oxidative baiB 
promoter (TN271Oprom) with baiA promoter 
(TN271Aprom).  Boxed regions correspond to 
conserved bai promoter elements. (c.)  
Results of 5’ SMART RACE PCR analysis of 
baiA cDNA from CA induced culture (See 
Figure 20).  mRNA initiation site (bold, 
underlined) indicated by arrow which points 
in direction of transcription. Italicized 
letters indicate 5’ end of baiA gene with 
corresponding amino acids (below).   
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Figure 38.   CLUSTALW alignment of amino acid sequence of 
baiA genes from C. hylemonae TN271, C. 
scindens VPI 12708 and C. hiranonis sp. 
strain TO931.  The baiA gene encodes a 3α-
hydroxysteroid dehydrogenase specific for 
cholyl-CoA (58). 
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Figure 39.  Genome-walking PCR upstream of partial baiA 
gene of Clostridium hylemonae TN271.  A 
nested PCR product derived from PvuII 
restriction library template (PN) ~2.5 kb 
was purified by GENECLEAN and ligated into 
pCR8 GW TOPO TA vector to produce vector 
p271PNUP1A.   
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Figure 40.   Downstream genome-walking PCR (DS1) from 
baiA gene of Clostridium hylemonae TN271. A 
nested PCR product derived from EcoRV (EN) 
restriction library template ~2.3 kb was 
purified by GENECLEAN and ligated into pCR8 
GW TOPO TA vector to produce vector 
p271ENDS1A. 
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 8).  An ORF was located 235 bp upstream of the baiA gene.  
The putative 732 bp gene was predicted to encode a 26 kDa 
short chain dehydrogenase/reductase.  Members of this 
family include the baiA gene which encodes a 3α-HSDH.  
However, these two gene products shared only 19% amino 
acid sequence identity and 35% similarity.  This ORF is of 
interest because we expect the final reductive step in the 
pathway to encode a 3α-HSDH recognizing 3-dehydro-DCA 
and/or 3-dehydro-LCA.  A second partial ORF was located 67 
bp upstream of the putative short chain dehydrogenase.  
Intriguingly, this ORF was suggested to encode a type III 
CoA transferase whose highest sequence identity was that 
of the baiF gene from C. scindens VPI 12708.  A second 
upstream genome-walk resulted in a PCR product 2,107 bp in 
length which increased the current contig length to 4,949 
bp (Figure 41).  The baiF homologue sequence was completed 
and found to be 1,332 bp in length and predicted to encode 
a 49.5 kDa polypeptide.  The baiF gene product from C. 
scindens VPI 12708 was previously overexpressed in E. coli 
and reported to encode a 47.5 kDa CoA hydrolase (130); 
however, recent data suggests this gene product belongs to 
the Type III family of CoA transferases (131).  The baiF 
178
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41.   Second genome-walking PCR upstream of baiA 
from C. hylemonae TN271.  a.) Nested PCR 
obtained from PvuII restriction digest (PN) 
of C. hylemonae genomic DNA template. b.) 2 
kb product GENECLEAN purified from agarose 
gel and ligated into pCR8 GW TOPO TA vector 
resulting in vector p271UP2A.  
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 and this second ORF share 60% amino acid sequence 
identity, 75% amino acid similarity.  Figure 42 shows an 
amino acid sequence alignment between the baiF gene and 
the putative CoA transferase.  
 Directly upstream, 52 bp from the hypothetical CoA 
transferase gene was another partial ORF with a flavin 
binding domain.  Further genome-walking resulted in 760 bp 
of sequence data and completion of this 1,722 bp ORF 
encoding a putative 62 kDa flavoprotein (Figure 43).   
BLAST analysis suggested this gene product encodes a 
flavoprotein similar to fumarate reductases and 3-
ketosteroid-Δ1-dehydrogenases.   The former can likely be 
ruled out due to the lack of four conserved N-terminal 
heme binding sites (CXXCH) found in fumarate reductases 
such as that of Shewanella putrefaciens MR-1, whose 
structure has been solved (192).   The latter possibility 
was of particular interest because we expect one of the 
reductive genes to encode a 3-oxo-Δ4-steroid 
oxidoreductase.  A fourth upstream genome-walk resulted in 
a 2,765 bp of additional sequence data which increased 
contig length to 7,993 (Figure 44).  This additional 
sequence data allowed analysis upstream of the putative 3-
181
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42.   Boxshade of CLUSTALW amino acid sequence 
alignment of baiF gene product of C. 
hylemonae and a predicted Type III CoA 
transferase which we have named the baiK 
gene (See text).   
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Figure 43.  Third upstream genome-walking PCR from baiA 
gene of C. hylemonae TN271.   a). Agarose 
gel of DS2 products using Dra1 (D), EcoRV 
(E), PvuII (P), StuI (S) restriction 
libraries of C. hylemonae TN271 genomic DNA 
as template with adaptor primer AP1 and 
gene-specific primer WALKDS-2 (See Table 6).  
b.) “EN” and “PN” represent nested PCR 
amplification using nested adaptor primer 
AP2 and gene-specific primer WALKDSNEST2 
(See Table 6).  “M” represents 1 kb DNA 
ladder.  C.) Schematic representation of TA 
cloning of GENECLEAN purified “DN” product 
(arrow) into pCR8/GW/TOPO TA vector (2.8 kb) 
yielding 3.56 kb vector p271DNCDUP3.   
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Figure 44.  Fourth upstream genome-walking PCR from baiA 
gene of Clostridium hylemonae TN271. a.) 
Nested PCR obtained from EcoRV (EN) 
restriction digest of C. hylemonae genomic 
DNA template. b.) 2.7 kb product GENECLEAN 
purified from agarose gel and ligated into 
pCR8 GW TOPO TA vector resulting in vector 
p271UP4A (5.5 kb) 
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 oxo-Δ4-steroid oxidoreductase gene for a bai promoter 
sequence.  Indeed, we located a putative bai promoter 24 
bp upstream of this ORF (Figure 45).  Additional conserved 
bai promoter regions were not found in any other portions 
of this contig.  5’ SMART RACE PCR was performed on the 
putative 3-oxo-Δ4-steroid oxidoreductase gene and the mRNA 
start site was determined at the very 5’ end of the 
conserved bai region suggesting the promoter is located 
upstream of this conserved region (Figure 46).    It is 
quite possible that this conserved region is a promoter 
region for both the baiA and baiB operons; however, this 
region does not appear to be a promoter for the baiJKL 
genes.  The functional significance of this conserved 
region remains to be elucidated. 
For the sake of simplicity in description we will 
provide a preliminary name to these gene products 
following the sequence of nomenclature ending with the 
baiI gene on the oxidative operon.  This first ORF 
encoding the putative 3-oxo-Δ4-steroid oxidoreductase will 
be called the baiJ gene.  The baiF homologue will be named 
the baiK gene and the putative short chain dehydrogenase 
will be referred to as the baiL gene.   
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Figure 45.  Identification of conserved bai promoter 
elements upstream of the putative baiJ gene 
of Clostridium hylemonae TN271. 
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Figure 46.   Determination of transcription initiation 
site for baiJ gene from Clostridium 
hylemonae TN271 based on SMART RACE PCR 
analysis.   Alignment above shows 
determination of transcription initiation 
site (TIS) based on alignment of SMART RACE 
sequence data (SR3, SR4) with baiJ gene and 
upstream region from Clostridium hylemonae 
TN271 (TN271D4).  TIS is determined based on 
the first base following 3’ end of SMART II 
A oligo sequence (italics) (5’-
AAGCAGTGGTATCAACGCAGAGTACGCGGG-3’).  This 
nucleotide (underlined, arrow) must also 
correspond to the known sequence of the 
upstream region of the gene.  Therefore, the 
TIS is 47 bp upstream of the ATG start site 
(underlined).  RBS=ribosome binding site.   
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SR3        CTAATACGACTCACTATAGGGCAAGCAGTGGTATCCACGC-AGAGTACGCGGGAGAAAAA 
SR4        CTAATACGACTC-CTATAGGGCAAGCAGTGGTATCCACGC-AGAGTACGCGGGAGAAAAA 58
TN271D4    -----------TTAAATTATACAGGCTGATTTTTAGATGTTAGAATA-AAAGCAGAAAAA 48                             
**    ** ** *   * *  * *  *** **    * *******
SR3        CATGTTATTAAAATAACAAATGATCAGAAAAAGGAGGCAAATGCGATGGCAAACTATGTA 119
SR4        CATGTTATTAAAATAACAAATGATCAGAAAAAGGAGGCAAATGCGATGGCAAACTATGTA 118
TN271D4    CATGTTATTAAAATAACAAATGATCAGAAAAAGGAGGCAAATGCGATGGCAAACTATGTA 108                   
************************************************************
SR3        CCAGGCACGTACGAAGGTATCGGTCACGGATACCAGGGCAGGCTTATCGTGAATGTAACA 179
SR4        CCAGGCACGTACGAAGGTATCGGTCACGGATACCAGGGCAGGCTTATCGTGAATGTAACA 178
TN271D4    CCAGGCACGTACGAAGGTATCGGTCACGGATACCAGGGCAGGCTTATCGTGAATGTAACA 168                        
************************************************************
SR3        GTTACGGAAGATGAGATCACGGAGGTTAAAATCATCAAACATAAGGAAGTGCGGGGGCTT 239
SR4        GTTACGGAAGATGAGATCACGGAGGTTAAAATCATCAAACATAAGGAAGTGCGGGGGCTT 238
TN271D4    GTTACGGAAGATGAGATCACGGAGGTTAAAATCATCAAACATAAGGAAGTGCGGGGGCTT 228                
************************************************************
SR3        GCGTGGGACCTTCCCACATCCCCTGTCGAGGTGATGCCGCCTCAAATTGTCAAATATCAG 299
SR4        GCGTGGGACCTTCCCACATCCCCTGTCGAGGTGATGCCGCCTCAAATTGTCAAATA---- 294
TN271D4    GCGTGGGACCTTCCCACATCCCCTGTCGAGGTGATGCCGCCTCAAATTGTCAAATATCAG 288                
********************************************************                                    
TN271 baiJ start site: 
AGAAAAACATGTTATTAAAATAACAAATGATCAGAAAAAGGAGGCAAATGRBS
192
  
Isolation of the baiJ gene from C. scindens VPI 12708 and 
elucidation of conserved baiJKL genes. 
 
A necessary question immediately arose: are these 
genes conserved in other 7α-dehydroxylating bacteria?  To 
answer this question, the baiJ gene from C. hylemonae 
TN271 was analyzed for short 7-8 amino acid stretches with 
regions of low codon degeneracy.  Amino acids 183-189 
(EEMCYNY) and 394-401 (NEWSYQYH) were selected as sites of 
lowest degeneracy, a section whose nucleotide sequence 
would result in an expected PCR product of 654 bp (Figure 
47).  A codon usage table was prepared using sequence data 
from bai genes from C. scindens VPI 12708 using the codonW 
program (Figure 48).  This table allowed design of least 
degenerate oligonucleotides for an attempt at isolation of 
the baiJ gene from C. scindens VPI 12708 (Table 9).  
Amplification using forward primer Delta4F1 and each of 
the reverse primers Delta4R1, Delta4R2 and Delta4R3 each 
resulted in a product around 650 bp (Figure 49) (See Table 
9 for primer sequences).  The 650 bp PCR product amplified 
using Delta4F1 and Delta4R2 primers was excised from the 
193
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 47.   Amino acid sequence of baiJ gene from 
Clostridium hylemonae TN271.  Residues 
highlighted in green have one or two 
possible codons.  Bold regions correspond to 
amino acids 183-189 (EEMCYNY) and 394-401 
(NEWSYQYH).  These regions were selected 
based on low codon degeneracy which will be 
used to design oligonucleotides to 
potentially isolate the baiJ gene from 
Clostridium scindens VPI 12708.  
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Figure 48.   Codon usage table for Clostridium scindens 
VPI 12708 and design of redundant 
oligonucleotides for isolation of the baiJ 
gene from C. scindens VPI 12708. a). Codon 
usage table generated using bai genes from 
Clostridium scindens as input (U57489).  b). 
Design of forward and reverse degenerate 
oligonucleotides based on regions identified 
in Figure 45.   
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Figure 49.  Isolation of partial baiJ gene from 
Clostridium scindens VPI 12708.  a).  PCR 
products generated from amplification with 
primers Delta4F1 and Delta4R2 from both 
Clostridium hylemonae TN271 and Clostridium 
scindens VPI 12708 genomic DNA templates.  
b).  0.65 kb PCR product from Clostridium 
scindens VPI 12708 was GENECLEAN purified 
and cloned into a pCR8/GW/TOPO TA vector 
generating a 3.45 kb vector p12708D4deg.  
c.) CLUSTALW alignment of sequence data 
obtained from p12708D4deg insert against 
baiJ gene from Clostridium hylemonae TN271.    
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 agarose gel, GENECLEAN purified, cloned into a pCR8 TOPO 
TA cloning vector and both strands sequenced.  An 
alignment of the partial baiJ sequence obtained from C. 
scindens against the baiJ gene from C. hylemonae TN271 
shows the high degree of amino acid sequence conservation 
(Figure 49).  The partial baiJ gene from C. scindens was 
used to design bidirectional genome-walking PCR 
oligonucleotides to both complete the gene sequence and 
obtain information about any flanking ORF. 
 The first upstream genome-walk from the partial baiJ 
gene resulted in a 1,330 bp product (Figure 50).  Addition 
of this sequence data to the partial baiJ sequence 
resulted in a contig of 1.8 kb.  This sequence data 
contained the 5’ end of the baiJ gene.  A conserved “bai 
promoter region” was located directly upstream of the baiJ 
gene and shared a high degree of sequence identity with 
the putative bai promoter region found upstream of the 
baiJ gene of C. hylemonae (Figure 51).  SMART RACE 
analysis of the 5’ end of the baiJ gene revealed the TIS 
upstream of the putative conserved bai “promoter” region 
(Figure 52).  These results were similar, but not 
identical to the TIS of the baiJ gene from C. hylemonae 
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Figure 50.  Genome-walking PCR upstream of partial baiJ 
gene of Clostridium scindens VPI 12708. a.) 
Nested PCR products obtained from DraI (DN) 
and EcoRV (EN) restriction digest of C. 
scindens genomic DNA template.  Due to 
larger size, product “EN” was isolated, 
cloned and sequenced.  b.) 1.3 kb product 
GENECLEAN purified from agarose gel and 
ligated into pCR8 GW TOPO TA vector 
resulting in vector p12708D4ENUP1 (1.3 kb). 
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Figure 51.  BOXSHADE of CLUSTALW alignment of upstream 
conserved bai promoter elements located 
upstream of baiJ genes of Clostridium 
scindens VPI 12708 and Clostridium hylemonae 
TN271.   
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Figure 52.  Verification of bile acid induction and 5’ 
SMART RACE PCR analysis of baiJ transcript 
from C. scindens VPI 12708.  (a). TLC 
autoradiograph (Top) between CA induced (I) 
and CA uninduced (UI)cultures of C. scindens 
VPI 12708.  RT-PCR (Below) of baiB gene 
comparing cDNA produced from RNA isolated 
from CA I and CA UI cultures of C. scindens 
VPI 12708 using primers baiB12708RTF (5’-GAT 
GAG CAG GGC TTA TCT GTA CTT T-3’), and 
baiB12708RTR (5’-GTA TCT CTT TCC CTG TCT CAA 
TGA C-3’)and compared to gyrA gene.  (b). 1% 
Agarose gel stained with ethidium bromide 
showing 5’ RACE PCR products using gene-
specific primer SR12708D1 (5’-TTC TAT GTC 
CTC ATC CGT TGC CCC TG-3’).  Lane “M” is a 1 
kB DNA marker, lanes 1, 2, and 3 represent 
PCR products obtained at various annealing 
temperatures (62˚C, 64˚C, 66˚C, 
respectively).  Arrow indicates band that 
was isolated, and sequenced.  (c). Schematic 
representation of TIS obtained from 5’RACE 
sequence data. “†”= TIS position obtained 
from 5’RACE of C. hylemonae TN271 baiJ gene 
(Figure 46).  “‡”= TIS position determined 
by primer extension (Mallonee et al. 2000) 
and 5’RACE (Figure 27) for the baiB gene 
from C. scindens VPI 12708. “▪” represents 
TIS position determined by primer extension 
analysis of the baiB gene from C. hiranonis 
sp. strain TO931. “◊” represents TIS 
position determined by 5’RACE PCR of baiB 
gene from C. hylemonae TN271 (Figure 26).  
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 TN271.  The TIS, located upstream of this conserved 
region, effectively rules this region out as the bai 
promoter.   
In addition, a partial ORF was found 128 bp upstream 
of the baiJ gene on the antisense strand.  A BLAST search 
of the ORF suggested this gene belonged to the LysR family 
of transcription factors.  Due to the proximity of the TIS 
of the baiJ gene to the LysR like gene on the opposite 
strand, it is very likely that the baiJ promoter overlaps 
the LysR-like gene.  A second upstream genome-walk 
resulted in a 4.0 kb PCR product which increased the 
contig to 5.7 kb (Figure 53).  This sequence data 
completed the remainder of a 960 bp gene encoding a 
deduced 36.2 kDa polypeptide predicted to encode a 
transcriptional regulator in the LysR family.  A second 
ORF located on the anti-sense strand relative to the baiJ 
gene was found 73 bp upstream of the putative 
transcription factor.   This 465 bp ORF was predicted to 
encode a 17.8 kDa polypeptide in the Tryptophan-rich 
sensory protein (TspO)/ mitochondrial benzodiazepine 
receptor (MBR) homolog family of signal transduction 
integral membrane proteins.   Further upstream, and on the 
208
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 53.  Second upstream genome-walking PCR (UP2) 
from partial baiJ gene of Clostridium 
scindens VPI 12708. a). Agarose gel of UP2 
products using Dra1 (D), EcoRV (E), PvuII 
(P), StuI (S) restriction libraries of C. 
scindens VPI 12708 genomic DNA as template 
with adaptor primer AP1 and gene-specific 
primer 12708WalkUP2 (See Table 6).  b.) “DN” 
and “SN” represent nested PCR amplification 
using nested adaptor primer AP2 and gene-
specific primer 12708WalkUP2N (See Table 6). 
A positive clone was obtained for product 
“SN”, so this was used for sequencing.  “M” 
represents 1 kb DNA ladder.  C.) Schematic 
representation of TA cloning of GENECLEAN 
purified “SN” product (arrow) into 
pCR8/GW/TOPO TA vector (2.8 kb) yielding 6.8 
kb vector p12708D4SNUP2.   
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 same strand relative to the baiJ gene, we located the 
baiA1 gene and promoter region which has been previously 
reported (122).  This gene was located directly upstream 
of the TspO homologue.   It is interesting to note that 
the baiA gene and baiA promoter located in C. hylemonae 
was found in proximity to this putative reductive bai 
operon.   
 The initial genome-walk downstream of the partial 
baiJ gene resulted in a PCR product 1,929 bp in length 
(Figure 54).  Alignment with the previous sequence data 
resulted in a contig of 7,114 bp.   This additional 
sequence data resulted in completion of the 1,722 bp baiJ 
gene predicted to encode a 61.2 kDa polypeptide.  Amino 
acid sequence identity of the baiJ gene is highly 
conserved between C. scindens and C. hylemonae (89%) 
(Figure 55).  In addition, a partial baiK gene was located 
37 bp downstream of the baiJ gene in C. scindens.  A 
second downstream genome-walk resulted in a fragment 3,366 
bp in length increasing the contig length to 10.13 kb.  
The 1,314 bp baiK was completed and predicted to encode a 
49.1 kDa polypeptide.  The baiL gene, 732 bp in length, 
was located 79 bp downstream of the baiK gene.  The 
211
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 54. Downstream genome-walking PCR (DS1) from 
partial baiJ gene of Clostridium scindens 
VPI 12708. a.) Nested PCR products obtained 
from DraI (DN) and EcoRV (EN) and StuI (SN) 
adaptor ligated restriction libraries of C. 
scindens VPI 12708 genomic DNA templates. 
Due to larger size, product “EN” was cloned.  
b.) 1.9 kb product GENECLEAN purified from 
agarose gel and ligated into pCR8 GW TOPO TA 
vector resulting in vector p12708D4ENDS1 
(4.7 kb). 
 
212
M   DN      EN    SN
3.0 kb
2.0 kb
1.6 kb
a.
p12708D4ENDS1
4.7 kb
T2
T1
attL1
attL2
TA cloning site
Specr
pUC ori
A A12708D4ENDS1
1.9 kb
b.
213
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 55.  Boxshade representation of CLUSTALW amino 
acid sequence alignment of putative 3-oxo-Δ4-
reductases (baiJ) between Clostridium 
scindens VPI 12708 and Clostridium hylemonae 
TN271.   
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 deduced amino acid sequence suggests this gene encodes a 
26.4 kDa polypeptide.  In addition, a partial ABC 
transport protein was located 85 bp downstream of the baiL 
gene in C. scindens.   This short intergenic distance 
suggests this gene may be found on the same operon.  
Indeed, we hypothesize that an additional ABC transporter 
will be involved in translocating DCA and LCA into the 
extracellular environment (Figure 8).  A short 850 bp 
genome-walk (Figure 56), and a fourth genome-walk of 3 kb 
(Figure 57) resulted in completion of the ABC transport 
gene 1854 bp in length, encoding a deduced 70.3 kDa 
polypeptide.   In addition, two ORF were located directly 
downstream of the ABC transport protein. BLAST analysis 
suggests this ORF encodes a flavoprotein with the highest 
similarity to guanine deaminases.  The second ORF is 
predicted to encode a flavoprotein with greatest 
similarity to xanthine dehydrogenases and 4-
hydroxybenzoyl-CoA reductases.   
 Figure 58 is a schematic representation of the 
putative reductive bai operons in both C. scindens VPI 
12708 and C. hylemonae TN271.   Some notable features 
include the similar organization of the baiJKL genes, 
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Figure 56.   Third genome-walking PCR downstream (DS3) of 
baiJ gene product in Clostridium scindens 
VPI 12708. a). Agarose gel of DS3 products 
using Dra1 (D), EcoRV (E), PvuII (P), StuI 
(S) restriction libraries of C. scindens VPI 
12708 genomic DNA as template with adaptor 
primer AP1 and gene-specific primer 
12708WDS3 (See Table 6).  b.) “DN” and “SN” 
represent nested PCR amplification using 
nested adaptor primer AP2 and gene-specific 
primer 12708WDS3N (See Table 6). Attempts to 
clone product “SN” were unsuccessful.  While 
“EN” was smaller in size, the specificity 
was high and attempted cloning yielded 
several positive clones.  “M” represents 1 
kb DNA ladder.  b.) Schematic representation 
of TA cloning of GENECLEAN purified “EN” 
product (arrow) into pCR8/GW/TOPO TA vector 
(2.8 kb) yielding 3.65 kb vector 
p12708D4ENDS3.   
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Figure 57. Genome-walking PCR downstream (DS4) of 
partial baiJ gene of Clostridium scindens 
VPI 12708. a.) Nested PCR products obtained 
from DraI (DN) restriction digest of C. 
scindens VPI 12708 genomic DNA template.  
b.) 3.0 kb product was GENECLEAN purified 
from agarose gel and ligated into pCR8 GW 
TOPO TA vector resulting in vector 
p12708D4DNDS4 (5.8 kb). 
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Figure 58.   Schematic representation of putative 
reductive genes from Clostridium scindens 
VPI 12708 and Clostridium hylemonae TN271. 
The baiA genes encode 27 kDa 3α-
hydroxysteroid dehydrogenases.  The baiJ 
genes encode 62 kDa flavoproteins.   The 
baiK genes encode a predicted 49 kDa Type 
III CoA transferase similar to the baiF.  
The baiL genes encode 27 kDa proteins of the 
short chain reductase family.  Finally, the 
baiM encodes a predicted ABC transport 
protein hypothesized to function as a 
secondary bile acid efflux protein.  “P” 
represents conserved bai “promoter” region.   
 
 
 
 
221
C. scindens
C. hylemonae
PP
PP
baiJ baiK baiL ABC transporter
baiA
ArsR ferrodoxin
ABC transporter
TspO/MBR
LysR
Guanine
deaminase
(TIM barrel)
Xanthine dehydrogenase
4-hydroxybenzoyl-CoA reductase
1 kb
222
 upstream conserved elements with the oxidative bai 
upstream region, and proximity of TIS.  Interestingly, the 
upstream ORFs are not conserved between C. scindens and C. 
hylemonae.  Each region includes an ORF predicted to 
encode a transcription factor of a different family of 
proteins on opposite strands.  In addition, the ORF 
immediately upstream of the baiJ gene from C. hylemonae 
TN271 is predicted to encode an 18 kDa 4Fe-4S ferrodoxin 
presumably involved in shuttling electrons.  This ORF was 
not located adjacent to the baiJKL genes from C. scindens.  
Finally, the baiA gene and conserved upstream “promoter” 
appear to cluster around the baiJKL genes.   
 
Isolation of a partial baiJ gene in Clostridium hiranonis 
sp. strain TO931 
 
The baiJ gene from C. hylemonae TN271 and C. scindens 
VPI 12708 are very similar at the amino acid sequence 
level.  Designing oligonucleotides for isolation of the 
same gene from more distantly related species can be 
difficult with such high sequence identities.  Attempts 
were made to isolate the baiJ gene from C. hiranonis using 
223
 redundant primers in Table 9 without success. Therefore, a 
multiple sequence alignment was prepared with the amino 
acid sequence of the baiJ gene product against several 
homologues in the databases.  This way, regions could be 
detected that would normally be highly conserved within 
this family of flavoproteins.  Two gene products were 
selected for the alignment: 1). ZP_01362869.1, a fumarate 
reductase flavoprotein subunit precursor from Clostridium 
sp. OhILAs (2) ZP_00802728.1, a Flavocytochrome C from 
Alkaliphilus metalliredigenes QYMF.  These protein 
sequences were then aligned with the 12708 baiJ using 
ClustalW (Figure 59).  Two regions of high amino acid 
sequence identity with low codon degeneracy spanning a 282 
bp stretch within the baiJ gene were identified (Figure 
59).  A codon usage table was prepared using bai gene 
sequences from C. hiranonis sp. strain TO931 (accession 
no. AF210152) (Figure 60).  These primers were used to 
isolate a 657 bp gene product corresponding to what 
appears to be a partial baiJ gene of C. hiranonis sp. 
strain TO931 (Figure 61).  A genome-walking library will 
have to be constructed for C. hiranonis sp. strain TO931 
to elucidate the remaining gene and flanking regions; 
224
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 59.  Boxshade of CLUSTALW alignment between the 
baiJ gene product from Clostridium scindens 
VPI 12708 and flavoprotein homologues.  
ZP_01362869.1 represents the GenBank 
accession number for the fumarate reductase 
flavoprotein subunit precursor from 
Clostridium sp. OhILAs and ZP_00802728.1 
represents the GenBank accession number for 
the Flavocytochrome c from Alkaliphilus 
metalliredigenes QYMF.  Arrows represent 
regions of high amino acid conservation and 
low codon degeneracy which will be used to 
design oligonucleotides to attempt to 
isolate the baiJ gene from more distantly 
related 7α-dehydroxylating clostridia.   
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Figure 60.  Codon Usage Table for Clostridium hiranonis 
sp. strain TO931.  The CodonW program was 
used with bai gene sequences from C. 
hiranonis sp. strain TO931 as input (GenBank 
accession no. AF210152).   
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Figure 61.   Isolation of putative baiJ gene from 
Clostridium hiranonis sp. strain TO931.  a.)  
Agarose gel of PCR products derived from 
amplification with primers TO931D4F (5’-GCW 
GCW GAY TCW ATA GAA GAA TTA GC-3’), and 
TO931D4R (5’-TTC WCC WGC WGC TAA WCC WGG 
TAT-3’) against (-) no DNA, (12708) 
Clostridium scindens VPI 12708 genomic DNA, 
(TO931) Clostridium hiranonis sp. strain 
TO931.  A single PCR product was obtained 
from C. hiranonis sp. strain TO931.  b.) PCR 
product (arrow) was cloned into a 
pCR8/GW/TOPO TA vector to obtain a 3.05 kb 
vector pD4TO931.  c). Boxshade alignment of 
multiple sequence alignment of C. hylemonae 
TN271 baiJ (TN271baiJ), C. scindens VPI 
12708 baiJ (12708baiJ) and partial sequence 
of C. hiranonis sp. strain TO931 baiJ.  
Asterisks signify amino acids corresponding 
to gene region where primers anneal.   
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 however, this data represents a significant step in 
possibily recovering these putative reductive genes from a 
third 7α-dehydroxylating clostridial species present in 
the human colon.    
 
Cloning and Overexpression of baiL gene in Escherichia 
coli.  
The baiL gene is predicted to encode a 26 kDa 
polypeptide in the 3-ketoacyl-acyl carrier protein 
reductase (fabG) family (Figure 62).  We predict this 
protein will convert 3-oxo-DCA(~SCoA) and/or 3-oxo-
LCA(~SCoA) to the secondary bile acids DCA(~SCoA) and 
LCA(~SCoA), respectively.  Therefore, the strategy for 
characterizing this gene product was to clone the baiL 
gene from C. hylemonae TN271 into a pET21(a+) vector, 
overexpress the recombinant protein in E. coli codon plus 
BL21(DE3) and test 3α-hydroxysteroid oxidoreductase 
activity with substrates NAD(P)H and [24-14C] 3-oxo-DCA or 
NAD(P) and [24-14C] DCA  (See Material and Methods).    
After cloning (Figure 63) and sequencing of the 
vector insert to verify proper reading frame, the BaiL was 
overexpressed in E. coli (Figure 64a).  The BaiL protein 
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Figure 62.  Boxshade of CLUSTALW amino acid sequence 
alignment of baiL genes from Clostridium 
scindens VPI 12708 and Clostridium hylemonae 
TN271 with similar short chain 
dehydrogenases/3-keto acyl reductases.  
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Figure 63. Cloning strategy of baiL gene from C. scindens 
VPI 12708. 
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Figure 64.  Overexpression of recombinant baiL gene from 
Clostridium hylemonae TN271 in E. coli BL21 
(DE3).  “M” stands for Kaleidograph protein 
standard, Lane 1= 30 μg soluble protein from 
IPTG uninduced E. coli, Lane 2= 25 μg 
insoluble protein from IPTG uninduced E. 
coli, Lane 4= 30 μg soluble protein from 1 
mM IPTG induced E. coli, Lane 5= 10 μg 
insoluble fraction 1 mM IPTG induced E. 
coli, Lane 6= 15 μg insoluble fraction IPTG 
induced E. coli, Lane 7= 30 μg insoluble 
fraction 1 mM IPTG induced E. coli.  a).  
Cultivation in LB broth  b).  Cultivation in 
LBS broth (See Text).    
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 was highly expressed, though found in inclusion bodies.  
Several attempts were made with different colonies, ranges 
of IPTG concentration (0.1-1mM), temperatures (18˚C to 
37˚C) and media (LB, TYGPN).  Indeed, we attempted the 
sorbitol/betaine method (medium LBS) of Blackwell and 
Horgan (1991) although results were similar between LB and 
LBS (Figure 64b) (193).  We verified expression of His-tag 
using anti-hexahistidine antibodies in the insoluble, but 
were unable to detect any soluble recombinant BaiL-His 
(Figure 65).     
The baiL gene was also cloned in a pET24(a+) vector 
as well as a pSport1 vector from both the SP6 and T7 
promoters and overexpressed.  In each case, the BaiL was 
located in the insoluble fraction.  Attempts at refolding 
by solublization in 8M urea followed by step-down buffer 
exchanges with urea in the presence of DTT and arginine 
were unsuccessful in producing soluble protein.   
 
Cloning and overexpression of the baiJ gene product in 
Escherichia coli. 
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Figure 65.  Western blot analysis of baiL expression in 
soluble and insoluble fractions of IPTG 
induced E. coli cell extracts.  Protein 
samples were electrophoresed on an SDS-PAGE 
gel (12%) and electroblotted onto 
nitrocellulose.  The blot was probed with 
anti-hexahistidine antibody.  Lane S=soluble 
fraction from 1 mM IPTG induced E. coli 
whole cells; Lane IS= insoluble fraction 
solubilized in 8.5 M urea.  Each lane 
contains 20 μg protein.  Expected size of 
recombinant baiL gene product is 27 kDa.  
Position of molecular weight markers shown 
to left of blot.   
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  The baiJ gene is predicted to encode a 3-oxo-Δ4-
DCA(~CoA) oxidoreductase.  To test this hypothesis, the 
baiJ gene was PCR amplified with primers 12708baiJ-F (5’-
TGCATCTCCCTCGAGGGCACATTATGTTCCAGGC-3’) and 12708baiJ-R 
(5’-TACAGGTACCAAGCATTGACTGTCCCGATGCT-3’).  Double 
digestion of the pT7-SBP-2 expression vector and PCR 
product with XhoI and KpnI restriction endonucleases and 
ligation resulted in the pT7SB2baiJ vector (Figure 13).  
The vector was initially transformed into E. coli DH5α and 
subsequently cloned into expression host E. coli 
ArcticExpress BL21(DE3).  After verifying the sequence and 
reading frame of the insert, the BaiJ gene was 
overexpressed by IPTG induction (0.8 mM).  The 
ArcticExpress strain was chosen so that growth and thus 
expression could be slowed to allow for less inclusion 
body formation which was observed for the baiL gene.  
Figure 66 shows the purification and immunoblot detection 
of the recombinant BaiJ gene product.  The strep-tag was 
chosen based on results with the BaiH protein which lost 
activity following Ni+ affinity chromatography.  The 
strep-tag recognizes biotin, which should not result in 
chelation of metals or flavins.  The BaiJ polypeptide was 
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Figure 66.  SDS-PAGE and Western immunoblot of elution 
fraction after biotin binding chromatography 
of overexpression of recombinant BaiJ-SBP 
fusion protein.  10 μg protein was loaded 
onto a 12% polyacrylamide gel.  MW (kDa) 
marker represented to left of SDS-PAGE (a) 
and right of immunoblot (b).  Expected size 
of recombinant fusion protein: ~66 kDa. 
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 purified to about 95% based on visual inspection of SDS-
PAGE of eluent fraction.  The eluent was concentrated by 
centrifugation on Centriprep YM10 (10 kDa cut-off) 
concentrators.  The concentrated material was yellow in 
color; indicative of bound flavins such as observed for 
the BaiCD and BaiH proteins (121).   
Synthesis of bile acid CoA thioester was tested by 
differential solubility.  CoA esters of bile acids are 
water soluble at low pH, while free bile acids precipitate 
and can be extracted into organic solvents; particularly 
relatively hydrophobic bile acids such as 3-oxo-DCA. 30 μl 
CoA conjugate sample (90 μM; 25,000 DPM) was added to 500 
μl reaction buffer (100 mM sodium phosphate, pH 6.8) and 
the pH was lowered to 3 with 1N HCl.  The sample was 
extracted three times with two volumes ethyl acetate.  The 
ethyl acetate fraction and 10μl aqueous phase were counted 
by liquid scintillation.  The aqueous phase was then 
brought to pH 10 with 5N NaOH and boiled 30 min.  The pH 
was then lowered to 3 with 10 N HCl and extracted three 
times with two volumes ethyl acetate.  Again, the ethyl 
acetate fraction and the aqueous phase were counted.  
Figure 67 shows that radioactivity is extracted only after 
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Figure 67.  Measurement of radioactivity in both aqueous 
and organic phase before and after sodium 
hydroxide treatment.  This assay was used to 
provide evidence for the presence of a CoA 
conjugate based on relative solubility.  
Ethyl acetate (ETOAC) extraction “before 
NaOH” represents organic extraction of the 
aqueous phase containing bile acid CoA 
conjugates.  The pH was lowered to 3 with 1N 
HCl.  Free bile acids are expected to 
partition to the organic phase, while 
conjugates are expected to remain in the 
aqueous phase.  “After NaOH” represents the 
DPM value in the organic and aqueous phase 
once the aqueous phase from the first 
extraction was increased to pH 10 with 5 N 
NaOH, boiled for 30 min, and lowered to pH 3 
with 5 N HCl.  Extraction of the aqueous 
phase resulted in the majority of 
radioactivity partitioning in the organic 
phase, suggesting hydrolysis of CoA 
thioester. 
 
 
 
 
245
02000
4000
6000
8000
10000
12000
14000
16000
ETOAC Aqueous ETOAC Aqueous
Treatment
DP
M
Before NaOH After NaOH
246
 boiling at pH 10, suggesting that the CoA thioester is 
being hydrolyzed.  
Initial enzyme assays were run for 30 min at 37˚C in 
a 500 μl volume of 100 mM sodium phosphate buffer 
containing 90 μM [24-14C] 3-oxo-deoxycholyl-CoA (or the 
free acid) (550 DPM/nmole), 150 μM NAD(P)(H) and 30 μg 
purified BaiJ.  When 3-oxo-DCA and NADP were substrates, a 
product of greater hydrophilicity than the substrate was 
obtained whose Rf value was even lower than the commercial 
DCA standard (Figure 68).  This strongly suggests the 3α-
hydroxyl group is reduced in addition to an oxidation 
reaction.  Additional characterization will be required to 
determine the function of this enzyme.  In summary, the 62 
kDa BaiJ gene was expressed and purified and initial 
enzyme assays suggest this polypeptide metabolizes bile 
acids; however, this enzyme does not appear to have 3-oxo-
Δ4-DCA oxidoreductase activity.   
 
Isolation of the gyrA gene: housekeeping gene for 
normalizing RT-PCR in C. scindens and C. hylemonae. 
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Figure 68.  Autoradiograph of a thin layer 
chromatography of BaiJ reaction products.  
Standards (not shown) are represented by 
arrows.  3-oxo-DCA and 3-oxo-DCA~SCoA (90 
μM; 25,000 DPM) were used as substrates in a 
500 μl reaction volume.  The reaction 
buffer, 100 μM sodium phosphate (pH 6.8), 
containing 150 μM pyridine nucleotide 
(labeled) and 30 μg purified recombinant 
BaiJ-SBP.   
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 Future characterization and studies of bai gene 
expression by RT and qRT PCR requires normalization using 
“housekeeping genes”.  Several studies have used the gyrA 
subunit in this capacity (194, 195).  At the time of study 
there was no genomic data for any 7α-dehydroxylating 
bacterium in the databases, which has since changed 
(currently Clostridium scindens VPI 12708 and Clostridium 
scindens ATCC 35704 by our lab and Jeffrey Gordon’s lab, 
respectively).  The strategy for isolating the gyrA 
subunit from Clostridium hylemonae TN271 was to generate a 
multiple sequence alignment of several gyrA genes from 
various species of Clostridia in addition to two gyrA 
genes from Alkaliphilus oremlandii OhILAs.  After a 
multiple alignment was generated and searched for regions 
of low codon degeneracy based on a codon usage table 
generated for C. hylemonae TN271 (Figure 69) two regions 
of high sequence identity and low codon degeneracy were 
identified.  Figure 70 illustrates these regions in Logo 
form along with redundant oligonucleotide variations based 
on these sequence regions.  PCR amplification using 
sixteen combinations of forward and reverse redundant 
oligonucleotides resulted in five positive reactions 
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Figure 69.  Codon usage table for Clostridium hylemonae 
TN271.  The CodonW program was used to 
generate table using baiJ, baiK and baiL 
gene sequences as input.  
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Figure 70. Design of degenerate oligonucleotides for 
isolation of the gyrA gene from C. hylemonae 
TN271. A CLUSTALW alignment was prepared 
from the gyrA gene from the following 
organisms:  Alkaliphilus oremlandii OhILAs 
(ABW17577.1; EAT31502.1 ), C. perfringens 
str. 13 (NP_560923.1), C. beijerinckii NCIMB 
8052 (YP_001307153.1), C. tetani E88 
(NP_780806.1), C. acetobutylicum ATCC 824 
(AAK77994.1).   Short stretches of conserved 
amino acids were examined manually within 
this alignment for low codon degeneracy.  
Two regions were found spanning 235 amino 
acids which would give a PCR product of 705 
bp.   a).  Logo representation of conserved 
residues 77-84 (C. tetani gyrA) identified 
in multiple sequence alignment of gyrA genes 
as highly conserved and low in codon 
degeneracy.  Lowest degenerate forward 
primers (gyrAF1, gyrAF2) are listed.  b.)  
Logo representation of residues 299-307 (C. 
tetani gyrA) identified as highly conserved 
and containing residues with low codon 
degeneracy. The sense strand reverse 
translated is shown below amino acid 
residues (bold) with wobble based listed as 
“N”.  “Rev Comp” is the reverse 
complementary strand for reverse 
oligonucleotides (gyrAR-gyrAR8).   
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R   E   G   M   R   I   C   I   E
5’CGN GAN GGN ATG CGN ATN TGN ATN GAN 3’
Rev   5’TCN ATN CAN ATN CGN ATN CCN TCN CGN 3’
Comp
gyrAR TCK ATR CAK ATS CGC ATK CCY TCS CG
gyrAR2  TCK ATR CAK ATT CTC ATK CCY TCT CT
gyrAR3  TCK ATR CAK ATT CTC ATK CCY TCS CG
gyrAR4  TCK ATR CAK ATS CGC ATK CCY TCT CT
gyrAR5  TCK ATS ACC ATS CGC ATK CCY TCS CG
gyrAR6  TCK ATS ACC ATT CTC ATK CCY TCT CT
gyrAR7  TCK ATS ACC ATT CTC ATK CCY TCS CG
gyrAR8  TCK ATS ACC ATS CGC ATK CCY TCT CT
G   K   Y   H   P   H   G   D
5’-GGN AAN TAN CAN CCN CAN GGN GAN-3’
gyrAF1  GGV AAR TAY CAY CCG CAY GGV GAY
gyrAF2  GGV AAR TAY CAY CCH CAY GGV GAY
a.
Primer Name                                  Sequence
Primer Name                                  Sequence
b.
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 (Figure 71).  Cloning of PCR product derived from primer 
pair gyrAF1/gyrAR4, sequencing of this product and 
alignment of the deduced amino acid sequence suggests the 
gyrA gene has been isolated. Primers gyrAF1 and gyrAR8 
were used to isolate the partial gyrA gene from C. 
scindens VPI 12708 (data not shown) which was cloned into 
a pCR8/GW/TOPO, sequenced and aligned with section of gyrA 
gene from C. hylemonae TN271.  Following this data, the 
entire gyrA gene from C. scindens VPI 12708 was detected 
by local BLAST search of the 13X coverage of the C. 
scindens VPI 12708 genome (Ridlon JM, Alves J, Kang D, 
Hylemon PB and Buck G unpublished data).  A multiple 
sequence alignment of the gyrA genes from C. hylemonae 
TN271, C. scindens VPI 12708 and gyrA genes from 
clostridial genome data available from GenBank (Figure 
72).  A set of RT-PCR primers were designed to detect the 
gyrA gene of C. hylemonae TN271 (gyrATN271F 5’-
ACTTTGACGAGACAGAAAAAGAACC-3’; gyrATN271R 5’-
CAGTATATGTTCGATCGTCGT) (primers used in Figure 26) and C. 
scindens VPI 12708 (gyrA12708F 5’-
ATCTATGGAGCACTGGTAAATATGG-3’; gyrA12708R 5’-
AGTTAGGAGCAAAATCAACCGTATC-3’) which showed high 
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Figure 71.  PCR amplification of gyrA gene from 
Clostridium hylemonae TN271.  Combinations 
of oligonucleotides listed in Figure 65 were 
used against 50 ng C. hylemonae TN271 
genomic DNA template. Combinations of 
primers used in PCR reaction are as follows: 
Lane M= 1kb DNA ladder; Lane 1= gyrAF1, 
gyrAR; Lane 2=gyrAF1, gyrAR2; Lane 3=gyrAF1, 
gyrAR3; Lane 4=gyrAF1, gyrAR4; Lane 
5=gyrAF1, gyrAR5; Lane 6=gyrAF1, gyrAR6; 
Lane 7=gyrAF1, gyrAR7; Lane 8=gyrAF1, 
gyrAR8; Lane 9=gyrAF2, gyrAR; Lane 
10=gyrAF2, gyrAR2; Lane 11=gyrAF2, gyrAR3; 
Lane 12=gyrAF2, gyrAR4; Lane 13=gyrAF2, 
gyrAR5; Lane 14=gyrAF2, gyrAR5; Lane 
13=gyrAF2, gyrAR5; Lane 14=gyrAF2, gyrAR6; 
Lane 15=gyrAF2, gyrAR7; Lane 16=gyrAF2, 
gyrAR8.  750 bp PCR product from Lane 4 was 
cloned into a pCR8/GW/TOPO TA vector 
generating a ~3.5 kb vector p271gyrA.   
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Figure 72. Boxshade alignment of gyrA gene product from 
C. scindens VPI 12708 with other clostridial 
and bacterial gyrA genes. Alkaliphilus 
oremlandii OhILAs (ABW17577.1; EAT31502.1 ), 
C. perfringens str. 13 (NP_560923.1), C. 
beijerinckii NCIMB 8052 (YP_001307153.1), C. 
tetani E88 (NP_780806.1), C. acetobutylicum 
ATCC 824 (AAK77994.1).   
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ABW17577.1     ---MLEKRGNIVPINIEKEMKNSYIDYSMSVIVGRALPDVRDGLKPVHRRILYSMIELGITPDKPHKKSARIVGDVLGKYHPHGDTA 85 
EAT31502.1     ---MLEKRGNIVPINIEKEMKNSYIDYSMSVIVGRALPDVRDGLKPVHRRILYSMIELGITPDKPHKKSARIVGDVLGKYHPHGDTA 85 
NP_560923.1    ---MSLNEGKVIPIDINKEMKKCYIDYAMSVIVGRALPDVRDGLKPVHRRILYSMQELGLYPERGYRKCARIVGEVLGKYHPHGDSS 85 
YP_001307153.1 ---MDFNEGKVIPVDIKNEMKKCYIDYAMSVIVGRALPDVRDGLKPVHRRILYSLQELGLTPEKGYRKCARIVGDVLGKYHPHGDSS 85 
NP_780806.1    MNYMNNNEGKVLEVDIKQEMKKCYIDYAMSVIVGRALPDVRDGLKPVHRRILYSMYELGLSPEKSYRKCARIVGDVLGKYHPHGDSS 88 
AAK77994.1     ----MLNEGKVLPVDISSEMKKCYIDYAMSVIVSRALPDVRDGLKPVHRRILYSMHELGLTPEKGYRKCARIVGDVLGKYHPHGDSS 84 
12708gyrA      --MEDNIFDKVHEVDLKKTMETSYIDYAMSVIASRALPDVRDGLKPVQRRILYSMIELNNGPDKPHRKCARIVGDTMGKYHPHGDSS 86 
 
 
ABW17577.1     VYDAMVRLAQDFSMRYMLVDGHGNFGSVDGDGAAAMRYTEARLSKMAMEMIRDINKDTVDYRPNFDESLKEPSVLPSKFPNLLVNGS 171  
EAT31502.1     VYDAMVRLAQDFSMRYMLVDGHGNFGSVDGDGAAAMRYTEARLSKMAMEMIRDINKDTVDYRPNFDESLKEPSVLPSKFPNLLVNGS 171 
NP_560923.1    VYDALVRMAQDFSLRYMLVDGHGNFGSVDGDSAAAMRYTEAKMNKIASEMLRDINKNTVDFIPNFDGEEKEPVVLPSRYPNLLVNGS 171 
YP_001307153.1 VYDALVRMAQDFSMRYMLVDGHGNFGSVDGDSAAAMRYTEAKMNKIAVEMLRDINKNTVDFMPNFDGEEQEPVVLPSRFPNLLVNGS 171 
NP_780806.1    VYDALVRMAQDFSIRYTLVDGHGNFGSVDGDSAAAMRYTEAKMGKITIEMLRDINKNTVDFTPNFDGSEKEPSVIPSRFPNLLVNGS 174 
AAK77994.1     VYGALVRLAQDFNLRYTVVDGHGNFGSVDGDSAAAMRYTEAKMNKIALEMVRDIGKNTVDFIPNFDGEEKEPVVLPSRFPNLLVNGS 170 
12708gyrA      IYGALVNMAQEWSTRYPLVDGHGNFGSVDGDGAAAMRYTEARLSKISMELTADINKDTVDFAPNFDETEKEPVVLPARFPNLLVNGT 172 
 
 
ABW17577.1     NGIAVGMATNIPPHNLGEVIDGVVTLIDN-----SEAQVEDLMEHIKGPDFPTAATIMGTEGIKEAYTTGRGRIKVRAKASIEEVNK 253 
EAT31502.1     NGIAVGMATNIPPHNLGEVIDGVVTLIDN-----SEAQVEDLMEHIKGPDFPTAATIMGTEGIKEAYTTGRGRIKVRAKASIEEVNK 253 
NP_560923.1    SGIAVGMATNIPPHNLGEVIDGTIALIDN-----PELTSLELMTYIKGPDFPTAGIIMGKSGIRAAYETGKGRIVVRAKAEIEEE-N 253 
YP_001307153.1 SGIAVGMATNIPPHNLAEIIDGTIMLIDN-----PESTVLELMTKITGPDFPTGATIMGKAGIRAAYETGKGKIIVRANAEIEEE-N 253 
NP_780806.1    SGIAVGMATNIPPHNLCEVIDGINMLIED-----PDTTILELMSKIKGPDFPTAGIIMGKSGIRSAYETGRGKVIMRAKAEIEEE-K 256 
AAK77994.1     AGIAVGMATNIPPHNLGEVIDGITMLIDN-----PEATILELMAQIKGPDFPTAGIIMGKSGIRAAYETGRGKITVRAKSEIEVEDN 252 
12708gyrA      SGIAVGMATNIPPHNLNEIINAVVKIIDDQIEDKEETTIEEILKIIKGPDFPTGGMILGTRGIEEAYRTGRGKIRVRAVTDIETMPN 259 
 
 
ABW17577.1     EEVNKGRQQIIITEIPYQVNKARLIEKIAELVRDKKVEGISDLRDESDREGMRIVIELKRDANANVVLNKLYKHTQLEDTFGVIMLA 335 
EAT31502.1     EEVNKGRQQIIITEIPYQVNKARLIEKIAELVRDKKVEGISDLRDESDREGMRIVIELKRDANANVVLNKLYKHTQLEDTFGVIMLA 335  
NP_560923.1    EEE-NGRHKIIVTELPYQVNKAKLIEYIADLVKDKKITGISDLRDESDREGMRMVIELKRDANPNVTLNLLYKHTKMQDTFGVIMLA 334 
YP_001307153.1 EEE-NGRHSIIVTEIPYQVNKAKLVENIADLVKDKKITGISDLRDESDRDGMRIVIELKRDANPSVVLNLLYKHTKLQDTFGIIMLA 334 
NP_780806.1    EEE-KGRYRIIVTELPYQVNKAKLIENMAELVKDKRIDGISDIRDESDREGMRIVVEIKRDSNPNVVLNQLYKHTKMQDTFGVIMIA 337 
AAK77994.1     EVEDNGKQKIIITEIPYQVNKARLVESIADLVKDKRIVGISDLRDESDRDGMRIVIEIKKDANSNIILNQLYKHTRLQDTFGINMLA 334 
12708gyrA      ETMPNGKSRIIVTELPYMVNKARLIEKIAEMVRDKKIDGITDLSDQSSREGMRVVIELRKDVNANVLLNQLYKHTQLQDTFGVIMLA 341 
 
 
ABW17577.1     IVNGEPKVLNLKEVLTHYLDHQKDIITRRTQFDLNKAEERAHILEGLKIAIDNLDEVIKLIRGSENTQIAKTGLMETFTLSEKQAQA 422 
EAT31502.1     IVNGEPKVLNLKEVLTHYLDHQKDIITRRTQFDLNKAEERAHILEGLKIAIDNLDEVIKLIRGSENTQIAKTGLMETFTLSEKQAQA 422 
NP_560923.1    LVDNQPQILNLKQVLVHYINFQKDVITRRTQFELNKAKERAHILEGLIIALDNIDEVINIIRSSKTSEIAKNTLIERFSLSEKQAAA 421 
YP_001307153.1 LVNNEPKVLNLKQILENYVEFQKEVITRRTIFDLNKAEARAHILEGLKIALDNIDEVISIIRNSNTTEIAKNTLMERFELSEKQSQA 421 
NP_780806.1    LVDNEPKVLNLKEILVNYIEFQKEIIRRRTKFDLDKALARAHILEGLRIALDHIDEVISLIRSSKNADEARNGLMTKFSLTEKQAQA 424 
AAK77994.1     LVDNRPEVLNLKQILQHYIKFQEQVIRRRTEFDLEKASARAHILEGLKIALDHIDEVISLIRGSKTAQEAKLGLMDKFGLSEKQAQA 421 
12708gyrA      LVNNEPRVMNILDMLNYYLQHQEEVVTRRTKYELNKAEERAHILQGLLIALDNIDEVIRIIRGSQTVQIAKAELMERFGLSEVQSQA 428 
 
 
ABW17577.1     ILDMRLQKLTGLEIEKVEEEYEDLIKLINHFKEILANERLMLNIIKDELIEIKEKYGDERRTEITRAIGEINIEDMITEEEVVITLT 509 
EAT31502.1     ILDMRLQKLTGLEIEKVEEEYEDLIKLINHFKEILANERLMLNIIKDELIEIKEKYGDERRTEITRAIGEINIEDMITEEEVVITLT 509 
NP_560923.1    ILEMRLRRLTGLERDKIENEYNELMKLIDYLNAILASEERLLEVIKEELLEIKAKYSDERRTQIEKQENEIDIEDLIQEEDVVITLT 508 
YP_001307153.1 ILEMRLRRLTGLERGKIEEEYNELMKQIEYLKSILASEEKLLDVIKEELLEIKNRYSDERKSKIEKIVNEIDIEDLIQEEDVVITLT 508 
NP_780806.1    ILDMRLQRLTGLERDKIEEEYNQLMETIKYLRDILNNEDLVLKIIKEELHEIKNKYGDERKTEIELNINEISIEDLIEEEEVVVTLT 511 
AAK77994.1     ILDLKLQRLTGLEREKIEDEYNELMKTIAELKSILADENKILAIIRDELNEIKAKYGDERKTAIERAENDIDIEDLIQEENVVITLT 508 
12708gyrA      IVDMRLRALTGLEREKLENEYQELMKQIRELKAILADRKLLLGVIKEEILIIRDKYGDERRTSIGFDEFDISMEDLIPKEDVVITMT 515 
 
 
ABW17577.1     HFGYIKRLPADTYKSQKRGGKGIAALTTREEDFVENLITSSSHDYLLFFTNFGRVYKLNVYEIPEARRQAKGTAIVNLIPLSPNETV 596 
EAT31502.1     HFGYIKRLPADTYKSQKRGGKGIAALTTREEDFVENLITSSSHDYLLFFTNFGRVYKLNVYEIPEARRQAKGTAIVNLIPLSPNETV 596 
NP_560923.1    HTGYIKRISSDVYSAQKRGGKGIQAMTTKEDDFVENVLVTSTHSNLLFFTTKGKVYKIKAYEVPDAGRTAKGTNLVNILPLEADEKI 595 
YP_001307153.1 HSGYIKRISADTYSSQRRGGKGIQAMSTKEDDFVEHLMITSTHSDVLFFTNKGRVYKLRAYEVHDAGRQAKGTNLINLIAIEPDEKI 595 
NP_780806.1    NSGYIKRISSDAYSSQKRGGKGIQAMTTKEDDFVERVFITSTHSDLLFFTNIGKVYKLKAYEIPEAGRTAKGTNIVNLLPVDANEHV 598 
AAK77994.1     HAGYIKRINADTYTSQKRGGRGIQAMTTKEDDFVENIFITSTHNNILFFTNKGRMYKLKAYQIPEAGRAAKGTNVVNLLQLDPNEKI 595 
12708gyrA      KLGYIKRMSHDTFKSQNRGGKGIKGMQTLKEDYVEELFMTHTHHYIMFFTNTGRVYRMKGYEIPEASRTSRGTAIVNLLQLMPGEKI 602 
 
 
ABW17577.1     AATIPVGRQFDSKYLVLATKNGIIKKTQLSQFESTRKSGLIAISIREDDELIKVKLTDEDSEIILITAQGMSIRFKEQDVRDMGRSA 683 
EAT31502.1     AATIPVGRQFDSKYLVLATKNGIIKKTQLSQFESTRKSGLIAISIREDDELIKVKLTDEDSEIILITAQGMSIRFKEQDVRDMGRSA 683 
NP_560923.1    QTVLSFKDVQEDGYLFMGTKLGIVKKTPLKDFKNIRKNGLIALNLREGDELLRAKITYGDADIIFVTQDGNAIRFNETDVRPMGRTA 682 
YP_001307153.1 QTVLTVTDEKKEGFLFMGTKQGIVKKTPLSEFKNLRKNGLIAISLKDGDELLKVKNTYGDANIMVVTQNGYAVKFNERDVRSMGRTA 682 
NP_780806.1    REVIALKKDLEEGYLIIGTKQGLIKKTSLNQFKNIRKNGIIAINLKDEDELLKVKVTRGDAEIIIVTQNGYAIRFSEKDVRPMGRNS 685 
AAK77994.1     QAVISIKEFDEESFLVMCTKKGIIKKTVVGMYKNIRKSGLIAINLNDDDELVSVRITKGDDDIIIVTNKGLAIRFNEVDVRPLGRNA 682 
12708gyrA      SAVIPIEEYKDGEYLFMATKKGLVKKTPITEYAHVRKTGLAAITLREEDELIEVKYTDNDRDVLLVTKYGQCIRFDEKDVRPTGRTS 689 
 
 
ABW17577.1     MGVKGINLSPKDHVVSMEIVEENKDLLVISEKGFGKRTDTSEYRLQTRGGKGIKTYNVTGKTGPLVGAKIVTDEDEVLLINNYGTVI 768   
EAT31502.1     MGVKGINLSPKDHVVSMEIVEENKDLLVISEKGFGKRTDTSEYRLQTRGGKGIKTYNVTGKTGPLVGAKIVTDEDEVLLINNYGTVI 768 
NP_560923.1    SGVKAISLREGDVAVCMDIAVEDEKLLVVSENGYGKRTNLDEYKVQNRGGIGLITYKVSDKTGKVVGATVCKEDDELMHYK------ 761 
YP_001307153.1 SGVKAINLKEDDIAVCMDIAVDGEELLVISENGYGKRTPIAEYKLQNRGGVGLITYKISEKTGKLAGATICKVDDELMLINSSGVAI 769 
NP_780806.1    TGVKAISLRKDDVAVSMDIVVEDEYVLTVTENGFGKRTLASEYTLQNRNGKGLITHRVTDKTGKIVSARVAKDSDELMLINSSNTAI 772 
AAK77994.1     LGVKGITLKEDDFVVGMEVPNQESDVLVVSENGFGKRTHVGEYKCQHRGGKGLITYKVSDKTGKLVGVRMVEDGDELMLINNLGIAI 769 
12708gyrA      MGVRGMNLADRDEVIGMQLDSQGCDLLIVSEKGMGKRTSIEEFTCQNRGGKGVKCYKITEKTGNVVGVKAVNHDDEVMIINTEGIII 776 
 
 
ABW17577.1     -------------------------------------------------------------    
EAT31502.1     RLNVSNISKLGRNTKGVTLMRMEEDQSIITIALMASTENEEVEEGLTEE------------ 819 
NP_560923.1    -------------------------------------------------------------     
YP_001307153.1 RINVADISVTSRSAMGVTLMRTNEDEKVVAIAKILSSDDQETESGDEA--ESESEINNIEE 828 
NP_780806.1    RICVSDVSITNRSAMGVTLMRTYEEEKILAIAKISSDEDSE-------------------- 813 
AAK77994.1     RINVSDISTTSRNAMGVTLMRNNGDEKVLALAKINKDDSEQLEDSEEVSEVHDAEENNSEE 830 
12708gyrA      RMKCEGISVLGRVTSGVKLINLQEGDIVASIAKVRKGDEEPIDSVEDTDEES--------- 828 
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 specificity against genomic DNA from their respective 
target species.   While preliminary studies suggest gyrA 
gene expression is not affected by bile acid induction, 
additional work must be done to verify the gyrA gene as an 
appropriate internal control for qRT-PCR.  This represents 
an important step toward development of a quantitative 
assay to measure bai gene expression in C. scindens VPI 
12708 and C. hylemonae TN271.  In addition, these probes 
have yet to be tested on C. hiranonis sp. strain TO931 
genomic DNA and may result in isolation of this gene from 
this organism as well.   
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Discussion 
The first life on earth evolved in an anoxic 
environment.  For several billion years, microorganisms 
have successfully exploited niches devoid of oxygen (196).  
In fact, it is interesting to note that one of the most 
densely inhabited environment on earth is the mammalian 
large intestine (>1011 bacteria/gram wet weight feces) 
(197, 198).   To put this in perspective, the adult human 
body contains an order of magnitude more prokaryotic cells 
(1014) than mammalian cells (1013).  The collective 
bacterial genomes (termed “microbiome”) of the human 
microflora encode an estimated 2-4 million genes, 
surpassing the human genome by a staggering 100-fold 
(199). Science continues to change the way we view 
ourselves, and our place in nature.  Advances in genomics 
and GI microbiology suggest that the human body should be 
regarded as a superorganism-a complex ecosystem composed 
of all three domains of life (eukaryote, prokaryote and 
archaea) balanced by selective pressures from both the 
top-down and the bottom-up (200).  
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 Intestinal bacteria and archaea can carry out 
hundreds, if not thousands, of enzymatic reactions not 
carried out by host cells.  Relman and Falkow (2001) have 
called for the task of sequencing this microbiome, which 
they have called ‘the second human genome project’ (201).   
Intestinal microbes actively metabolize molecules of 
endogenous and exogenous origin.  The products of this 
metabolism then interact with host cells with both 
beneficial and harmful consequences.  Bile acid metabolism 
represents a particularly important aspect of microbial 
metabolism of endogenous substrates due to enterohepatic 
circulation, which allows accumulation of bacterial 
products of bile acid metabolism.  Bile acids also 
represent a strong top-down selection pressure on 
potential colonizers (95).  A microbe must be prepared to 
cope with mmol concentrations of bile salts and bile 
acids. Bile resistance is a major factor used to screen 
potential “probiotic” species (202). In addition, numerous 
studies have shown that bile acids induce expression of 
virulence genes in intestinal pathogens (95). Host-microbe 
co-evolution has resulted in widespread acquisition of 
262
 bile-salt metabolizing enzymes in all major gut colonizing 
microbial species (See introduction) (95).   
Interestingly, it appears that genes involved in bile 
acid 7α/β-dehydroxylation are found in the tiniest 
fraction of Firmicutes classified within various clusters 
of the heterogenous genus Clostridium (189). 7α-
dehydration of bile acids represents a microbial pathway 
which may significantly alter host physiology. Bile acids, 
once regarded as simple detergents involved in lipid 
digestion, are now recognized as potent signaling 
molecules (203). A full understanding of the biology and 
biochemistry of bile acid metabolism by intestinal 
bacteria represents an important and challenging area of 
research.  The current work represents a significant step 
in understanding the biochemistry of bile acid 7α/β-
dehydroxylation by intestinal clostridia. 
The current work provides strong evidence that the 
baiCD and baiH gene products encode NAD+-dependent 3-oxo-
Δ4-cholenoic acid oxidoreductases recognizing 7α-hydroxy 
and 7β-hydroxy bile acids, respectively (Figure 5).  
Previously, we demonstrated loss of the 5β-hydrogen during 
7α-dehydroxylation of [5β-3H] + [24-14C]-CA both in vivo 
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 and from cell extracts of CA induced C. scindens whole 
cells suggesting introduction of a C4-C5 double-bond (118).  
Addition of [24-14C] 3-oxo-Δ4-cholenoic acid to CA induced 
whole cells and cell-extracts of C. scindens VPI 12708 
resulted in conversion to [24-14C] DCA (117).  Subsequent 
studies elucidated the first two steps of the bile acid 
7α/β-dehydroxylation pathway; CoA ligation (125) and 
oxidation of the 3α-hydroxy group producing a 3-dehydro-
CA-CoA intermediate (58). Collectively, these data 
suggested the presence of an enzyme catalyzing the region-
selective oxidation at C4-C5 yielding a 3-dehydro-Δ4-CA-CoA 
intermediate. Others have speculated that the baiH and 
baiCD genes were involved in C-C double bond 
oxidation/reduction based on homology to enzymes with 
similar function (204, 205).  The fact that there are two 
homologous flavin oxidoreductases of similar Mr (70-72 kDa) 
with 32 % identity and 46 % similarity that are co-
expressed from a bai operon suggests a possible similar 
function.   
This hypothesis was tested by incubation of a crude 
cell extract of E. coli overexpressing the baiCD gene with 
[24-14C] 3-dehydro-UDCA or [24-14C] 3-dehydro-CDCA, and 
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 indeed the reaction yielded a 3-dehydro-Δ4-CDCA metabolite 
as suggested by mass spectrometry (Figure 19).  3-dehydro-
UDCA did not appear to be a substrate of the baiCD gene 
product.  Bile acid 7α-hydroxy groups are axial while 7β-
hydroxy groups are equatorial.  These data suggest that 
the key to substrate recognition between the baiCD and 
baiH is the stereochemistry of the 7-hydroxy group, whose 
orientation apparently requires a different architecture 
in the substrate binding pocket. Taken together these 
results suggest these homologous enzymes act at an 
analogous step in the 7-dehydroxylation pathway, and 
therefore, two distinct branches of the oxidative arm of 
the pathway exist in C. scindens and C. hiranonis.   
The BaiH is a homotrimer composed of 72 kDa subunits, 
each subunit containing 1 mol of FMN and 1 mol of FAD per 
subunit.  BaiH is homologous to a class of flavoenzymes 
involved in reduction of unsaturated fatty acids and 
aldehydes (Table 2) (129).  Enoate reductase (enr) from 
Clostridium tyrobutyricum catalyzes the reduction of C-C 
double bonds of several α/β-unsaturated aldehydes as well 
as cyclic ketones and methylketones (184). Enr is a 
dodecamer with subunit Mr of 73 kDa each containing a 4Fe-
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 4S cluster and 1 mol of FMN and 1 mol of FAD (206).  2, 4-
dienoyl-CoA reductase from E. coli is a 73 kDa monomeric 
enzyme that reduces C-C double bonds with NADPH and 
contains FMN, FAD as well as a 4Fe-4S cluster (182, 207).  
The noxB gene from Archaeoglobus fulgidus encodes an NADH 
oxidase of unknown physiological function (204).  The noxB 
gene product is a 69 kDa monomer containing 1 mol FAD and 
shares the same conserved ferrodoxin domain (C-2X-C-2-3X-
C-11-12X-C) with each of these proteins including the baiH 
and baiCD gene products (204). The noxB-2 gene shares 98.9 
% identity with the noxB-1 gene from A. fulgidus and is 
found upstream of medium-chain acyl-CoA ligase in this 
bacterium suggesting these genes are also involved in 
fatty acid metabolism (204).  The more distantly related 
Old Yellow Enzyme (OYE) family homologues are found both 
in eukaryotes such as Saccaromyces cerevisiae (OYE1, OYE2) 
(205) and S. carlsbergensis (OYE1) (208), as well as the 
prokaryotes including Bacillus subtilis (YqjM) (209), and 
Shewanella oneidensis (SYE1-SYE4) (210).  OYE genes have 
been extensively characterized both biochemically and 
structurally (206, 209, 211).  Numerous compounds act as 
electron acceptors including various quinones, as well as 
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 α, β-unsaturated aldehydes and ketones which are reduced 
at the olefinic bond (211); however, only recently have 
physiologically relevant electron acceptors been 
identified.  The oye2 and oye3 gene from Sac. cerevisiae, 
sye1 from She. oneidensis, and the yqjM gene from B. 
subtilis were shown to be inducible by small α/β-
unsaturated aldehydes during oxidative stress responses to 
lipid peroxidation (186, 210, 212) and actin cytoskeletal 
oxidative damage in yeast (213).  Detoxification does not 
appear to be the function of the bile acid 7α/β-
dehydroxylating pathways, but rather the substrates appear 
to serve as electron sinks to enhance fermentation (95).  
 Electron flow in the E. coli DCR as determined by 
redox titrations (214), and crystallography (182) show 
that two reducing equivalents are supplied to FAD by 
direct hydride transfer and follow an electron flow from 
FAD to a 4Fe-4S cluster to FMN and finally to the oxidized 
substrate.  OYEs reduce C=C double bonds through a ping-
pong bi-bi mechanism in which FMN is reduced by NADPH, 
followed by substrate binding and hydride transfer from 
FMNH2 to the Cβ carbon of the substrate (215).  Additional 
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 studies will be required to determine the mechanism of the 
reaction catalyzed by the baiCD and baiH gene products.  
We observed low NAD(H)-dependent 3-oxo-Δ4-cholenoic 
acid oxidoreductase activity based on the amount of 
products formed, as observed by autoradiography of TLC 
(Figure 16). However, we would predict that the 
physiological substrates for these enzymes are the CoA 
conjugates of 3-oxo-cholanoic acids.  This is based on the 
observations that the baiA gene product encodes a 3α-
hydroxysteroid dehydrogenase that has high specificity for 
coenzyme A conjugated bile acids (58).   However, large 
quantities of the CoA derivatives of 3-dehydro-CDCA and 3-
dehydro-UDCA will have to be chemically synthesized to 
test this hypothesis.  In this regard, we have detected 
NAD(H)-dependent 3-oxo-Δ4-cholenoic acid oxidoreductase 
activity using small quantities of enzymatically generated 
radiolabeled CoA conjugates of 3-dehydro-UDCA and 3-
dehydro-CDCA (D. Kang, J.M. Ridlon, and P.B. Hylemon, 
unpublished data).  Moreover, other members of this gene 
family recognize substrates linked to CoA (Table II).  
Future mechanistic and structural studies will require 
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 chemical synthesis of CoA conjugated bile acid 
intermediates.   
This is the first report of a gene product 
specifically involved in 7β-dehydroxylation of UDCA.  We 
predict that the baiI gene encodes a bile acid 7β-
dehydratase, based on its amino acid sequence identity (20 
%) and similarity (40 %) with the baiE gene product as 
well as co-expression of this gene product during CA 
induction in C. scindens VPI. We have previously 
demonstrated that the baiE gene encodes a bile acid 7α-
dehydratase (128).  Determining the function of the baiI 
as well as identifying genes involved in reducing the 3-
oxo-4, 6-choladienoic structure to LCA will be the focus 
of future of research.  
In summary, these data indicate that the baiCD and 
baiH genes encode NAD(H)-dependent 3-oxo-Δ4-cholenoic acid 
oxidoreductases.  These results can account for the 
ability of this organism to use UDCA as a substrate for 
7β-dehydroxylation, and provide additional support for 
formation of a 3-oxo-Δ4-cholenoic acid intermediate during 
bile acid 7-dehydroxylation. 
269
 Doerner et al (1997) demonstrated that 7α/β-
dehydroxylating bacteria cluster into two groups based on 
relative rates of conversion of CA to DCA (189).  Our 
current understanding of the molecular biology and 
enzymology of bile acid 7α/β-dehydroxylation come from 
study of C. scindens VPI 12708 and C. hiranonis sp. strain 
TO931 which are “high activity strains” (1-7 nmol mg-1 h-1).   
Genes involved in bile acid 7α/β-dehydroxylation have not 
been identified in a “low activity” strain (0.05-0.16 nmol 
mg-1 h-1).  Wells et al. (2003) detected the baiCD gene from 
the low activity strain C. hylemonae TN271 which 
facilitated design of bidirectional genome-walking PCR 
primers (106).  The genome-walking by PCR technique is 
useful for amplification of unknown stretches of DNA 
provided at least a small amount of adjacent sequence data 
is available for design of gene specific primers.  Adaptor 
sequences are engineered and ligated to restriction 
libraries of total genomic DNA.  These adaptor molecules 
provide the second stretch of known sequence, allowing PCR 
amplification between adaptor-specific and gene-specific 
primers (216). PCR products up to ~4 kb were obtained in 
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 this study, with an average of 2 kb using a starting 
genomic template >48 kb (Figure 21).   
 Two upstream genome-walking PCR products (Figures 22, 
23) and three downstream genome-walking PCR products 
(Figures 28, 30, 31) were cloned, sequenced and assembled, 
along with the partial baiCD gene into a single contiguous 
sequence of ~9.5 kb.  ORFs were identified by the ORF 
Finder program and BLAST searches were used to determine 
the putative function of these ORFs.  The gene 
organization of the baiBCDEFGHI operon from C. hylemonae 
TN271 was almost identical to the baiBCDEAFGHI operon from 
C. scindens VPI 12708 (Figure 32).  Table 7 compares both 
nucleotide and amino acid sequence identity/similarity 
between bai genes from C. hylemonae TN271 and C. scindens 
VPI 12708.  Nucleotide sequence identity was >65% and 
amino acid sequence identities ranging from 61.4 to 88% 
with similarity ranging from 76.6% to 94.8%.   The 
upstream putative “promoter” regions were also found to be 
highly conserved along with relative location of TIS 
(Figures 24, 25).  Finally, a conserved transcriptional 
regulator of the AraC/XylS family (barA) was located 
upstream of the C. hylemonae TN271 baiB gene and 
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 “promoter” region on the antisense strand (Figures 27, 
32).  It is unclear at present the reason for the 10 fold 
difference in levels of bile acid 7α-dehydroxylating 
activity between C. hylemonae TN271 and “high activity” 
strains.  However, it is very likely that this regulation 
is at the transcriptional level.  Indeed, design of qRT-
PCR oligonucleotides against genes in the baiBCDE(A)FGHI 
operons from C. hylemonae and C. scindens VPI 12708 and 
quantitation of message following bile acid induction 
should provide the relevant information.  Isolation and 
sequencing of the gyrA gene in the current study and 
current genomic data for Clostridium scindens will allow 
normalization of qRT-PCR results.  Finally, it is 
interesting to note that C. hylemonae TN271, despite 
having a baiH and baiI gene, were unable to 7β-
dehydroxylate UDCA over a 30 min or overnight incubation 
following induction by CA (Figure 33).  It is unclear at 
present the reason for this loss-of-function.  
Importantly, this data represents the first 
characterization of bai genes from a “low activity” 7α-
dehydroxylating bacterium.    
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  The baiA gene from C. hylemonae TN271 was isolated by 
PCR amplification using redundant oligonucleotides whose 
design was based on a nucleotide multiple sequence 
alignment of baiA genes isolated from C. scindens VPI 
12708 and C. hiranonis sp. strain TO931 (Figures 34, 35, 
37).  5’ SMART RACE PCR analysis of the baiA transcript 
revealed a TIS 56 bp upstream of the baiA gene and 
downstream of the putative bai promoter region (Figure 
36).  Gopal-Srivastava et al (1990) identified multiple 
copies of the baiA gene in C. scindens VPI 12708, two of 
which were monocistrons with conserved bai “promoters” 
(67).   
 Completion of the baiA gene sequence, facilitated by 
bidirectional genome-walking from the partial sequence 
obtained with primers baiA271F and baiA271R (Table 8) 
resulted in isolation of genes with predicted function 
suggested to be involved in bile acid 7α/β-
dehydroxylation.  In silico (ORF Finder, BLAST) analysis 
upstream of the baiA gene revealed a deduced 26 kDa short 
chain dehydrogenase/reductase (baiL), a 49.5 kDa baiF 
homologue (baiK) and a putative 62 kDa 3-keto-steroid Δ1-
dehydrogenase (baiJ).  Upstream of the baiJ gene was a 
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 conserved bai “promoter” region (Figure 44).  5’ SMART 
RACE analysis suggests the TIS is at the very 5’ end of 
this conserved region whle the TIS is downstream of this 
conserved region in the baiB and baiA operons of both C. 
scindens VPI 12708 and C. hylemonae TN271 (Figure 45).  
This would suggest that the baiJ promoter is upstream of 
this conserved region.  
In order to determine whether these novel genes were 
conserved in C. scindens VPI 12708, the baiJKL genes from 
C. hylemonae were analysed for 7-8 amino acid stretches of 
low codon degeneracy (Figures 46, 47).  A region within 
the baiJ gene allowed design of redundant oligonucleotides 
which allowed isolation of a partial baiJ gene from C. 
scindens VPI 12708.  Several upstream and downstream 
genome-walks resulted in identification of the baiJKL 
genes in C. scindens VPI 12708 which were highly conserved 
both in sequence and organization to the baiJKL genes from 
C. hylemonae TN271 (Figure 56).  Elucidation of the TIS 
for the baiJ gene provided similar results to those 
obtained for TIS of the baiJ gene from C. hylemonae in 
respect to the upstream position relative to the conserved 
“promoter” region identified previously for the baiB and 
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 baiA genes from C. scindens VPI 12708 (124, 191), 
Clostridium hiranonis sp. strain TO931 (59) and here for 
the baiB gene of Clostridium hylemonae TN271 (Figure 26).  
This brings into question whether this conserved region is 
indeed a bile acid inducible promoter rather than a 
repressor or operator sequence.  Figure 73 is a Weblogo 
representation of a CLUSTALW alignment of these conserved 
upstream regions between C. scindens VPI 12708, C. 
hiranonas sp. strain TO931 and C. hylemonae TN271. Further 
experimental work is necessary to determine the function 
of these regions. 
A particularly interesting find in this study is a 
predicted Type III CoA transferase which appears to share 
a common evolutionary history with the baiF gene (Figure 
42). This gene has been given the preliminary name baiK 
(Figure 58). Alignment of characterized type III CoA 
transferases such as the crotonoyl-CoA (caiB) and yfdW 
gene products from E. coli as well as the formyl CoA 
transferase from Oxalobacter formigenes with the baiF and 
baiK gene products from C. scindens VPI 12708 and C. 
hylemonae TN271 demonstrates a remarkable degree of 
conservation (Figure 74).  Numerous authors have 
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Figure 73.  Logo representation of bai promoter regions 
from Clostridium scindens VPI 12708, 
Clostridium hiranonis sp. strain TO931 and 
Clostridium hylemonae TN271.   Promoter 
sequences from Figure 24 and Figure 49 were 
aligned using T-COFFEE and FASTA format was 
run in the Weblogo program 
(http://weblogo.berkeley.edu/).  Large 
letters represent based of potential 
biological relevance to promoter function.    
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Figure 74.  Boxshade alignment of baiF and baiK genes 
from C. scindens VPI 12708 and C. hylemonae 
TN271 with homologues in the Type III CoA 
transferase family. Proteins used in 
alignment include: E. coli Crotonobetainyl-
CoA:carnitine CoA-transferase (CaiB) ( 
P31572), E. coli Formyl-CoA transferase 
(YfdWA) (P69902), Oxalobacter formigenes 
formyl-CoA transferase (fCTOx) (AAC45298).                
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                                  *   ** 
12708baiK   MKGTGLNNFPQFGVMEGVKILVCGGAIAGPFGATLLGEIGAEVVHFESPKNPDSVRGHYG  61 
TN271baiK   MEGTGLNNFPQFGVLAGVKILVCGGAIAGPFGATLLGEIGAEVVHLESPKNPDSTRGHYG  61 
12708baiF   --MAGIKDFPKFGALAGLKILDSGSNIAGPLGGGLLAECGATVIHFEGPKKPDNQRGWYG  59 
TN271baiF   --MAGLKDFPSFGALAGLKILDSGSNIAGPLGGGLLSECGATVIHFEGPKKPDNQRGWYG  59 
caiBEco     ---MDHLPMPKFGPLAGLRVVFSGIEIAGPFAGQMFAEWGAEVIWIENVAWADTIRVQPN  58 
YfdwA       ----------MSTPLQGIKVLDFTGVQSGPSCTQMLAWFGADVIKIERPGVGDVTRHQLR  51 
fCTOx       ----------MTKPLDGINVLDFTHVQAGPACTQMMGFLGANVIKIERRGSGDMTRGWLQ  51 
 
                                    *                      *     ** 
12708baiK   --------YSQN-HRNQLSMVADMKTPEGLEIFKKLIKWTDIFIESSKGGTYEKMGLTDE 111 
TN271baiK   --------YSQN-HRNQISMVADMKTPEGLEIFKKLIKWTDIFIESSKGGTYEKMGLTDE 111 
12708baiF   --------YPQN-HRNQLSMVADIKSEEGRKIFLDLIKWADIWVESSKGGQYDRLGLSDE 109 
TN271baiF   --------YPQN-HRNQLSMVADIKTEEGREIFMKLIKWADIWVESSKGGQYDRLGLSDE 109 
caiBEco     --------YPQLSRRNLHALSLNIFKDEGREAFLKLMETTDIFIEASKGPAFARRGITDE 109 
YfdwA       DIPDIDALYFTMLNSNKRSIELNTKTAEGKEVMEKLIREADILVENFHPGAIDHMGFTWE 110 
fCTOx       DKPNVDSLYFTMFNCNKRSIELDMKTPEGKELLEQMIKKADVMVENFGPGALDRMGFTWE 110 
 
                                          * 
12708baiK   VLWEINPRLAIVHVSGFGQTGVPEYIDRASYDAVGQAFSGYMSFNGTPKEAMKVS-PYLS 170 
TN271baiK   VLWEVNPGLVIVHVSGFGQTGVPEYISRASYDAVGQAFSGYMSFNGTPKEALKIS-PYLS 170 
12708baiF   VIWEVNPKIAIVHVSGYGQTGDPSYVTRASYDAVGQAFSGYMSLNGT-TEALKIN-PYLS 167 
TN271baiF   EIFKVNPKIAIVHVSGYGQTGDPSYVTRASYDAVGQAFSGYMSLNGT-TEALKTN-PYLS 167 
caiBEco     VLWQHNPKLVIAHLSGFGQYGTEEYTNLPAYNTIAQAFSGYLIQNGDVDQPMPAF-PYTA 168 
YfdwA       HIQEINPRLIFGSIKGFDEC--SPYVNVKAYENVAQAAGGAASTTGFWDGPPLVSAAALG 168 
fCTOx       YIQELNPRVILASVKGYAEG--HANEHLKVYENVAQCSGGAAATTGFWDGPPTVSGAALG 168 
 
            † 
12708baiK   DYVTALNTCWTALAAYVHVLRTGKGESVDVAQYESLARILDTRPMEYFTDGKE------- 223 
TN271baiK   DYVTALNTCWTALAAYVHVLRTGRGEAVDVAQYESLARILDTRPIEYFTDGKE------- 223 
12708baiF   DFVCGLTTCWAMLACYVSTILTGKGESVDVAQYEALARIMDGRMIQYATDGVK------- 220 
TN271baiF   DFVCGLTTCWAMLACYVSTVLTGKGESVDIAQYEALARIMDGRVMQFATDGVK------- 220 
caiBEco     DYFSGLTATTAALAALHKVRETGKGESIDIAMYEVMLRMGQYFMMDYFNGGEM------- 221   
YfdwA       DSNTGMHLLIGLLAALLHREKTGRGQRVTMSMQDAVLNLCRVKLRDQQRLDKLGYLEEYP 228   
fCTOx       DSNSGMHLMIGILAALEMRHKTGRGQKVAVAMQDAVLNLVRIKLRDQQRLERTGILAEYP 228 
 
 
12708baiK   ----------------------FPRTGN-KDTQAALFSFYTCKDGGEIFIGMNGYGPVRR 260 
TN271baiK   ----------------------FPRTGN-KDSQAALFSFYTCKDGGTIFIGMNGYGPVHR 260 
12708baiF   ----------------------MPRTGN-KDAQAALFSFYTCKDGRTIFIGMTGAEVCKR 257 
TN271baiF   ----------------------VPRTGN-KDGQAALFSFYTCKDGRTIFIGMTGAEVCKR 257 
caiBEco     ----------------------CPRMSKGKDPYYAGCGLYKCADG-YIVMELVGITQIEE 258 
YfdwA       QY-PNGTFG-----------DAVPRGGN-AGGGGQPGWILKCKGWETDPNAYIYFTIQEQ 275 
fCTOx       QAQPNFAFDRDGNPLSFDNITSVPRGGN-AGGGGQPGWMLKCKGWETDADSYVYFTIAAN 287 
 
 
12708baiK   GYPLIGLPKPGDGDPEIDEILSG-WMADTDLGRRLEAAMEKFVSEHTVDEVEKIMLENQI 319 
TN271baiK   GYPLIGLPKPGDGDPEIDQIISG-WMADTDLGRRLEAAMEKFVSEHTVDEVEKIMLENQI 319 
12708baiF   GFPIIGLPVPGTGDPDFPEGFTG-WMIYTPVGQRMEKAMEKYVSEHTMEEVEAEMQAHQI 316 
TN271baiF   GFPIIGLPQPGSGDPDFPEGFTG-WLIDSPVGRRMEAAMEKYVSEHTMEEVEAVMQENQI 316 
caiBEco     CFKDIGLAHL-LGTPEIPEGTQLIHRIECPYGPLVEEKLDAWLATHTIAEVKERFAELNI 317 
YfdwA       NWENTCKAIGKPEWITDPAYSTAHARQPHIFD--IFAEIEKYTVTIDKHEAVAYLTQFDI 333 
fCTOx       MWPQICDMIDKPEWKDDPAYNTFEGRVDKLMD--IFSFIETKFADKDKFEVTEWAAQYGI 345 
 
 
12708baiK   PCLKVYTLKDCAKDPHWKARDIFVEWDDPMMGRVKGLGIINKWKNNPGEIKWGAPLFGEN 379 
TN271baiK   PCQKVYSLEDCVRDPHWKAREIFTEWDDPMMGRVKGIGIVNKWKNNPGEIKWGAPLFGEN 379 
12708baiF   PCQRVYELEDCLNDPHWKARGTITEWDDPMMGHITGLGLINKFKRNPSEIWRGAPLFGMD 376 
TN271baiF   PCQRVYELEDCISDPHWIARETITEWDDPMLGHVTGLGLINKFKNNPSKIWRGAPLFGMD 376 
caiBEco     ACAKVLTVPELESNPQYVARESITQWQTMDGRTCKGPNIMPKFKNNPGQIWRGMPSHGMD 377 
YfdwA       PCAPVLSMKEISLDPSLRQSGSVVEVEQPLRGKYLTVGCPMKFSAFTPDIKA-APLLGEH 392    
fCTOx       PCGPVMSMKELAHDPSLQKVGTVVEVVDEIRGNHLTVGAPFKFSGFQPEITR-APLLGEH 404 
 
 
12708baiK   NEEVLKDLGYTEEEIEDFAKRGITASFDFDQTY 
TN271baiK   NKEVLRDLGYTEEETEDLARRGITACLDFEQTY 
12708baiF   NRDILKDLGYDDAKIDELYEQGIVNEFDLDTTI 
TN271baiF   NRDILRDLGYTDEEIDGLYEKGITNEFDRETTI 
caiBEco     TAAILKNIGYSENDIQELVSKGLAKVED----- 
YfdwA       TAAVLQELGYSDDEIAAMKQNHAI--------- 
fCTOx       TDEVLKELGLDDAKIKELHAKQVV--------- 
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 speculated that CoA transfer proceeds through Asp169 
acylation (217-219). Mutagenesis of Asp169 (D169A, D169S, 
D169E) in the formyl-CoA transferase (FRC) from 
O.formigenes resulted in abolition of, or appreciable 
decrease in specific activity despite no significant 
structural alterations (217).  The proposed catalytic 
mechanism for the FCR suggests that formyl-CoA forms an 
acid anhydride with Asp169 resulting in elimination of -
SCoA.  The second substrate, oxalate, then 
nucleophilically attacks the Asp169-formate anhydride 
resulting in release of formate and formation of Asp169-
oxalate anhydride.  The anion –SCoA then attacks the 
carbonyl carbon of oxalate resulting in release of oxalyl-
CoA and regeneration of Asp169 (217).  Asp169 is conserved in 
the baiF and baiK genes of C. scindens VPI 12708 and C. 
hylemonae TN271 suggesting that these proteins act through 
a similar mechanism (Figure 74).  Crystallization with 
CaiB yielded crystals with only CoA bound suggesting 
hydrolysis occurs in the absence of the CoA accepting 
substrates (220).   This would provide a plausible 
explanation for observed CoA hydrolase activity shown for 
the baiF gene product in the absence of co-substrate 
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 (130).  We speculate that a similar mechanism is involved 
in bile acid CoA transfer by the baiF and possibly the 
baiK genes to that proposed for the FRC.  Isolation of a 
3-oxo-Δ4-DCA~CoA intermediate from cell extracts of cholic 
acid induced cultures of C. scindens VPI 12708 would 
suggest that CoA transfer would occur at this step or 
possibly following formation of 3-oxo-DCA or DCA.  
Therefore, these three metabolites would substitute for 
formate in the FRC model and cholyl-CoA would substitute 
for oxalate in the FRC model.  
There are several gene homologues in the oxidative 
arm of the 7α/β-dehydroxylation pathway performing a 
similar function but recognizing a distinct stereoisomer.  
Indeed, in the present work, the baiCD and baiH gene 
products were shown to act as 3-oxo-Δ4-steroid 
oxidoreductases recognizing 7α-hydroxy and 7β-hydroxy bile 
acids, respectively.  Additionally, the baiE was shown to 
7α-dehydrate bile acids while the baiI is predicted to 7β-
dehydrate bile acids.  In each case, stereospecificity is 
directed at the orientation of the 7-hydroxyl group.  
However, in the reductive arm of the 7α/β-dehydroxylation 
the only differences include hydroxylation at C12, and 
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 stereochemical differences about the A/B ring.  Assuming 
the baiK gene is involved in bile acid CoA transfer, there 
are a few possibilities: (1) one transferase recognizes 
LCA (not hydroxylated at C12) while the other recognizes 
DCA (hydroxylated at C12) (2) one transferase recognizes 
DCA and LCA (A/B ring in “cis” orientation) while the 
other transferase recognizes alloDCA and alloLCA (A/B ring 
in “trans” orientation) (3) both transferases recognize 
the same substrate(s); similar to the multiple copies of 
the baiA genes (124). Testing these possibilities will 
require acquisition of alloDCA (not available 
commercially; highly concentrated in rabbit gallstones 
(221)) and synthesis of 3-oxo-alloDCA(~SCoA).  
The baiL gene is predicted to encode a 3-keto-acyl 
reductase, similar in function to the baiA gene.  The 
predicted function in terms of bile acid 7α-
dehydroxylation is NAD(P)H dependent 3α-hydroxysteroid 
dehydrogenation resulting in DCA and LCA.  An attempt was 
made to overexpress the baiL gene in E. coli as a hexa-
histidine tagged fusion protein.  Unfortunately, and 
often, the production of biologically active recombinant 
proteins is prevented by the formation of insoluble 
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 inclusion bodies.  Numerous variables were modified to 
improve solubility including decreased temperature, IPTG 
concentration, different media, various host strains, and 
vectors.  However, while the protein was highly expressed, 
I was unable to detect soluble BaiL by Western immunoblot 
or NAD(P)-dependent 3α-HSDH activity against DCA.  It may 
be necessary to experiment with additional fusion tags, 
further decrease in temperature, or attempt expression in 
a different host.  Shuttle vectors have been developed 
between E. coli and gram-positive bacterial genera 
including Clostridium (222).  
    The baiJ gene is predicted to encode a 62 kDa 
flavoprotein similar to fumarate reductase and 3-
ketosteroid-Δ1-dehydrogenases.  Alignment of the baiJ gene 
product with the fumarate reductase from Shewanella 
putrefaciens MR-1, whose structure has been elucidated, 
suggests the similarity between these proteins is in the 
Rossman fold of the FAD-binding motif.  The BaiJ lacks the 
cytochrome domain containing four conserved heme-binding 
sites common to fumarate reductases (CXXCH) and there was 
no conservation of active-site amino acids (data not 
shown).  The baiJ gene was cloned into a pT7-SBP-2 vector 
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 containing an N-terminal Streptavidin Binding Peptide 
(SBP) fusion tag.  IPTG induced overexpression of the BaiJ 
polypeptide resulted in a soluble protein ~64 kDa which 
was detected by anti-SBP antibody (Figure 66).  Initial 
characterization of the enzyme with radiolabelled 3-oxo-
DCA and 3-oxo-DCA-CoA resulted in three products formed 
when NADP was used as co-substrate.  The two hydrophobic 
products were also detected when NAD+ was co-substrate.  A 
substrate of greater hydrophilicity than DCA was detected 
in the presence of NADP.  This class of enzyme is 
predicted to metabolize C=C double bonds.  This 
hydrophilic product is puzzling because the migration 
suggests the 3-oxo group has been reduced.  Further, the 
reduced migration may indicate oxidation of the bile acid 
structure as there is no other source of reducing 
equivalents.  It is possible that a double bond is being 
introduced in the side-chain of the steroid rings.  
Indeed, Δ22-bile acids have been identified in rats (223). 
Additional studies will be required to determine the 
identity of these bile acid metabolites.  These findings 
may indicate a novel bile acid metabolic activity in C. 
scindens VPI 12708.   
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  Future studies may include determining which genes 
are co-transcribed in both the baiBCDEFGHI and baiJKL 
operons from C. hylemonae TN271 and the baiJKLM operon 
from C. scindens VPI 12708.  A sensitive method for 
determining this would be PCR amplification of cDNA 
fragments containing intergenic regions between adjacent 
ORF’s.  Additionally, attempts to isolate bai genes from 
C. leptum and C. sordellii using degenerate 
oligonucleotides based on conserved regions in the 
oxidative bai genes from C. scindens VPI 12708, C. 
hylemonae TN271 and C. hiranonis sp. strain TO931 have 
failed (Ridlon JM and Hylemon PB, unpublished data).  It 
would be interesting to try and design degenerate 
oligonucleotides to isolate the baiJKL genes, if present, 
in C. leptum. This group of “low activity” organisms was 
not detected by Southern blot (189) or by PCR using 
primers against the baiCD gene (106).  Isolation of bai 
genes from this organism could allow design of gene probes 
which could be used to quantify levels of a wide group of 
known 7α-dehydroxylating bacteria.  Additionally, large-
scale metagenomic sequencing will provide a wealth of 
information which will, in the future, allow in silico 
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 mining of putative bai genes.  Another study of interest 
would be to determine whether the baiF and baiK genes 
encode bile acid CoA transferases, and determine 
physiological substrate(s) through kinetic analysis.  The 
limiting factor in such a study is chemical synthesis of 
numerous bile acid intermediates as both free acids and 
CoA conjugates. In addition, comparison of wild-type 
proteins with site-directed mutagenesis of Asp169 would 
provide additional evidence for a common mechanism of the 
baiF and baiK with that of the FRC protein.   
 Finally, the major aim of research into bile acid 7α-
dehydroxylation is to identify targets for development of 
specific inhibitors aimed at lowering 7α-dehydroxylation, 
and thus secondary bile acids in individuals with high 
levels (Figure 11).  A particularly interesting gene was 
located upstream of the baiJKL genes and directly 
downstream, and on the opposite strand relative to the 
baiA gene in C. scindens VPI 12708 (Figure 58). The ORF 
encodes a protein similar to the TspO/MBR family of cell 
surface sensors.  TspO, or Tryptophan Rich Sensory 
protein, is a negative regulator of photosynthesis in 
response to light/oxygen.  The tryptophan rich region acts 
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 as part of a hydrophobic pore that acts in pumping 
porphyrin across the cell wall.  Could it be that this 
protein, in 7α-dehydroxylating bacteria, may be involved 
in regulation of 7α-dehydroxylating gene expression and 
efflux of hydrophobic secondary bile acids from the cell?  
MBR, or mitochondrial peripheral benzodiazepine receptor, 
has been shown to substitute for bacterial TspO (224) and 
is thought to function in cholesterol transport across the 
mitochondrial membrane.  If this gene product could be 
shown to regulate bile acid repression/efflux, this could 
serve as potential drug target; particularly because this 
polypeptide is predicted to be located in the outer 
membrane.  Also, an ABC transport protein was located 
directly downstream of the baiL gene; possibly co-
transcribed.  This suggests that this polypeptide may be 
involved in efflux of secondary bile acids.  ABC 
transporters have been targeted for chemotherapy due to 
their ability to transport antibiotics and other 
cytotoxins from the cell (225).  This protein, if involved 
in bile acid efflux, may serve as a potential drug target.  
A possible approach for studying the function of these 
genes is insertional inactivation.  Recently, a new vector 
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 has been developed specifically for insertional 
inactivation of clostridial genes, which has been named 
ClosTron (226).  Phenotypic tests could be performed in 
the presence and absence of bile acids.  Ultimately, a 
goal for future research will be to identify a target for 
drug development to lower secondary bile acid production 
in patients with high levels of these cytotoxic, and co-
carcingenic metabolites produced by the human microbiome.
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